JAX Mouse Strain Datasheet - 002207

B6.129S7-Ldlr^tm1Her/J

Stock No:: 002207 |; Ldlr KO

Readily Available

Overview

Also Known As: Ldlr KO

Mice homozygous for the Ldlr^tm1Her mutation have an elevated serum cholesterol level of 200-400 mg/dl and they have very high levels (>2,000 mg/dl) when fed a high fat diet. Normal serum cholesterol in the mouse is 80-100 mg/dl.

Donating Investigator

IMR Colony, The Jackson Laboratory

Genetic overview

Genetic Background	Generation
000664 C57BL/6J	N13F17 (05-AUG-14)

Ldlr^tm1Her

Allele Type	Gene Symbol	Gene Name
Targeted (Null/Knockout)	Ldlr	low density lipoprotein receptor

View Genetics

Research Applications

Diabetes and Obesity Research
Cardiovascular Research
Metabolism Research

View All Research Applications

Base Price

Starting at:

$122.11 Domestic price for female 3-week

View Price List

Details

Detailed Description

Development

The Ldlr^tm1Her mutant strain was developed in the laboratory of Dr. Robert Hammer and Dr. Joachim Herz at the Howard Hughes Medical Institute Research Laboratories, University of Texas Southwestern Medical Center at Dallas. The 129-derived AB1 ES cell line was used. The strain has been backcrossed to C57BL/6J mice for 10 generations (N10).

Control Suggestions

000664 C57BL/6J

Additional Information

Considerations for Choosing Controls

Selected References

Ishibashi S; Brown MS; Goldstein JL; Gerard RD; Hammer RE; Herz J. 1993. Hypercholesterolemia in low density lipoprotein receptor knockout mice and its reversal by adenovirus-mediated gene delivery [see comments] J Clin Invest 92(2):883-93. PubMed: 8349823 MGI: J:37394

View All References

Genetics

Ldlr^tm1Her

Allele Symbol: Ldlr^tm1Her

Allele Name	targeted mutation 1, Joachim Herz
Allele Type	Targeted (Null/Knockout)
Allele Synonym(s)	LDLR KO; LDLR-; LDLr-KO; LDLr0; LDLrKO; Ldlrtm1Her
Gene Symbol and Name	Ldlr, low density lipoprotein receptor
Gene Synonym(s)	FH; FHC; LDLCQ2; LDLRA
Site of Expression	Immunoblot analysis of liver membranes detected a truncated protein in homozygous mutant animals.
Strain of Origin	129S7/SvEvBrd-Hprt<+>
Chromosome	9
General Note	When used in bone marrow transplant into Ldlr^tm1Her homozygous mice, Abca1^tm1Jdm Abcg1^tm1Dgen homozygous cells accelerate the development of atherosclerosis. (J:130777) Phenotypic Similarity to Human Syndrome: Atherosclerosis, Susceptibility to J:29950, J:225091 in mice fed a high-cholesterol diet.
Molecular Note	Insertion of a neomycin resistance cassette into exon 4. The authors predict that the targeted allele would encode a truncated non-functional protein that will not bind LDL, and that lacks a membrane spanning segment. Immunoblot analysis of liver membranes detected a truncated protein in homozygous mutant animals.
Mutations Made By	Dr. Joachim Herz, Univ of Texas Southwest Med Ctr Dallas

Disease/Phenotype

Disease Terms

Research Areas By Genotype

This mouse can be used to support research in many areas including:

Diabetes and Obesity Research
- Obesity With Diabetes
  - diet-induced

Genotype: Ldlr^tm1Her related

Cardiovascular Research
- Atherosclerosis
- Hypercholesterolemia
Metabolism Research
- Lipid Metabolism

Mammalian Phenotype Terms by Genotype

Genotype: Ldlr^tm1Her/Ldlr⁺
B6.129S7-Ldlr^tm1Her

homeostasis/metabolism phenotype

increased circulating cholesterol level
- seen at 3-4 months of age

increased circulating triglyceride level
- seen at 3-4 months of age

Genotype: Ldlr^tm1Her/Ldlr^tm1Her
B6.129S7-Ldlr^tm1Her

homeostasis/metabolism phenotype

abnormal circulating cholesterol level
- streptozotocin (STZ) induced diabetes leads to blood cholesterol levels that are twice those of non-diabetic mice 6 weeks post-induction and three times greater 8 weeks post- induction
- when fed a western style diet for 12 weeks, male mice exhibit a higher circulating cholesterol level than in Ldlr^tm1Her Scd1^ab-2J homozygotes

abnormal triglyceride level

amyloid beta deposits
- increased amyloid beta 40 but not amyloid beta 42 on a high fat diet

decreased circulating HDL cholesterol level
- when fed a high-cholesterol diet, NMR proton spectra of lipids indicates a level of photon intensity for HDL of 0.77 compared to 0.83 in wild-type mice

decreased circulating interleukin-10 level

hyperglycemia
- streptozotocin (STZ) treatment leads to 3-fold higher level of blood glucose in mice fed a high fat diet
- these high glucose levels persist for at least 12 weeks after STZ treatment
- when fed a western style diet for 12 weeks

impaired glucose tolerance
- when fed a western style diet for 12 weeks

increased circulating HDL cholesterol level
- slightly elevated at 3 and 8 months of age

increased circulating LDL cholesterol level
- when fed a high cholesterol diet, NMR proton spectra of lipids indicates a level of photon intensity for LDL of 0.88 compared to 0.84 in wild-type mice

increased circulating VLDL cholesterol level
- compared to in Ldlr^tm1Her Scd1^ab-2J homozygotes when fed a western style diet for 12 weeks
- when fed a high cholesterol diet, NMR proton spectra of lipids indicates a level of photon intensity for VLDL of 0.92 compared to 0.88 in wild-type mice

increased circulating VLDL triglyceride level
- compared to in Ldlr^tm1Her Scd1^ab-2J homozygotes when fed a western style diet for 12 weeks

increased circulating cholesterol level
- 10 fold increase in total cholesterol on a high fat diet compared to a 150% increase for controls
- 3 fold cholesterol elevation on a normal diet relative to controls
- mice develop severe cholesterolemia when receiving a high fat diet from 6 to 30 weeks (elevated levels are detected at 6, 15, and 30 weeks)
- seen at 3-4 months of age

increased circulating insulin level
- when fed a western style diet for 12 weeks

increased circulating interleukin-1 beta level

increased circulating interleukin-6 level

increased circulating triglyceride level
- elevated on a high fat diet
- seen at 3-4 months of age
- when fed a western style diet for 12 weeks, female mice exhibit a higher circulating triglyceride level than in Ldlr^tm1Her Scd1^ab-2J homozygotes

increased circulating tumor necrosis factor level
- increased TNFalpha levels

increased liver cholesterol level
- livers exhibit slightly, but significantly, higher levels of cholesterol

increased liver triglyceride level
- when fed a western style diet for 12 weeks, mice exhibit a 5-fold higher hepatic triglyceride level than in Ldlr^tm1Her Scd1^ab-2J homozygotes

adipose tissue phenotype

abnormal fat pad morphology
- increased when fed a western style diet for 12 weeks

increased percent body fat/body weight
- when fed a western style diet for 12 weeks

growth/size/body region phenotype

decreased susceptibility to weight gain
- lower body weight on a low cholesterol diet than controls on any diet

increased susceptibility to weight gain
- when fed a western style diet for 12 weeks

cardiovascular system phenotype

atherosclerotic lesions

increased susceptibility to atherosclerosis
- 4 weeks on the Western diet mice have lesions of small fatty streaks on the aorta
- STZ-induced diabetes leads to an almost 3-fold greater size in total lesion area in the aorta compared to non-diabetic Ldlr^tm1Her homozyogotes
- after 12 weeks on a high cholesterol diet, mice exhibit endothelial disruption and an accumulation of macrophage and foam cells at the site of atherosclerotic plaques
- after 12 weeks on a high cholesterol diet, mice exhibit extensive intimal thickening and 60% to 80% of the aortic surface is sudanophilic unlike in wild-type mice
- high-fat diet leads to atherosclerosis

immune system phenotype

abnormal microglial cell morphology
- increased number of microglia in the hippocampus

decreased circulating interleukin-10 level

increased circulating interleukin-1 beta level

increased circulating interleukin-6 level

increased circulating tumor necrosis factor level
- increased TNFalpha levels

liver/biliary system phenotype

hepatic steatosis
- when fed a western style diet for 12 weeks

increased liver cholesterol level
- livers exhibit slightly, but significantly, higher levels of cholesterol

increased liver triglyceride level
- when fed a western style diet for 12 weeks, mice exhibit a 5-fold higher hepatic triglyceride level than in Ldlr^tm1Her Scd1^ab-2J homozygotes

behavior/neurological phenotype

abnormal spatial learning
- take longer to reach the target site in a Morris water maze when fed a high cholesterol diet

abnormal spatial working memory
- deficient performance in a water radial arm maze regardless of the diet

hyperactivity
- travel greater distances and spend more time in motion in an open field test

increased grip strength
- perform better than controls on a hanging bar test

nervous system phenotype

abnormal CNS glial cell morphology

abnormal astrocyte morphology
- further increase in reactive astrocytes on a high fat diet
- increased numbers of reactive astrocytes

abnormal microglial cell morphology
- increased number of microglia in the hippocampus

amyloid beta deposits
- increased amyloid beta 40 but not amyloid beta 42 on a high fat diet

hematopoietic system phenotype

abnormal microglial cell morphology
- increased number of microglia in the hippocampus

Genotype: Ldlr^tm1Her/Ldlr^tm1Her
B6.129S7-Ldlr^tm1Her/J

homeostasis/metabolism phenotype

decreased circulating triglyceride level
- when fed regular chow or a high fat diet for 16 weeks, serum triglyceride levels are decreased compared to similarly treated Apoa1^tm1Unc Ldlr^tm1Her homozygotes

homeostasis/metabolism phenotype
- mice fed a Western diet exhibit normal HDL cholesterol

increased cholesterol level
- when fed a high fat diet, mice exhibit an increase in cholesterol content in the adrenal gland

increased circulating HDL cholesterol level
- when fed regular chow or a high fat diet for 16 weeks, serum HDL levels are increased compared to similarly treated Apoa1^tm1Unc Ldlr^tm1Her homozygotes

increased circulating LDL cholesterol level
- when fed a Western diet compared to Ldlr^tm1Her homozygotes fed regular chow
- when fed a high fat diet, mice exhibit a greater increase in VLDL and LDL (6-fold) compared to Ldlr^tm1Her homozygotes (3-fold)

increased circulating VLDL cholesterol level
- when fed a Western diet
- when fed a high fat diet, mice exhibit a greater increase in VLDL and LDL (6-fold) compared to Ldlr^tm1Her homozygotes (3-fold)

increased circulating cholesterol level
- 15 fold higher on a normal diet than controls
- 40 fold higher than controls on a high fat diet
- when fed a high fat diet, mice exhibit a greater increase in VLDL and LDL (6-fold) compared to Ldlr^tm1Her homozygotes (3-fold)
- whether are fed a high fat diet or regular chow, plasma cholesterol levels are increased relative to similarly treated Apoa1^tm1Unc Ldlr^tm1Her homozygotes

increased circulating triglyceride level
- when fed a Western diet

increased liver cholesterol level
- when fed a high fat diet, mice exhibit a greater increase in liver cholesterol content (11-fold) compared to in similarly treated Apoa1^tm1Unc Ldlr^tm1Her homozygotes (2.5-fold)

liver/biliary system phenotype

abnormal liver physiology
- LDL updake is decreased by about 2X

hepatic steatosis
- when fed a high fat diet, mice exhibit larger diameter and more frequent lipid droplets than in Apoa1^tm1Unc Ldlr^tm1Her homozygotes

increased liver cholesterol level
- when fed a high fat diet, mice exhibit a greater increase in liver cholesterol content (11-fold) compared to in similarly treated Apoa1^tm1Unc Ldlr^tm1Her homozygotes (2.5-fold)

endocrine/exocrine gland phenotype

abnormal adrenal gland morphology
- when fed a high fat diet, mice exhibit an increase in cholesterol content in the adrenal gland

cardiovascular system phenotype

atherosclerotic lesions
- after 8 or 20 weeks on a cholesterol diet aortic lesion size is increased compared to mice that are homozygous for both Ldlr^tm1Her and Ifng^tm1Ts

integument phenotype

alopecia
- when fed a high fat diet

scaly skin
- when fed a high fat diet

thick skin
- when fed a high fat diet

The following phenotype information is associated with a similar, but not exact match to this JAX^® Mice strain

Genotype: Ldlr^tm1Her/Ldlr⁺
involves: 129S7/SvEvBrd * C57BL/6 * DBA/2

homeostasis/metabolism phenotype

hyperglycemia
- streptozotocin (STZ) treatment leads to 3-fold higher level of blood glucose in mice fed a high fat diet
- these high glucose levels persist for at least 12 weeks after STZ treatment

Genotype: Ldlr^tm1Her/Ldlr^tm1Her
involves: 129P2/OlaHsd * 129S7/SvEvBrd * C57BL/6 * DBA

homeostasis/metabolism phenotype

abnormal cholesterol homeostasis
- increase in the APOB lipoprotein cholesterol level compared to wild-type controls
- plasma cholesterol is nearly equal distribution between the HDL and LDL fractions
- the ratio of saturated + monounsaturated/polyunsaturated cholesterol ester fatty acid species in the LDL fraction is significantly decreased compared to Apoe^tm1Unc single mutantsts
- there is a 2.3 fold decrease in the ratio of saturated + monounsaturated/polyunsaturated cholesterol ester fatty acid species compared to Apoe^tm1Unc single mutants

abnormal circulating protein level
- increase in APOB-100

abnormal lipid homeostasis
- the HDL phospholipid fraction contains less 16:0 and 18:0 species and is enriched for 20:4 and 22:6 species compared to Apoe^tm1Unc single mutants

Genotype: Ldlr^tm1Her/Ldlr^tm1Her
involves: 129S7/SvEvBrd

homeostasis/metabolism phenotype

abnormal circulating LDL cholesterol level
- LDL clearance is slowed

abnormal circulating cholesterol level
- circulating VLDL/LDL cholesterol levels are increased compared to in Apobec1^tm1Chan homozygotes and wild-type mice

increased circulating LDL cholesterol level
- in wild-type mice parabiosed with Ldlr-null mice (resulting in shared circulation), plasma total cholesterol levels did not increase significantly over pre-surgery levels
- male mice have a marked increase in plasma LDL cholesterol compared to wild-type
- on a chow diet, plasma LDL levels were higher than both those of wild-type mice and Ldlrap1^tm1Her homozygous mutant mice
- plasma LDL levels become further elevated on high cholesterol diets
- plasma levels are increased 2.5 fold relative to controls

increased circulating cholesterol level
- increased plasma cholesterol levels after 20 weeks on Western diet
- levels are higher than those exhibited by in transgenic Tg(Alb-MYLIP*)1Pton mice after 30 weeks on Western diet
- plasma cholesterol level is 196mg/dl on a normal diet
- when fed a chow diet or Western-type diet for 2 and 4 weeks, mice exhibit increased serum cholesterol levels compared to in Apobec1^tm1Chan homozygotes and wild-type mice

increased circulating triglyceride level
- when fed a chow diet or a Western-type diet for 2 and 4 weeks, mice exhibit increased serum triglyceride levels compared to in Apobec1^tm1Chan homozygotes and wild-type mice

cardiovascular system phenotype

atherosclerotic lesions
- mice develop atherosclerotic lesions after 20 weeks on Western diet
- total lesion area is larger when compared to lesion area in transgenic Tg(Alb-MYLIP*)1Pton mice after 30 weeks on Western diet

increased susceptibility to atherosclerosis

Genotype: Ldlr^tm1Her/Ldlr^tm1Her
involves: 129S6/SvEvTac * 129S7/SvEvBrd * C57BL/6

cardiovascular system phenotype

atherosclerotic lesions
- atherosclerosis in both aortic arch and descending aorta

homeostasis/metabolism phenotype

increased circulating cholesterol level
- hypercholesterolemic

Genotype: Ldlr^tm1Her/Ldlr^tm1Her
involves: 129S7/SvEvBrd * C57BL/6J

cardiovascular system phenotype

atherosclerotic lesions
- males show more aortic atherosclerosis than females, both in the arch and in the thoracic and abdominal aorta, whereas the average plasma cholesterol levels are similar in males and females
- mice fed a cholate-free high-cholesterol diet (1%) for 6 months develop more extensive lesions throughout the aorta compared to controls which show smaller lesions that are almost exclusively in the aortic origin; the extent of atherosclerosis in the entire aorta correlates with the size of lesions in the aortic originre aorta correlates with the size of lesions in the aortic origin

increased susceptibility to atherosclerosis
- when fed a high-cholesterol diet, mice develop more extensive atherosclerotic lesions than similarly fed controls, with males more affected than females

homeostasis/metabolism phenotype

increased circulating cholesterol level
- mice fed a high-fat diet (1% cholesterol) exhibit increased average total plasma cholesterol levels

Genotype: Ldlr^tm1Her/Ldlr^tm1Her
involves: 129S7/SvEvBrd * C57BL/6

growth/size/body region phenotype

decreased lean body mass

obese
- mice fed a diabetogenic high fat diet (35.5% carbohydrate and 36.6% fat) (DD diet) or a a diabetogenic high fat diet (35.5% carbohydrate and 36.6% fat) with 0.15% added cholesterol (DDC diet) exhibit weight gain leading to obesity; similar weight gain is seen regardless of dietseen regardless of diet

pigmentation phenotype

abnormal retinal pigment epithelium morphology
- basal membrane infoldings are less regular
- decreased and irregular height
- numerous vacuoles in cytoplasm

cellular phenotype

increased hepatocyte apoptosis
- DD diet fed mice show some apoptotic cells in the liver while those on the DDC diet have a larger increase

maternal effect
- also reduced birth weight persisting to at least 90 days of age
- intrauterine growth restriction of pups from mothers on a high fat diet
- offspring with larger atherosclerotic lesions
- offspring with lower gonadal fat pad to body weight ratio
- poor survival of pups from mothers on a high fat diet

oxidative stress
- mice on the DDC diet exhibit an increase in hepatic oxidative stress

liver/biliary system phenotype

hepatic steatosis
- mice fed the DD diet exhibit diffuse macrovesicular steatosis with limited inflammation and fibrosis in the liver
- mice fed the DDC diet exhibit both macrovesicular and microvesicular steatosis in the liver

increased hepatocyte apoptosis
- DD diet fed mice show some apoptotic cells in the liver while those on the DDC diet have a larger increase

increased liver cholesterol level
- hepatic cholesterol levels are increased only in the mice fed the DDC diet

increased liver triglyceride level
- hepatic triglyceride levels are increased in mice fed the DD or the DDC diet, but higher in those on the DDC diet

increased liver weight
- mice on the DD diet and on the DDC diet exhibit higher liver weights than regular chow-fed mice

liver fibrosis
- intrasinusoidal and pericellular fibrosis is seen to a greater extend in the livers of mice fed the DDC diet than the DD diet

liver inflammation
- inflammatory cell foci is seen to a greater extend in the livers of mice fed the DDC diet than the DD diet

homeostasis/metabolism phenotype

abnormal circulating amino acid level
- levels of other amino acids are normal
- mothers on a high fat diet have reduced plasma concentrations of phenylalanine, lysine, valine, isoleucine, and leucine

abnormal glucose homeostasis

decreased circulating corticosterone level
- levels in response to ACTH are significantly reduced

impaired glucose tolerance
- 30 minute insulin levels elevated
- glucose levels increase during a glucose tolerance test

increased circulating LDL cholesterol level
- clearance of ¹²⁵I-LDL from circulation is retarded, uptake of DiI-LDL by hepatocytes is decreased, and uptake of ³H-CE-LDL by the liver is lower compared to wild-type

increased circulating alanine transaminase level
- ALT levels are increased in mice fed the DD diet and even more so in those fed the DDC diet

increased circulating cholesterol level
- similar levels of hypercholesterolemia are seen in mice fed the DD diet and those fed the DDC diet

increased circulating free fatty acid level
- circulating fatty free acids are increased in mice fed the DD or the DDC diet, however levels are higher in the mice on the DDC diet

increased circulating glucose level
- increased fasting glucose levels after dexamethasone treatment

increased circulating insulin level
- after dexamethasone treatment

increased circulating triglyceride level
- similar levels of hypertriglyceridemia are seen in mice fed the DD diet and those fed the DDC diet

increased liver cholesterol level
- hepatic cholesterol levels are increased only in the mice fed the DDC diet

increased liver triglyceride level
- hepatic triglyceride levels are increased in mice fed the DD or the DDC diet, but higher in those on the DDC diet

insulin resistance
- less likely to become hypoglycemic during an insulin tolerance test

nervous system phenotype

abnormal hippocampus morphology
- reduced cell proliferation in the hippocampus

abnormal microglial cell morphology
- 2X as many arterioles have microglia
- on a Western diet, even small arterioles have associated microglia, sometimes within the basal lamina

abnormal synapse morphology
- 32% of the cholesterol in the synaptic plasma membrane is in the exofacial leaflet as compared to 15% for controls
- cholesterol levels in the cytofacial leaflet are reduced
- cholesterol/phospholipid ratio in the synaptic plasma membrane is elevated
- fluidity of both the exofacial leaflet and the cytofacial leaflet of the synaptic plasma membrane are increased relative to controls

abnormal synaptic bouton morphology
- normal density of synaptophysin-immunoreactive presynaptic boutons in the dentate gyrus
- reduced density of synaptophysin-immunoreactive presynaptic boutons in the CA1 of the hippocampus

photoreceptor outer segment degeneration
- mild degeneration

cardiovascular system phenotype

abnormal arteriole morphology
- wall thickness increases on a Western diet
- wall thickness is directly related to the number of associated microglia
- wall thickness of brain arterioles having a lumen diameter of 15-40 um is greater than controls

abnormal choriocapillaris morphology
- narrowing of lumina
- reduced number of fenestrations
- thickened endothelial basal lamina

behavior/neurological phenotype

abnormal short term spatial reference memory
- mice fed a Western diet and tested in a T-maze demonstrate reduced alternation returning more frequently to the blind arm of the maze

abnormal spatial learning
- less time spent in the target quadrant during a probe test
- mice on a Western diet fail to show improved performance over time in a Morris water maze test
- somewhat slower swimming speed in the acquisition phase of a Morris water maze test

vision/eye phenotype

abnormal Bruch membrane morphology
- enhanced condensation of collagenous and elastic fibers
- laminations disrupted and large vacuoles become diffusely distributed
- thickened (up to 0.8um on a high fat diet)

abnormal choriocapillaris morphology
- narrowing of lumina
- reduced number of fenestrations
- thickened endothelial basal lamina

abnormal retinal pigment epithelium morphology
- basal membrane infoldings are less regular
- decreased and irregular height
- numerous vacuoles in cytoplasm

photoreceptor outer segment degeneration
- mild degeneration

hematopoietic system phenotype

abnormal microglial cell morphology
- 2X as many arterioles have microglia
- on a Western diet, even small arterioles have associated microglia, sometimes within the basal lamina

immune system phenotype

abnormal microglial cell morphology
- 2X as many arterioles have microglia
- on a Western diet, even small arterioles have associated microglia, sometimes within the basal lamina

liver inflammation
- inflammatory cell foci is seen to a greater extend in the livers of mice fed the DDC diet than the DD diet

Genotype: Ldlr^tm1Her/Ldlr^tm1Her
involves: 129S7/SvEvBrd * C57BL/6 * SJL

homeostasis/metabolism phenotype

increased circulating LDL cholesterol level
- greatly elevated

increased circulating cholesterol level
- total cholesterol greatly elevated

References

Ishibashi S; Brown MS; Goldstein JL; Gerard RD; Hammer RE; Herz J. 1993. Hypercholesterolemia in low density lipoprotein receptor knockout mice and its reversal by adenovirus-mediated gene delivery [see comments] J Clin Invest 92(2):883-93. PubMed: 8349823 MGI: J:37394

Additional References

Babaev VR; Patel MB; Semenkovich CF; Fazio S; Linton MF. 2000. Macrophage lipoprotein lipase promotes foam cell formation and atherosclerosis in low density lipoprotein receptor-deficient mice J Biol Chem 275(34):26293-9. PubMed: 10858435 MGI: J:64000
Binder CJ; Horkko S; Dewan A; Chang MK; Kieu EP; Goodyear CS; Shaw PX; Palinski W; Witztum JL; Silverman GJ. 2003. Pneumococcal vaccination decreases atherosclerotic lesion formation: molecular mimicry between Streptococcus pneumoniae and oxidized LDL. Nat Med 9(6):736-43. PubMed: 12740573 MGI: J:83726
Herz J; Qiu SQ; Oesterle A; DeSilva HV; Shafi S; Havel RJ. 1995. Initial hepatic removal of chylomicron remnants is unaffected but endocytosis is delayed in mice lacking the low density lipoprotein receptor. Proc Natl Acad Sci U S A 92(10):4611-5. PubMed: 7753850 MGI: J:25195
Huszar D; Varban ML; Rinninger F; Feeley R; Arai T; Fairchild-Huntress V; Donovan MJ; Tall AR. 2000. Increased LDL cholesterol and atherosclerosis in LDL receptor-deficient mice with attenuated expression of scavenger receptor B1. Arterioscler Thromb Vasc Biol 20(4):1068-73. PubMed: 10764675 MGI: J:62371
Ishibashi S; Goldstein JL; Brown MS; Herz J; Burns DK. 1994. Massive xanthomatosis and atherosclerosis in cholesterol-fed low density lipoprotein receptor-negative mice. J Clin Invest 93(5):1885-93. PubMed: 8182121 MGI: J:77012
Ishibashi S; Herz J; Maeda N; Goldstein JL; Brown MS. 1994. The two-receptor model of lipoprotein clearance: tests of the hypothesis in knockout mice lacking the low density lipoprotein receptor, apolipoprotein E, or both proteins. Proc Natl Acad Sci U S A 91(10):4431-5. PubMed: 8183926 MGI: J:18138
Keren P; George J; Shaish A; Levkovitz H; Janakovic Z; Afek A; Goldberg I; Kopolovic J; Keren G; Harats D. 2000. Effect of hyperglycemia and hyperlipidemia on atherosclerosis in LDL receptor-deficient mice: establishment of a combined model and association with heat shock protein 65 immunity. Diabetes 49(6):1064-9. PubMed: 10866061 MGI: J:62295
Knouff C; Briand O; Lestavel S; Clavey V; Altenburg M; Maeda N. 2004. Defective VLDL metabolism and severe atherosclerosis in mice expressing human apolipoprotein E isoforms but lacking the LDL receptor. Biochim Biophys Acta 1684(1-3):8-17. PubMed: 15450205 MGI: J:92554
Kulinski A; Rustaeus S; Vance JE. 2002. Microsomal Triacylglycerol Transfer Protein Is Required for Lumenal Accretion of Triacylglycerol Not Associated with ApoB, as Well as for ApoB Lipidation. J Biol Chem 277(35):31516-25. PubMed: 12072432 MGI: J:78774
Lie J; de Crom R; van Gent T; van Haperen R; Scheek L; Sadeghi-Niaraki F; van Tol A. 2004. Elevation of plasma phospholipid transfer protein increases the risk of atherosclerosis despite lower apolipoprotein B-containing lipoproteins. J Lipid Res 45(5):805-11. PubMed: 14993244 MGI: J:89308
Merkel M; Velez-Carrasco W; Hudgins LC; Breslow JL. 2001. Compared with saturated fatty acids, dietary monounsaturated fatty acids and carbohydrates increase atherosclerosis and VLDL cholesterol levels in LDL receptor-deficient, but not apolipoprotein E-deficient, mice. Proc Natl Acad Sci U S A 98(23):13294-9. PubMed: 11606787 MGI: J:72580
Renard CB; Kramer F; Johansson F; Lamharzi N; Tannock LR; von Herrath MG; Chait A; Bornfeldt KE. 2004. Diabetes and diabetes-associated lipid abnormalities have distinct effects on initiation and progression of atherosclerotic lesions. J Clin Invest 114(5):659-68. PubMed: 15343384 MGI: J:92597
Schiller NK; Black AS; Bradshaw GP; Bonnet DJ; Curtiss LK. 2004. Participation of macrophages in atherosclerotic lesion morphology in LDLr-/- mice. J Lipid Res 45(8):1398-409. PubMed: 15175354 MGI: J:91367
Schonbeck U; Sukhova GK; Shimizu K; Mach F; Libby P. 2000. Inhibition of CD40 signaling limits evolution of established atherosclerosis in mice [see comments] Proc Natl Acad Sci U S A 97(13):7458-63. PubMed: 10861012 MGI: J:63076
Schreyer SA; Vick C; Lystig TC; Mystkowski P; LeBoeuf RC. 2002. LDL receptor but not apolipoprotein E deficiency increases diet-induced obesity and diabetes in mice. Am J Physiol Endocrinol Metab 282(1):E207-14. PubMed: 11739102 MGI: J:75609
Schreyer SA; Vick CM; LeBoeuf RC. 2002. Loss of Lymphotoxin-alpha but Not Tumor Necrosis Factor-alpha Reduces Atherosclerosis in Mice. J Biol Chem 277(14):12364-8. PubMed: 11809756 MGI: J:75788
Shi W; Wang X; Wong J; Hedrick CC; Wong H; Castellani LW; Lusis AJ. 2004. Effect of macrophage-derived apolipoprotein E on hyperlipidemia and atherosclerosis of LDLR-deficient mice. Biochem Biophys Res Commun 317(1):223-9. PubMed: 15047172 MGI: J:88891
Tangirala RK; Pratico D; FitzGerald GA; Chun S; Tsukamoto K; Maugeais C; Usher DC; Pure E; Rader DJ. 2001. Reduction of isoprostanes and regression of advanced atherosclerosis by apolipoprotein E. J Biol Chem 276(1):261-6. PubMed: 11024044 MGI: J:66833
Truong TQ; Auger A; Denizeau F; Brissette L. 2000. Analysis of low-density lipoprotein catabolism by primary cultures of hepatic cells from normal and low-density lipoprotein receptor knockout mice. Biochim Biophys Acta 1484(2-3):307-15. PubMed: 10760479 MGI: J:61821
Welch CL; Bretschger S; Latib N; Bezouevski M; Guo Y; Pleskac N; Liang CP; Barlow C; Dansky H; Breslow JL; Tall AR. 2001. Localization of atherosclerosis susceptibility loci to chromosomes 4 and 6 using the Ldlr knockout mouse model. Proc Natl Acad Sci U S A 98(14):7946-51. PubMed: 11438740 MGI: J:70259
Welch CL; Bretschger S; Wen PZ; Mehrabian M; Latib N; Fruchart-Najib J; Fruchart JC; Myrick C; Lusis AJ. 2004. Novel QTLs for HDL levels identified in mice by controlling for Apoa2 allelic effects: confirmation of a chromosome 6 locus in a congenic strain. Physiol Genomics 17(1):48-59. PubMed: 14722362 MGI: J:88731
Whitman SC; Rateri DL; Szilvassy SJ; Cornicelli JA; Daugherty A. 2002. Macrophage-specific expression of class A scavenger receptors in LDL receptor(-/-) mice decreases atherosclerosis and changes spleen morphology. J Lipid Res 43(8):1201-8. PubMed: 12177164 MGI: J:78922
van Eck M; Bos IS; Kaminski WE; Orso E; Rothe G; Twisk J; Bottcher A; Van Amersfoort ES; Christiansen-Weber TA; Fung-Leung WP; Van Berkel TJ; Schmitz G. 2002. Leukocyte ABCA1 controls susceptibility to atherosclerosis and macrophage recruitment into tissues. Proc Natl Acad Sci U S A 99(9):6298-303. PubMed: 11972062 MGI: J:76337

Additional - Ldlr^tm1Her related

Accad M; Smith SJ; Newland DL; Sanan DA; King LE Jr; Linton MF; Fazio S; Farese RV Jr. 2000. Massive xanthomatosis and altered composition of atherosclerotic lesions in hyperlipidemic mice lacking acyl CoA:cholesterol acyltransferase 1 [see comments] J Clin Invest 105(6):711-9. PubMed: 10727439 MGI: J:61147
Adachi H; Kondo T; Koh GY; Nagy A; Oike Y; Araki E. 2011. Angptl4 deficiency decreases serum triglyceride levels in low-density lipoprotein receptor knockout mice and streptozotocin-induced diabetic mice. Biochem Biophys Res Commun 409(2):177-80. PubMed: 21549101 MGI: J:172599
Afek A; Keren G; Harats D; George J. 2001. Whole body hyperthermia accelerates atherogenesis in low-density lipoprotein receptor deficient mice. Exp Mol Pathol 71(1):63-72. PubMed: 11502098 MGI: J:106255
Ahmad PJ; Trcka D; Xue S; Franco C; Speer MY; Giachelli CM; Bendeck MP. 2009. Discoidin domain receptor-1 deficiency attenuates atherosclerotic calcification and smooth muscle cell-mediated mineralization. Am J Pathol 175(6):2686-96. PubMed: 19893047 MGI: J:155320
Ait-Oufella H; Herbin O; Lahoute C; Coatrieux C; Loyer X; Joffre J; Laurans L; Ramkhelawon B; Blanc-Brude O; Karabina S; Girard CA; Payre C; Yamamoto K; Binder CJ; Murakami M; Tedgui A; Lambeau G; Mallat Z. 2013. Group X secreted phospholipase A2 limits the development of atherosclerosis in LDL receptor-null mice. Arterioscler Thromb Vasc Biol 33(3):466-73. PubMed: 23349189 MGI: J:216884
Ait-Oufella H; Kinugawa K; Zoll J; Simon T; Boddaert J; Heeneman S; Blanc-Brude O; Barateau V; Potteaux S; Merval R; Esposito B; Teissier E; Daemen MJ; Leseche G; Boulanger C; Tedgui A; Mallat Z. 2007. Lactadherin deficiency leads to apoptotic cell accumulation and accelerated atherosclerosis in mice. Circulation 115(16):2168-77. PubMed: 17420351 MGI: J:135906
Ait-Oufella H; Pouresmail V; Simon T; Blanc-Brude O; Kinugawa K; Merval R; Offenstadt G; Leseche G; Cohen PL; Tedgui A; Mallat Z. 2008. Defective mer receptor tyrosine kinase signaling in bone marrow cells promotes apoptotic cell accumulation and accelerates atherosclerosis. Arterioscler Thromb Vasc Biol 28(8):1429-31. PubMed: 18467644 MGI: J:159811
Ait-Oufella H; Salomon BL; Potteaux S; Robertson AK; Gourdy P; Zoll J; Merval R; Esposito B; Cohen JL; Fisson S; Flavell RA; Hansson GK; Klatzmann D; Tedgui A; Mallat Z. 2006. Natural regulatory T cells control the development of atherosclerosis in mice. Nat Med 12(2):178-80. PubMed: 16462800 MGI: J:105800
Albrecht C; Preusch MR; Hofmann G; Morris-Rosenfeld S; Blessing E; Rosenfeld ME; Katus HA; Bea F. 2010. Egr-1 deficiency in bone marrow-derived cells reduces atherosclerotic lesion formation in a hyperlipidaemic mouse model. Cardiovasc Res 86(2):321-9. PubMed: 20110335 MGI: J:175882
Alger HM; Brown JM; Sawyer JK; Kelley KL; Shah R; Wilson MD; Willingham MC; Rudel LL. 2010. Inhibition of acyl-coenzyme A:cholesterol acyltransferase 2 (ACAT2) prevents dietary cholesterol-associated steatosis by enhancing hepatic triglyceride mobilization. J Biol Chem 285(19):14267-74. PubMed: 20231283 MGI: J:162960
Allred KF; Smart EJ; Wilson ME. 2006. Estrogen receptor-alpha mediates gender differences in atherosclerosis induced by HIV protease inhibitors. J Biol Chem 281(3):1419-25. PubMed: 16299001 MGI: J:107322
Altenburg M; Arbones-Mainar J; Johnson L; Wilder J; Maeda N. 2008. Human LDL receptor enhances sequestration of ApoE4 and VLDL remnants on the surface of hepatocytes but not their internalization in mice. Arterioscler Thromb Vasc Biol 28(6):1104-10. PubMed: 18369154 MGI: J:149026
Angeli V; Llodra J; Rong JX; Satoh K; Ishii S; Shimizu T; Fisher EA; Randolph GJ. 2004. Dyslipidemia associated with atherosclerotic disease systemically alters dendritic cell mobilization. Immunity 21(4):561-74. PubMed: 15485633 MGI: J:93917
Anggraeni VY; Emoto N; Yagi K; Mayasari DS; Nakayama K; Izumikawa T; Kitagawa H; Hirata K. 2011. Correlation of C4ST-1 and ChGn-2 expression with chondroitin sulfate chain elongation in atherosclerosis. Biochem Biophys Res Commun 406(1):36-41. PubMed: 21284936 MGI: J:170936
Arai S; Shelton JM; Chen M; Bradley MN; Castrillo A; Bookout AL; Mak PA; Edwards PA; Mangelsdorf DJ; Tontonoz P; Miyazaki T. 2005. A role for the apoptosis inhibitory factor AIM/Spalpha/Api6 in atherosclerosis development. Cell Metab 1(3):201-13. PubMed: 16054063 MGI: J:129845
Aryal B; Rotllan N; Araldi E; Ramirez CM; He S; Chousterman BG; Fenn AM; Wanschel A; Madrigal-Matute J; Warrier N; Martin-Ventura JL; Swirski FK; Suarez Y; Fernandez-Hernando C. 2016. ANGPTL4 deficiency in haematopoietic cells promotes monocyte expansion and atherosclerosis progression. Nat Commun 7:12313. PubMed: 27460411 MGI: J:241166
Aslanian AM; Chapman HA; Charo IF. 2005. Transient role for CD1d-restricted natural killer T cells in the formation of atherosclerotic lesions. Arterioscler Thromb Vasc Biol 25(3):628-32. PubMed: 15591216 MGI: J:110061
Aslanian AM; Charo IF. 2006. Targeted disruption of the scavenger receptor and chemokine CXCL16 accelerates atherosclerosis. Circulation 114(6):583-90. PubMed: 16880330 MGI: J:123851
Ason B; van der Hoorn JW; Chan J; Lee E; Pieterman EJ; Nguyen KK; Di M; Shetterly S; Tang J; Yeh WC; Schwarz M; Jukema JW; Scott R; Wasserman SM; Princen HM; Jackson S. 2014. PCSK9 inhibition fails to alter hepatic LDLR, circulating cholesterol, and atherosclerosis in the absence of ApoE. J Lipid Res 55(11):2370-9. PubMed: 25258384 MGI: J:216603
Asterholm IW; Rutkowski JM; Fujikawa T; Cho YR; Fukuda M; Tao C; Wang ZV; Gupta RK; Elmquist JK; Scherer PE. 2014. Elevated resistin levels induce central leptin resistance and increased atherosclerotic progression in mice. Diabetologia 57(6):1209-18. PubMed: 24623101 MGI: J:210884
Averill MM; Kim EJ; Goodspeed L; Wang S; Subramanian S; Den Hartigh LJ; Tang C; Ding Y; Reardon CA; Getz GS; Chait A. 2014. The apolipoprotein-AI mimetic peptide L4F at a modest dose does not attenuate weight gain, inflammation, or atherosclerosis in LDLR-null mice. PLoS One 9(10):e109252. PubMed: 25286043 MGI: J:223469
Avraham-Davidi I; Ely Y; Pham VN; Castranova D; Grunspan M; Malkinson G; Gibbs-Bar L; Mayseless O; Allmog G; Lo B; Warren CM; Chen TT; Ungos J; Kidd K; Shaw K; Rogachev I; Wan W; Murphy PM; Farber SA; Carmel L; Shelness GS; Iruela-Arispe ML; Weinstein BM; Yaniv K. 2012. ApoB-containing lipoproteins regulate angiogenesis by modulating expression of VEGF receptor 1. Nat Med 18(6):967-73. PubMed: 22581286 MGI: J:187459
Azhar S; Luo Y; Medicherla S; Reaven E. 1999. Upregulation of selective cholesteryl ester uptake pathway in mice with deletion of low-density lipoprotein receptor function. J Cell Physiol 180(2):190-202. PubMed: 10395289 MGI: J:56099
Babaev VR; Chew JD; Ding L; Davis S; Breyer MD; Breyer RM; Oates JA; Fazio S; Linton MF. 2008. Macrophage EP4 deficiency increases apoptosis and suppresses early atherosclerosis. Cell Metab 8(6):492-501. PubMed: 19041765 MGI: J:144376
Babaev VR; Ding L; Reese J; Morrow JD; Breyer MD; Dey SK; Fazio S; Linton MF. 2006. Cyclooxygenase-1 deficiency in bone marrow cells increases early atherosclerosis in apolipoprotein E- and low-density lipoprotein receptor-null mice. Circulation 113(1):108-17. PubMed: 16380543 MGI: J:121507
Babaev VR; Hebron KE; Wiese CB; Toth CL; Ding L; Zhang Y; May JM; Fazio S; Vickers KC; Linton MF. 2014. Macrophage deficiency of Akt2 reduces atherosclerosis in Ldlr null mice. J Lipid Res 55(11):2296-308. PubMed: 25240046 MGI: J:216614
Babaev VR; Ishiguro H; Ding L; Yancey PG; Dove DE; Kovacs WJ; Semenkovich CF; Fazio S; Linton MF. 2007. Macrophage expression of peroxisome proliferator-activated receptor-alpha reduces atherosclerosis in low-density lipoprotein receptor-deficient mice. Circulation 116(12):1404-12. PubMed: 17724261 MGI: J:139843
Babaev VR; Yancey PG; Ryzhov SV; Kon V; Breyer MD; Magnuson MA; Fazio S; Linton MF. 2005. Conditional knockout of macrophage PPARgamma increases atherosclerosis in C57BL/6 and low-density lipoprotein receptor-deficient mice. Arterioscler Thromb Vasc Biol 25(8):1647-53. PubMed: 15947238 MGI: J:114332
Baeyens N; Mulligan-Kehoe MJ; Corti F; Simon DD; Ross TD; Rhodes JM; Wang TZ; Mejean CO; Simons M; Humphrey J; Schwartz MA. 2014. Syndecan 4 is required for endothelial alignment in flow and atheroprotective signaling. Proc Natl Acad Sci U S A 111(48):17308-13. PubMed: 25404299 MGI: J:216650
Baldan A; Pei L; Lee R; Tarr P; Tangirala RK; Weinstein MM; Frank J; Li AC; Tontonoz P; Edwards PA. 2006. Impaired development of atherosclerosis in hyperlipidemic Ldlr-/- and ApoE-/- mice transplanted with Abcg1-/- bone marrow. Arterioscler Thromb Vasc Biol 26(10):2301-7. PubMed: 16888235 MGI: J:128048
Banko NS; McAlpine CS; Venegas-Pino DE; Raja P; Shi Y; Khan MI; Werstuck GH. 2014. Glycogen synthase kinase 3alpha deficiency attenuates atherosclerosis and hepatic steatosis in high fat diet-fed low density lipoprotein receptor-deficient mice. Am J Pathol 184(12):3394-404. PubMed: 25451156 MGI: J:218258
Barish GD; Yu RT; Karunasiri MS; Becerra D; Kim J; Tseng TW; Tai LJ; Leblanc M; Diehl C; Cerchietti L; Miller YI; Witztum JL; Melnick AM; Dent AL; Tangirala RK; Evans RM. 2012. The Bcl6-SMRT/NCoR cistrome represses inflammation to attenuate atherosclerosis. Cell Metab 15(4):554-62. PubMed: 22465074 MGI: J:184208
Barlic J; Murphy PM. 2007. Chemokine regulation of atherosclerosis. J Leukoc Biol 82(2):226-36. PubMed: 17329566 MGI: J:123530
Bartelt A; Bruns OT; Reimer R; Hohenberg H; Ittrich H; Peldschus K; Kaul MG; Tromsdorf UI; Weller H; Waurisch C; Eychmuller A; Gordts PL; Rinninger F; Bruegelmann K; Freund B; Nielsen P; Merkel M; Heeren J. 2011. Brown adipose tissue activity controls triglyceride clearance. Nat Med 17(2):200-5. PubMed: 21258337 MGI: J:168555
Barthwal MK; Anzinger JJ; Xu Q; Bohnacker T; Wymann MP; Kruth HS. 2013. Fluid-phase pinocytosis of native low density lipoprotein promotes murine M-CSF differentiated macrophage foam cell formation. PLoS One 8(3):e58054. PubMed: 23536783 MGI: J:199527
Basak JM; Verghese PB; Yoon H; Kim J; Holtzman DM. 2012. Low-density lipoprotein receptor represents an apolipoprotein E-independent pathway of Abeta uptake and degradation by astrocytes. J Biol Chem 287(17):13959-71. PubMed: 22383525 MGI: J:241474
Bassett CM; Edel AL; Patenaude AF; McCullough RS; Blackwood DP; Chouinard PY; Paquin P; Lamarche B; Pierce GN. 2010. Dietary vaccenic acid has antiatherogenic effects in LDLr-/- mice. J Nutr 140(1):18-24. PubMed: 19923390 MGI: J:155556
Basso F; Amar MJ; Wagner EM; Vaisman B; Paigen B; Santamarina-Fojo S; Remaley AT. 2006. Enhanced ABCG1 expression increases atherosclerosis in LDLr-KO mice on a western diet. Biochem Biophys Res Commun 351(2):398-404. PubMed: 17070501 MGI: J:116554
Basso F; Freeman LA; Ko C; Joyce C; Amar MJ; Shamburek RD; Tansey T; Thomas F; Wu J; Paigen B; Remaley AT; Santamarina-Fojo S; Brewer HB Jr. 2007. Hepatic ABCG5/G8 overexpression reduces apoB-lipoproteins and atherosclerosis when cholesterol absorption is inhibited. J Lipid Res 48(1):114-26. PubMed: 17060690 MGI: J:117682
Bauer RC; Tohyama J; Cui J; Cheng L; Yang J; Zhang X; Ou K; Paschos GK; Zheng XL; Parmacek MS; Rader DJ; Reilly MP. 2015. Knockout of Adamts7, a novel coronary artery disease locus in humans, reduces atherosclerosis in mice. Circulation 131(13):1202-13. PubMed: 25712206 MGI: J:234324
Bavendiek U; Zirlik A; LaClair S; MacFarlane L; Libby P; Schonbeck U. 2005. Atherogenesis in mice does not require CD40 ligand from bone marrow-derived cells. Arterioscler Thromb Vasc Biol 25(6):1244-9. PubMed: 15746436 MGI: J:114293
Becker L; Liu NC; Averill MM; Yuan W; Pamir N; Peng Y; Irwin AD; Fu X; Bornfeldt KE; Heinecke JW. 2012. Unique proteomic signatures distinguish macrophages and dendritic cells. PLoS One 7(3):e33297. PubMed: 22428014 MGI: J:186914
Becker M; Rabe K; Lebherz C; Zugwurst J; Goke B; Parhofer KG; Lehrke M; Broedl UC. 2010. Expression of human chemerin induces insulin resistance in the skeletal muscle but does not affect weight, lipid levels, and atherosclerosis in LDL receptor knockout mice on high-fat diet. Diabetes 59(11):2898-903. PubMed: 20724582 MGI: J:169337
Bell TA 3rd; Kelley K; Wilson MD; Sawyer JK; Rudel LL. 2007. Dietary fat-induced alterations in atherosclerosis are abolished by ACAT2-deficiency in ApoB100 only, LDLr-/- mice. Arterioscler Thromb Vasc Biol 27(6):1396-402. PubMed: 17431188 MGI: J:134910
Berbee JF; Boon MR; Khedoe PP; Bartelt A; Schlein C; Worthmann A; Kooijman S; Hoeke G; Mol IM; John C; Jung C; Vazirpanah N; Brouwers LP; Gordts PL; Esko JD; Hiemstra PS; Havekes LM; Scheja L; Heeren J; Rensen PC. 2015. Brown fat activation reduces hypercholesterolaemia and protects from atherosclerosis development. Nat Commun 6:6356. PubMed: 25754609 MGI: J:232977
Bernal-Mizrachi C; Weng S; Feng C; Finck BN; Knutsen RH; Leone TC; Coleman T; Mecham RP; Kelly DP; Semenkovich CF. 2003. Dexamethasone induction of hypertension and diabetes is PPAR-alpha dependent in LDL receptor-null mice. Nat Med 9(8):1069-75. PubMed: 12847522 MGI: J:84844
Bernhagen J; Krohn R; Lue H; Gregory JL; Zernecke A; Koenen RR; Dewor M; Georgiev I; Schober A; Leng L; Kooistra T; Fingerle-Rowson G; Ghezzi P; Kleemann R; McColl SR; Bucala R; Hickey MJ; Weber C. 2007. MIF is a noncognate ligand of CXC chemokine receptors in inflammatory and atherogenic cell recruitment. Nat Med 13(5):587-596. PubMed: 17435771 MGI: J:121807
Bhasin KK; van Nas A; Martin LJ; Davis RC; Devaskar SU; Lusis AJ. 2009. Maternal low-protein diet or hypercholesterolemia reduces circulating essential amino acids and leads to intrauterine growth restriction. Diabetes 58(3):559-66. PubMed: 19073773 MGI: J:146932
Bhatia VK; Yun S; Leung V; Grimsditch DC; Benson GM; Botto MB; Boyle JJ; Haskard DO. 2007. Complement C1q reduces early atherosclerosis in low-density lipoprotein receptor-deficient mice. Am J Pathol 170(1):416-26. PubMed: 17200212 MGI: J:117210
Bi X; Zhu X; Duong M; Boudyguina EY; Wilson MD; Gebre AK; Parks JS. 2013. Liver ABCA1 deletion in LDLrKO mice does not impair macrophage reverse cholesterol transport or exacerbate atherogenesis. Arterioscler Thromb Vasc Biol 33(10):2288-96. PubMed: 23814116 MGI: J:222231
Bi X; Zhu X; Gao C; Shewale S; Cao Q; Liu M; Boudyguina E; Gebre AK; Wilson MD; Brown AL; Parks JS. 2014. Myeloid cell-specific ATP-binding cassette transporter A1 deletion has minimal impact on atherogenesis in atherogenic diet-fed low-density lipoprotein receptor knockout mice. Arterioscler Thromb Vasc Biol 34(9):1888-99. PubMed: 24833800 MGI: J:227105
Bie J; Wang J; Marqueen KE; Osborne R; Kakiyama G; Korzun W; Ghosh SS; Ghosh S. 2013. Liver-specific cholesteryl ester hydrolase deficiency attenuates sterol elimination in the feces and increases atherosclerosis in ldlr-/- mice. Arterioscler Thromb Vasc Biol 33(8):1795-802. PubMed: 23744992 MGI: J:221021
Bie J; Wang J; Yuan Q; Kakiyama G; Ghosh SS; Ghosh S. 2014. Liver-specific transgenic expression of cholesteryl ester hydrolase reduces atherosclerosis in Ldlr-/- mice. J Lipid Res 55(4):729-38. PubMed: 24563511 MGI: J:208896
Bie J; Zhao B; Ghosh S. 2011. Atherosclerotic lesion progression is attenuated by reconstitution with bone marrow from macrophage-specific cholesteryl ester hydrolase transgenic mice. Am J Physiol Regul Integr Comp Physiol 301(4):R967-74. PubMed: 21795638 MGI: J:178811
Bie J; Zhao B; Song J; Ghosh S. 2010. Improved insulin sensitivity in high fat- and high cholesterol-fed Ldlr-/- mice with macrophage-specific transgenic expression of cholesteryl ester hydrolase: role of macrophage inflammation and infiltration into adipose tissue. J Biol Chem 285(18):13630-7. PubMed: 20189995 MGI: J:163056
Bieghs V; Van Gorp PJ; Wouters K; Hendrikx T; Gijbels MJ; van Bilsen M; Bakker J; Binder CJ; Lutjohann D; Staels B; Hofker MH; Shiri-Sverdlov R. 2012. LDL receptor knock-out mice are a physiological model particularly vulnerable to study the onset of inflammation in non-alcoholic fatty liver disease. PLoS One 7(1):e30668. PubMed: 22295101 MGI: J:184219
Bietrix F; Lombardo E; van Roomen CP; Ottenhoff R; Vos M; Rensen PC; Verhoeven AJ; Aerts JM; Groen AK. 2010. Inhibition of glycosphingolipid synthesis induces a profound reduction of plasma cholesterol and inhibits atherosclerosis development in APOE*3 Leiden and low-density lipoprotein receptor-/- mice. Arterioscler Thromb Vasc Biol 30(5):931-7. PubMed: 20167657 MGI: J:175820
Billon-Gales A; Fontaine C; Douin-Echinard V; Delpy L; Berges H; Calippe B; Lenfant F; Laurell H; Guery JC; Gourdy P; Arnal JF. 2009. Endothelial estrogen receptor-alpha plays a crucial role in the atheroprotective action of 17beta-estradiol in low-density lipoprotein receptor-deficient mice. Circulation 120(25):2567-76. PubMed: 19996016 MGI: J:168125
Billon-Gales A; Fontaine C; Filipe C; Douin-Echinard V; Fouque MJ; Flouriot G; Gourdy P; Lenfant F; Laurell H; Krust A; Chambon P; Arnal JF. 2009. The transactivating function 1 of estrogen receptor alpha is dispensable for the vasculoprotective actions of 17beta-estradiol. Proc Natl Acad Sci U S A 106(6):2053-8. PubMed: 19188600 MGI: J:144952
Billon-Gales A; Krust A; Fontaine C; Abot A; Flouriot G; Toutain C; Berges H; Gadeau AP; Lenfant F; Gourdy P; Chambon P; Arnal JF. 2011. Activation function 2 (AF2) of estrogen receptor-alpha is required for the atheroprotective action of estradiol but not to accelerate endothelial healing. Proc Natl Acad Sci U S A 108(32):13311-6. PubMed: 21788522 MGI: J:175619
Binder CJ; Hartvigsen K; Chang MK; Miller M; Broide D; Palinski W; Curtiss LK; Corr M; Witztum JL. 2004. IL-5 links adaptive and natural immunity specific for epitopes of oxidized LDL and protects from atherosclerosis. J Clin Invest 114(3):427-37. PubMed: 15286809 MGI: J:118092
Binder CJ; Horkko S; Dewan A; Chang MK; Kieu EP; Goodyear CS; Shaw PX; Palinski W; Witztum JL; Silverman GJ. 2003. Pneumococcal vaccination decreases atherosclerotic lesion formation: molecular mimicry between Streptococcus pneumoniae and oxidized LDL. Nat Med 9(6):736-43. PubMed: 12740573 MGI: J:83726
Bischoff ED; Daige CL; Petrowski M; Dedman H; Pattison J; Juliano J; Li AC; Schulman IG. 2010. Non-redundant roles for LXRalpha and LXRbeta in atherosclerosis susceptibility in low density lipoprotein receptor knockout mice. J Lipid Res 51(5):900-6. PubMed: 20388921 MGI: J:160160
Bjorkegren JL; Hagg S; Talukdar HA; Foroughi Asl H; Jain RK; Cedergren C; Shang MM; Rossignoli A; Takolander R; Melander O; Hamsten A; Michoel T; Skogsberg J. 2014. Plasma cholesterol-induced lesion networks activated before regression of early, mature, and advanced atherosclerosis. PLoS Genet 10(2):e1004201. PubMed: 24586211 MGI: J:211003
Blasiole DA; Oler AT; Attie AD. 2008. Regulation of ApoB secretion by the low density lipoprotein receptor requires exit from the endoplasmic reticulum and interaction with ApoE or ApoB. J Biol Chem 283(17):11374-81. PubMed: 18272520 MGI: J:136523
Boisvert WA; Rose DM; Johnson KA; Fuentes ME; Lira SA; Curtiss LK; Terkeltaub RA. 2006. Up-regulated expression of the CXCR2 Ligand KC/GRO-alpha in atherosclerotic lesions plays a central role in macrophage accumulation and lesion progression. Am J Pathol 168(4):1385-95. PubMed: 16565511 MGI: J:107325
Boisvert WA; Santiago R; Curtiss LK; Terkeltaub RA. 1998. A leukocyte homologue of the IL-8 receptor CXCR-2 mediates the accumulation of macrophages in atherosclerotic lesions of LDL receptor-deficient mice. J Clin Invest 101(2):353-63. PubMed: 9435307 MGI: J:45392
Bojic LA; Telford DE; Fullerton MD; Ford RJ; Sutherland BG; Edwards JY; Sawyez CG; Gros R; Kemp BE; Steinberg GR; Huff MW. 2014. PPARdelta activation attenuates hepatic steatosis in Ldlr-/- mice by enhanced fat oxidation, reduced lipogenesis, and improved insulin sensitivity. J Lipid Res 55(7):1254-1266. PubMed: 24864274 MGI: J:214996
Bol V; Desjardins F; Reusens B; Balligand JL; Remacle C. 2010. Does early mismatched nutrition predispose to hypertension and atherosclerosis, in male mice? PLoS One 5(9):. PubMed: 20844591 MGI: J:165129
Bolduc V; Baraghis E; Duquette N; Thorin-Trescases N; Lambert J; Lesage F; Thorin E. 2012. Catechin prevents severe dyslipidemia-associated changes in wall biomechanics of cerebral arteries in LDLr-/-:hApoB+/+ mice and improves cerebral blood flow. Am J Physiol Heart Circ Physiol 302(6):H1330-9. PubMed: 22268108 MGI: J:186586
Bolduc V; Drouin A; Gillis MA; Duquette N; Thorin-Trescases N; Frayne-Robillard I; Des Rosiers C; Tardif JC; Thorin E. 2011. Heart rate-associated mechanical stress impairs carotid but not cerebral artery compliance in dyslipidemic atherosclerotic mice. Am J Physiol Heart Circ Physiol 301(5):H2081-92. PubMed: 21926346 MGI: J:178785
Bolick DT; Skaflen MD; Johnson LE; Kwon SC; Howatt D; Daugherty A; Ravichandran KS; Hedrick CC. 2009. G2A deficiency in mice promotes macrophage activation and atherosclerosis. Circ Res 104(3):318-27. PubMed: 19106413 MGI: J:163438
Bonfleur ML; Vanzela EC; Ribeiro RA; de Gabriel Dorighello G; de Franca Carvalho CP; Collares-Buzato CB; Carneiro EM; Boschero AC; de Oliveira HC. 2010. Primary hypercholesterolaemia impairs glucose homeostasis and insulin secretion in low-density lipoprotein receptor knockout mice independently of high-fat diet and obesity. Biochim Biophys Acta 1801(2):183-90. PubMed: 19913637 MGI: J:164825
Bostrom MA; Boyanovsky BB; Jordan CT; Wadsworth MP; Taatjes DJ; de Beer FC; Webb NR. 2007. Group v secretory phospholipase A2 promotes atherosclerosis: evidence from genetically altered mice. Arterioscler Thromb Vasc Biol 27(3):600-6. PubMed: 17204667 MGI: J:149057
Bot M; Bot I; Lopez-Vales R; van de Lest CH; Saulnier-Blache JS; Helms JB; David S; van Berkel TJ; Biessen EA. 2010. Atherosclerotic lesion progression changes lysophosphatidic acid homeostasis to favor its accumulation. Am J Pathol 176(6):3073-84. PubMed: 20431029 MGI: J:161328
Bot M; Van Veldhoven PP; de Jager SC; Johnson J; Nijstad N; Van Santbrink PJ; Westra MM; Van Der Hoeven G; Gijbels MJ; Muller-Tidow C; Varga G; Tietge UJ; Kuiper J; Van Berkel TJ; Nofer JR; Bot I; Biessen EA. 2013. Hematopoietic sphingosine 1-phosphate lyase deficiency decreases atherosclerotic lesion development in LDL-receptor deficient mice. PLoS One 8(5):e63360. PubMed: 23700419 MGI: J:200844
Bot M; de Jager SC; MacAleese L; Lagraauw HM; van Berkel TJ; Quax PH; Kuiper J; Heeren RM; Biessen EA; Bot I. 2013. Lysophosphatidic acid triggers mast cell-driven atherosclerotic plaque destabilization by increasing vascular inflammation. J Lipid Res 54(5):1265-74. PubMed: 23396975 MGI: J:196303
Bouchareb R; Mahmut A; Nsaibia MJ; Boulanger MC; Dahou A; Lepine JL; Laflamme MH; Hadji F; Couture C; Trahan S; Page S; Bosse Y; Pibarot P; Scipione CA; Romagnuolo R; Koschinsky ML; Arsenault BJ; Marette A; Mathieu P. 2015. Autotaxin Derived From Lipoprotein(a) and Valve Interstitial Cells Promotes Inflammation and Mineralization of the Aortic Valve. Circulation 132(8):677-90. PubMed: 26224810 MGI: J:239051
Boucher P; Gotthardt M; Li WP; Anderson RG; Herz J. 2003. LRP: role in vascular wall integrity and protection from atherosclerosis. Science 300(5617):329-32. PubMed: 12690199 MGI: J:82871
Boucher P; Li WP; Matz RL; Takayama Y; Auwerx J; Anderson RG; Herz J. 2007. LRP1 functions as an atheroprotective integrator of TGFbeta and PDFG signals in the vascular wall: implications for Marfan syndrome. PLoS One 2(5):e448. PubMed: 17505534 MGI: J:129347
Bovenschen N; Mertens K; Hu L; Havekes LM; van Vlijmen BJ. 2005. LDL receptor cooperates with LDL receptor-related protein in regulating plasma levels of coagulation factor VIII in vivo. Blood 106(3):906-12. PubMed: 15840700 MGI: J:117317
Boyanovsky B; Zack M; Forrest K; Webb NR. 2009. The capacity of group V sPLA2 to increase atherogenicity of ApoE-/- and LDLR-/- mouse LDL in vitro predicts its atherogenic role in vivo. Arterioscler Thromb Vasc Biol 29(4):532-8. PubMed: 19164803 MGI: J:159779
Boyanovsky BB; van der Westhuyzen DR; Webb NR. 2005. Group V secretory phospholipase A2-modified low density lipoprotein promotes foam cell formation by a SR-A- and CD36-independent process that involves cellular proteoglycans. J Biol Chem 280(38):32746-52. PubMed: 16040605 MGI: J:102157
Breevoort SR; Angdisen J; Schulman IG. 2014. Macrophage-independent regulation of reverse cholesterol transport by liver X receptors. Arterioscler Thromb Vasc Biol 34(8):1650-60. PubMed: 24947527 MGI: J:227095
Bretillon L; Acar N; Seeliger MW; Santos M; Maire MA; Juaneda P; Martine L; Gregoire S; Joffre C; Bron AM; Creuzot-Garcher C. 2008. ApoB100,LDLR-/- mice exhibit reduced electroretinographic response and cholesteryl esters deposits in the retina. Invest Ophthalmol Vis Sci 49(4):1307-14. PubMed: 18385042 MGI: J:136142
Broedl UC; Maugeais C; Millar JS; Jin W; Moore RE; Fuki IV; Marchadier D; Glick JM; Rader DJ. 2004. Endothelial lipase promotes the catabolism of ApoB-containing lipoproteins. Circ Res 94(12):1554-61. PubMed: 15117821 MGI: J:100064
Brown JM; Bell TA 3rd; Alger HM; Sawyer JK; Smith TL; Kelley K; Shah R; Wilson MD; Davis MA; Lee RG; Graham MJ; Crooke RM; Rudel LL. 2008. Targeted depletion of hepatic ACAT2-driven cholesterol esterification reveals a non-biliary route for fecal neutral sterol loss. J Biol Chem 283(16):10522-34. PubMed: 18281279 MGI: J:136556
Brown JM; Chung S; Sawyer JK; Degirolamo C; Alger HM; Nguyen T; Zhu X; Duong MN; Wibley AL; Shah R; Davis MA; Kelley K; Wilson MD; Kent C; Parks JS; Rudel LL. 2008. Inhibition of stearoyl-coenzyme A desaturase 1 dissociates insulin resistance and obesity from atherosclerosis. Circulation 118(14):1467-75. PubMed: 18794388 MGI: J:158044
Brown JM; Chung S; Sawyer JK; Degirolamo C; Alger HM; Nguyen TM; Zhu X; Duong MN; Brown AL; Lord C; Shah R; Davis MA; Kelley K; Wilson MD; Madenspacher J; Fessler MB; Parks JS; Rudel LL. 2010. Combined therapy of dietary fish oil and stearoyl-CoA desaturase 1 inhibition prevents the metabolic syndrome and atherosclerosis. Arterioscler Thromb Vasc Biol 30(1):24-30. PubMed: 19834103 MGI: J:171803
Brown PM; Kennedy DJ; Morton RE; Febbraio M. 2015. CD36/SR-B2-TLR2 Dependent Pathways Enhance Porphyromonas gingivalis Mediated Atherosclerosis in the Ldlr KO Mouse Model. PLoS One 10(5):e0125126. PubMed: 25938460 MGI: J:235246
Brunham LR; Singaraja RR; Duong M; Timmins JM; Fievet C; Bissada N; Kang MH; Samra A; Fruchart JC; McManus B; Staels B; Parks JS; Hayden MR. 2009. Tissue-specific roles of ABCA1 influence susceptibility to atherosclerosis. Arterioscler Thromb Vasc Biol 29(4):548-54. PubMed: 19201688 MGI: J:159775
Bu DX; Tarrio M; Maganto-Garcia E; Stavrakis G; Tajima G; Lederer J; Jarolim P; Freeman GJ; Sharpe AH; Lichtman AH. 2011. Impairment of the programmed cell death-1 pathway increases atherosclerotic lesion development and inflammation. Arterioscler Thromb Vasc Biol 31(5):1100-7. PubMed: 21393583 MGI: J:191478
Buga GM; Frank JS; Mottino GA; Hakhamian A; Narasimha A; Watson AD; Yekta B; Navab M; Reddy ST; Anantharamaiah GM; Fogelman AM. 2008. D-4F reduces EO6 immunoreactivity, SREBP-1c mRNA levels, and renal inflammation in LDL receptor-null mice fed a Western diet. J Lipid Res 49(1):192-205. PubMed: 17925450 MGI: J:130095
Buga GM; Frank JS; Mottino GA; Hendizadeh M; Hakhamian A; Tillisch JH; Reddy ST; Navab M; Anantharamaiah GM; Ignarro LJ; Fogelman AM. 2006. D-4F decreases brain arteriole inflammation and improves cognitive performance in LDL receptor-null mice on a Western diet. J Lipid Res 47(10):2148-60. PubMed: 16835442 MGI: J:116493
Buono C; Binder CJ; Stavrakis G; Witztum JL; Glimcher LH; Lichtman AH. 2005. T-bet deficiency reduces atherosclerosis and alters plaque antigen-specific immune responses. Proc Natl Acad Sci U S A 102(5):1596-601. PubMed: 15665085 MGI: J:96110
Buono C; Come CE; Stavrakis G; Maguire GF; Connelly PW; Lichtman AH. 2003. Influence of interferon-gamma on the extent and phenotype of diet-induced atherosclerosis in the LDLR-deficient mouse. Arterioscler Thromb Vasc Biol 23(3):454-60. PubMed: 12615659 MGI: J:103072
Buono C; Come CE; Witztum JL; Maguire GF; Connelly PW; Carroll M; Lichtman AH. 2002. Influence of C3 deficiency on atherosclerosis. Circulation 105(25):3025-31. PubMed: 12081998 MGI: J:103349
Burkhardt R; Sundermann S; Ludwig D; Ceglarek U; Holdt LM; Thiery J; Teupser D. 2011. Cosegregation of aortic root atherosclerosis and intermediate lipid phenotypes on chromosomes 2 and 8 in an intercross of C57BL/6 and BALBc/ByJ low-density lipoprotein receptor-/- mice. Arterioscler Thromb Vasc Biol 31(4):775-84. PubMed: 21252064 MGI: J:184168
Burkhardt R; Toh SA; Lagor WR; Birkeland A; Levin M; Li X; Robblee M; Fedorov VD; Yamamoto M; Satoh T; Akira S; Kathiresan S; Breslow JL; Rader DJ. 2010. Trib1 is a lipid- and myocardial infarction-associated gene that regulates hepatic lipogenesis and VLDL production in mice. J Clin Invest 120(12):4410-4. PubMed: 21084752 MGI: J:171867
Burleigh ME; Babaev VR; Oates JA; Harris RC; Gautam S; Riendeau D; Marnett LJ; Morrow JD; Fazio S; Linton MF. 2002. Cyclooxygenase-2 promotes early atherosclerotic lesion formation in LDL receptor-deficient mice. Circulation 105(15):1816-23. PubMed: 11956125 MGI: J:103220
Busch M; Westhofen TC; Koch M; Lutz MB; Zernecke A. 2014. Dendritic cell subset distributions in the aorta in healthy and atherosclerotic mice. PLoS One 9(2):e88452. PubMed: 24551105 MGI: J:213070
Cai B; Thorp EB; Doran AC; Sansbury BE; Daemen MJ; Dorweiler B; Spite M; Fredman G; Tabas I. 2017. MerTK receptor cleavage promotes plaque necrosis and defective resolution in atherosclerosis. J Clin Invest 127(2):564-568. PubMed: 28067670 MGI: J:239828
Cain WJ; Millar JS; Himebauch AS; Tietge UJ; Maugeais C; Usher D; Rader DJ. 2005. Lipoprotein [a] is cleared from the plasma primarily by the liver in a process mediated by apolipoprotein [a]. J Lipid Res 46(12):2681-91. PubMed: 16150825 MGI: J:106146
Calara F; Silvestre M; Casanada F; Yuan N; Napoli C; Palinski W. 2001. Spontaneous plaque rupture and secondary thrombosis in apolipoprotein E-deficient and LDL receptor-deficient mice. J Pathol 195(2):257-63. PubMed: 11592107 MGI: J:71794
Caligiuri G; Levy B; Pernow J; Thoren P; Hansson GK. 1999. Myocardial infarction mediated by endothelin receptor signaling in hypercholesterolemic mice. Proc Natl Acad Sci U S A 96(12):6920-4. PubMed: 10359814 MGI: J:55973
Calkin AC; Lee SD; Kim J; Van Stijn CM; Wu XH; Lusis AJ; Hong C; Tangirala RI; Tontonoz P. 2014. Transgenic expression of dominant-active IDOL in liver causes diet-induced hypercholesterolemia and atherosclerosis in mice. Circ Res 115(4):442-9. PubMed: 24935961 MGI: J:228420
Campbell IC; Weiss D; Suever JD; Virmani R; Veneziani A; Vito RP; Oshinski JN; Taylor WR. 2013. Biomechanical modeling and morphology analysis indicates plaque rupture due to mechanical failure unlikely in atherosclerosis-prone mice. Am J Physiol Heart Circ Physiol 304(3):H473-86. PubMed: 23203971 MGI: J:194633
Cao C; Zhao J; Doughty EK; Migliorini M; Strickland DK; Kann MG; Zhang L. 2015. Mac-1 Regulates IL-13 Activity in Macrophages by Directly Interacting with IL-13Ralpha1. J Biol Chem 290(35):21642-51. PubMed: 26160172 MGI: J:225500
Cao D; Fukuchi K; Wan H; Kim H; Li L. 2006. Lack of LDL receptor aggravates learning deficits and amyloid deposits in Alzheimer transgenic mice. Neurobiol Aging 27(11):1632-43. PubMed: 16236385 MGI: J:114480
Cao Q; Wang X; Jia L; Mondal AK; Diallo A; Hawkins GA; Das SK; Parks JS; Yu L; Shi H; Shi H; Xue B. 2014. Inhibiting DNA Methylation by 5-Aza-2'-deoxycytidine ameliorates atherosclerosis through suppressing macrophage inflammation. Endocrinology 155(12):4925-38. PubMed: 25251587 MGI: J:219682
Carpenter B; Lin Y; Stoll S; Raffai RL; McCuskey R; Wang R. 2005. VEGF is crucial for the hepatic vascular development required for lipoprotein uptake. Development 132(14):3293-303. PubMed: 15944181 MGI: J:100427
Casagrande V; Menghini R; Menini S; Marino A; Marchetti V; Cavalera M; Fabrizi M; Hribal ML; Pugliese G; Gentileschi P; Schillaci O; Porzio O; Lauro D; Sbraccia P; Lauro R; Federici M. 2012. Overexpression of tissue inhibitor of metalloproteinase 3 in macrophages reduces atherosclerosis in low-density lipoprotein receptor knockout mice. Arterioscler Thromb Vasc Biol 32(1):74-81. PubMed: 22015660 MGI: J:195978
Casquero AC; Berti JA; Salerno AG; Bighetti EJ; Cazita PM; Ketelhuth DF; Gidlund M; Oliveira HC. 2006. Atherosclerosis is enhanced by testosterone deficiency and attenuated by CETP expression in transgenic mice. J Lipid Res 47(7):1526-34. PubMed: 16603720 MGI: J:112057
Cassis LA; Gupte M; Thayer S; Zhang X; Charnigo R; Howatt DA; Rateri DL; Daugherty A. 2009. ANG II infusion promotes abdominal aortic aneurysms independent of increased blood pressure in hypercholesterolemic mice. Am J Physiol Heart Circ Physiol 296(5):H1660-5. PubMed: 19252100 MGI: J:150893
Cassis LA; Rateri DL; Lu H; Daugherty A. 2007. Bone marrow transplantation reveals that recipient AT1a receptors are required to initiate angiotensin II-induced atherosclerosis and aneurysms. Arterioscler Thromb Vasc Biol 27(2):380-6. PubMed: 17158350 MGI: J:130546
Castellani LW; Chang JJ; Wang X; Lusis AJ; Reynolds WF. 2006. Transgenic mice express human MPO -463G/A alleles at atherosclerotic lesions, developing hyperlipidemia and obesity in -463G males. J Lipid Res 47(7):1366-77. PubMed: 16639078 MGI: J:112085
Catanozi S; Rocha JC; Passarelli M; Guzzo ML; Alves C; Furukawa LN; Nunes VS; Nakandakare ER; Heimann JC; Quintao EC. 2003. Dietary sodium chloride restriction enhances aortic wall lipid storage and raises plasma lipid concentration in LDL receptor knockout mice. J Lipid Res 44(4):727-32. PubMed: 12562870 MGI: J:120709
Cazita PM; Berti JA; Aoki C; Gidlund M; Harada LM; Nunes VS; Quintao EC; Oliveira HC. 2003. Cholesteryl ester transfer protein expression attenuates atherosclerosis in ovariectomized mice. J Lipid Res 44(1):33-40. PubMed: 12518020 MGI: J:120685
Chadjichristos CE; Matter CM; Roth I; Sutter E; Pelli G; Luscher TF; Chanson M; Kwak BR. 2006. Reduced connexin43 expression limits neointima formation after balloon distension injury in hypercholesterolemic mice. Circulation 113(24):2835-43. PubMed: 16769907 MGI: J:122443
Chakraborty M; Lou C; Huan C; Kuo MS; Park TS; Cao G; Jiang XC. 2013. Myeloid cell-specific serine palmitoyltransferase subunit 2 haploinsufficiency reduces murine atherosclerosis. J Clin Invest 123(4):1784-97. PubMed: 23549085 MGI: J:197606
Chan JC; Piper DE; Cao Q; Liu D; King C; Wang W; Tang J; Liu Q; Higbee J; Xia Z; Di Y; Shetterly S; Arimura Z; Salomonis H; Romanow WG; Thibault ST; Zhang R; Cao P; Yang XP; Yu T; Lu M; Retter MW; Kwon G; Henne K; Pan O; Tsai MM; Fuchslocher B; Yang E; Zhou L; Lee KJ; Daris M; Sheng J; Wang Y; Shen WD; Yeh WC; Emery M; Walker NP; Shan B; Schwarz M; Jackson SM. 2009. A proprotein convertase subtilisin/kexin type 9 neutralizing antibody reduces serum cholesterol in mice and nonhuman primates. Proc Natl Acad Sci U S A 106(24):9820-5. PubMed: 19443683 MGI: J:150005
Chattopadhyay A; Navab M; Hough G; Grijalva V; Mukherjee P; Fogelman HR; Hwang LH; Faull KF; Lusis AJ; Reddy ST; Fogelman AM. 2016. Tg6F ameliorates the increase in oxidized phospholipids in the jejunum of mice fed unsaturated LysoPC or WD. J Lipid Res 57(5):832-47. PubMed: 26965826 MGI: J:231659
Chehaibi K; Cedo L; Metso J; Palomer X; Santos D; Quesada H; Naceur Slimane M; Wahli W; Julve J; Vazquez-Carrera M; Jauhiainen M; Blanco-Vaca F; Escola-Gil JC. 2015. PPAR-beta/delta activation promotes phospholipid transfer protein expression. Biochem Pharmacol 94(2):101-8. PubMed: 25662586 MGI: J:219883
Chellan B; Koroleva EP; Sontag TJ; Tumanov AV; Fu YX; Getz GS; Reardon CA. 2013. LIGHT/TNFSR14 can regulate hepatic lipase expression by hepatocytes independent of T cells and Kupffer cells. PLoS One 8(1):e54719. PubMed: 23355893 MGI: J:195803
Chen CT; Ma DW; Kim JH; Mount HT; Bazinet RP. 2008. The low density lipoprotein receptor is not necessary for maintaining mouse brain polyunsaturated fatty acid concentrations. J Lipid Res 49(1):147-52. PubMed: 17932396 MGI: J:130078
Chen X; Rateri DL; Howatt DA; Balakrishnan A; Moorleghen JJ; Morris AJ; Charnigo R; Cassis LA; Daugherty A. 2013. Amlodipine reduces AngII-induced aortic aneurysms and atherosclerosis in hypercholesterolemic mice. PLoS One 8(11):e81743. PubMed: 24244746 MGI: J:209689
Chen Z; Fitzgerald RL; Li G; Davidson NO; Schonfeld G. 2004. Hepatic secretion of apoB-100 is impaired in hypobetalipoproteinemic mice with an apoB-38.9-specifying allele. J Lipid Res 45(1):155-63. PubMed: 13130124 MGI: J:87974
Cheng HY; Gaddis DE; Wu R; McSkimming C; Haynes LD; Taylor AM; McNamara CA; Sorci-Thomas M; Hedrick CC. 2016. Loss of ABCG1 influences regulatory T cell differentiation and atherosclerosis. J Clin Invest 126(9):3236-46. PubMed: 27482882 MGI: J:237255
Cheng SL; Behrmann A; Shao JS; Ramachandran B; Krchma K; Bello Arredondo Y; Kovacs A; Mead M; Maxson R; Towler DA. 2014. Targeted reduction of vascular Msx1 and Msx2 mitigates arteriosclerotic calcification and aortic stiffness in LDLR-deficient mice fed diabetogenic diets. Diabetes 63(12):4326-37. PubMed: 25056439 MGI: J:230113
Cheng SL; Shao JS; Halstead LR; Distelhorst K; Sierra O; Towler DA. 2010. Activation of vascular smooth muscle parathyroid hormone receptor inhibits Wnt/beta-catenin signaling and aortic fibrosis in diabetic arteriosclerosis. Circ Res 107(2):271-82. PubMed: 20489161 MGI: J:175050
Choi JH; Cheong C; Dandamudi DB; Park CG; Rodriguez A; Mehandru S; Velinzon K; Jung IH; Yoo JY; Oh GT; Steinman RM. 2011. Flt3 Signaling-Dependent Dendritic Cells Protect against Atherosclerosis. Immunity 35(5):819-31. PubMed: 22078798 MGI: J:178831
Choi JH; Nam KH; Kim J; Baek MW; Park JE; Park HY; Kwon HJ; Kwon OS; Kim DY; Oh GT. 2005. Trichostatin A exacerbates atherosclerosis in low density lipoprotein receptor-deficient mice. Arterioscler Thromb Vasc Biol 25(11):2404-9. PubMed: 16141407 MGI: J:116800
Choi SH; Yin H; Ravandi A; Armando A; Dumlao D; Kim J; Almazan F; Taylor AM; McNamara CA; Tsimikas S; Dennis EA; Witztum JL; Miller YI. 2013. Polyoxygenated cholesterol ester hydroperoxide activates TLR4 and SYK dependent signaling in macrophages. PLoS One 8(12):e83145. PubMed: 24376657 MGI: J:225168
Christoffersen C; Benn M; Christensen PM; Gordts PL; Roebroek AJ; Frikke-Schmidt R; Tybjaerg-Hansen A; Dahlback B; Nielsen LB. 2012. The plasma concentration of HDL-associated apoM is influenced by LDL receptor-mediated clearance of apoB-containing particles. J Lipid Res 53(10):2198-204. PubMed: 22826357 MGI: J:188041
Christoffersen C; Jauhiainen M; Moser M; Porse B; Ehnholm C; Boesl M; Dahlback B; Nielsen LB. 2008. Effect of apolipoprotein M on high density lipoprotein metabolism and atherosclerosis in low density lipoprotein receptor knock-out mice. J Biol Chem 283(4):1839-47. PubMed: 18006500 MGI: J:130647
Christoffersen C; Pedersen TX; Gordts PL; Roebroek AJ; Dahlback B; Nielsen LB. 2010. Opposing effects of apolipoprotein m on catabolism of apolipoprotein B-containing lipoproteins and atherosclerosis. Circ Res 106(10):1624-34. PubMed: 20360257 MGI: J:172136
Cochain C; Chaudhari SM; Koch M; Wiendl H; Eckstein HH; Zernecke A. 2014. Programmed cell death-1 deficiency exacerbates T cell activation and atherogenesis despite expansion of regulatory T cells in atherosclerosis-prone mice. PLoS One 9(4):e93280. PubMed: 24691202 MGI: J:215043
Coenen KR; Gruen ML; Chait A; Hasty AH. 2007. Diet-induced increases in adiposity, but not plasma lipids, promote macrophage infiltration into white adipose tissue. Diabetes 56(3):564-73. PubMed: 17327423 MGI: J:122029
Coenen KR; Gruen ML; Lee-Young RS; Puglisi MJ; Wasserman DH; Hasty AH. 2009. Impact of macrophage toll-like receptor 4 deficiency on macrophage infiltration into adipose tissue and the artery wall in mice. Diabetologia 52(2):318-28. PubMed: 19052722 MGI: J:144370
Coenen KR; Hasty AH. 2007. Obesity potentiates development of fatty liver and insulin resistance, but not atherosclerosis, in high-fat diet-fed agouti LDLR-deficient mice. Am J Physiol Endocrinol Metab 293(2):E492-9. PubMed: 17566116 MGI: J:123342
Collins AR; Gupte AA; Ji R; Ramirez MR; Minze LJ; Liu JZ; Arredondo M; Ren Y; Deng T; Wang J; Lyon CJ; Hsueh WA. 2012. Myeloid deletion of nuclear factor erythroid 2-related factor 2 increases atherosclerosis and liver injury. Arterioscler Thromb Vasc Biol 32(12):2839-46. PubMed: 23023374 MGI: J:208317
Constantinou C; Mpatsoulis D; Natsos A; Petropoulou PI; Zvintzou E; Traish AM; Voshol PJ; Karagiannides I; Kypreos KE. 2014. The low density lipoprotein receptor modulates the effects of hypogonadism on diet-induced obesity and related metabolic perturbations. J Lipid Res 55(7):1434-1447. PubMed: 24837748 MGI: J:215003
Curtiss LK; Black AS; Bonnet DJ; Tobias PS. 2012. Atherosclerosis induced by endogenous and exogenous toll-like receptor (TLR)1 or TLR6 agonists. J Lipid Res 53(10):2126-32. PubMed: 22822027 MGI: J:188042
Cybulsky MI; Iiyama K; Li H; Zhu S; Chen M; Iiyama M; Davis V; Gutierrez-Ramos JC; Connelly PW; Milstone DS. 2001. A major role for VCAM-1, but not ICAM-1, in early atherosclerosis. J Clin Invest 107(10):1255-62. PubMed: 11375415 MGI: J:69597
Cyrus T; Tang LX; Rokach J; FitzGerald GA; Pratico D. 2001. Lipid peroxidation and platelet activation in murine atherosclerosis. Circulation 104(16):1940-5. PubMed: 11602498 MGI: J:103216
Daissormont IT; Christ A; Temmerman L; Sampedro Millares S; Seijkens T; Manca M; Rousch M; Poggi M; Boon L; van der Loos C; Daemen M; Lutgens E; Halvorsen B; Aukrust P; Janssen E; Biessen EA. 2011. Plasmacytoid dendritic cells protect against atherosclerosis by tuning T-cell proliferation and activity. Circ Res 109(12):1387-95. PubMed: 22021930 MGI: J:192720
Dandapat A; Hu CP; Chen J; Liu Y; Khan JA; Remeo F; Carey RM; Hermonat PL; Mehta JL. 2008. Over-expression of angiotensin II type 2 receptor (agtr2) decreases collagen accumulation in atherosclerotic plaque. Biochem Biophys Res Commun 366(4):871-7. PubMed: 18037370 MGI: J:130186
Daugherty A; Rateri DL; Howatt DA; Charnigo R; Cassis LA. 2013. PD123319 augments angiotensin II-induced abdominal aortic aneurysms through an AT2 receptor-independent mechanism. PLoS One 8(4):e61849. PubMed: 23593499 MGI: J:200118
Davies MR; Lund RJ; Mathew S; Hruska KA. 2005. Low turnover osteodystrophy and vascular calcification are amenable to skeletal anabolism in an animal model of chronic kidney disease and the metabolic syndrome. J Am Soc Nephrol 16(4):917-28. PubMed: 15743994 MGI: J:110048
Day SM; Reeve JL; Pedersen B; Farris DM; Myers DD; Im M; Wakefield TW; Mackman N; Fay WP. 2005. Macrovascular thrombosis is driven by tissue factor derived primarily from the blood vessel wall. Blood 105(1):192-8. PubMed: 15339841 MGI: J:96377
Deane R; Sagare A; Hamm K; Parisi M; Lane S; Finn MB; Holtzman DM; Zlokovic BV. 2008. apoE isoform-specific disruption of amyloid beta peptide clearance from mouse brain. J Clin Invest 118(12):4002-13. PubMed: 19033669 MGI: J:144730
Deevska GM; Rozenova KA; Giltiay NV; Chambers MA; White J; Boyanovsky BB; Wei J; Daugherty A; Smart EJ; Reid MB; Merrill AH Jr; Nikolova-Karakashian M. 2009. Acid Sphingomyelinase Deficiency Prevents Diet-induced Hepatic Triacylglycerol Accumulation and Hyperglycemia in Mice. J Biol Chem 284(13):8359-68. PubMed: 19074137 MGI: J:148558
Degrace P; Moindrot B; Mohamed I; Gresti J; Du ZY; Chardigny JM; Sebedio JL; Clouet P. 2006. Upregulation of liver VLDL receptor and FAT/CD36 expression in LDLR-/- apoB100/100 mice fed trans-10,cis-12 conjugated linoleic acid. J Lipid Res 47(12):2647-55. PubMed: 16957181 MGI: J:117203
Denis M; Marcinkiewicz J; Zaid A; Gauthier D; Poirier S; Lazure C; Seidah NG; Prat A. 2012. Gene inactivation of proprotein convertase subtilisin/kexin type 9 reduces atherosclerosis in mice. Circulation 125(7):894-901. PubMed: 22261195 MGI: J:196628
Depner CM; Torres-Gonzalez M; Tripathy S; Milne G; Jump DB. 2012. Menhaden oil decreases high-fat diet-induced markers of hepatic damage, steatosis, inflammation, and fibrosis in obese ldlr-/- mice. J Nutr 142(8):1495-503. PubMed: 22739374 MGI: J:186393
Derwall M; Malhotra R; Lai CS; Beppu Y; Aikawa E; Seehra JS; Zapol WM; Bloch KD; Yu PB. 2012. Inhibition of bone morphogenetic protein signaling reduces vascular calcification and atherosclerosis. Arterioscler Thromb Vasc Biol 32(3):613-22. PubMed: 22223731 MGI: J:195959
Devlin CM; Kuriakose G; Hirsch E; Tabas I. 2002. Genetic alterations of IL-1 receptor antagonist in mice affect plasma cholesterol level and foam cell lesion size. Proc Natl Acad Sci U S A 99(9):6280-5. PubMed: 11983917 MGI: J:76336
Devlin CM; Leventhal AR; Kuriakose G; Schuchman EH; Williams KJ; Tabas I. 2008. Acid sphingomyelinase promotes lipoprotein retention within early atheromata and accelerates lesion progression. Arterioscler Thromb Vasc Biol 28(10):1723-30. PubMed: 18669882 MGI: J:148825
Dichek HL; Agrawal N; El Andaloussi N; Qian K. 2006. Attenuated corticosterone response to chronic ACTH stimulation in hepatic lipase-deficient mice: evidence for a role for hepatic lipase in adrenal physiology. Am J Physiol Endocrinol Metab 290(5):E908-15. PubMed: 16368783 MGI: J:108412
Dichek HL; Johnson SM; Akeefe H; Lo GT; Sage E; Yap CE; Mahley RW. 2001. Hepatic lipase overexpression lowers remnant and LDL levels by a noncatalytic mechanism in LDL receptor-deficient mice. J Lipid Res 42(2):201-10. PubMed: 11181749 MGI: J:68351
Dichek HL; Qian K; Agrawal N. 2004. The bridging function of hepatic lipase clears plasma cholesterol in LDL receptor-deficient 'apoB-48-only' and 'apoB-100-only' mice. J Lipid Res 45(3):551-60. PubMed: 14679168 MGI: J:88634
Dichek HL; Qian K; Agrawal N. 2004. Divergent effects of the catalytic and bridging functions of hepatic lipase on atherosclerosis. Arterioscler Thromb Vasc Biol 24(9):1696-702. PubMed: 15205216 MGI: J:134693
Ding Z; Mizeracki AM; Hu C; Mehta JL. 2013. LOX-1 deletion and macrophage trafficking in atherosclerosis. Biochem Biophys Res Commun 440(2):210-4. PubMed: 24036126 MGI: J:211431
Dong Y; Zhang M; Liang B; Xie Z; Zhao Z; Asfa S; Choi HC; Zou MH. 2010. Reduction of AMP-activated protein kinase alpha2 increases endoplasmic reticulum stress and atherosclerosis in vivo. Circulation 121(6):792-803. PubMed: 20124121 MGI: J:170442
Doring Y; Manthey HD; Drechsler M; Lievens D; Megens RT; Soehnlein O; Busch M; Manca M; Koenen RR; Pelisek J; Daemen MJ; Lutgens E; Zenke M; Binder CJ; Weber C; Zernecke A. 2012. Auto-antigenic protein-DNA complexes stimulate plasmacytoid dendritic cells to promote atherosclerosis. Circulation 125(13):1673-83. PubMed: 22388324 MGI: J:198616
Drechsler M; Megens RT; van Zandvoort M; Weber C; Soehnlein O. 2010. Hyperlipidemia-triggered neutrophilia promotes early atherosclerosis. Circulation 122(18):1837-45. PubMed: 20956207 MGI: J:179481
Drouin A; Bolduc V; Thorin-Trescases N; Belanger E; Fernandes P; Baraghis E; Lesage F; Gillis MA; Villeneuve L; Hamel E; Ferland G; Thorin E. 2010. Catechin treatment improves cerebrovascular flow-mediated dilation and learning abilities in atherosclerotic mice. Am J Physiol Heart Circ Physiol :. PubMed: 21186270 MGI: J:167205
Du B; Ouyang A; Eng JS; Fleenor BS. 2015. Aortic perivascular adipose-derived interleukin-6 contributes to arterial stiffness in low-density lipoprotein receptor deficient mice. Am J Physiol Heart Circ Physiol 308(11):H1382-90. PubMed: 25840831 MGI: J:224652
Du W; Wong C; Song Y; Shen H; Mori D; Rotllan N; Price N; Dobrian AD; Meng H; Kleinstein SH; Fernandez-Hernando C; Goldstein DR. 2016. Age-associated vascular inflammation promotes monocytosis during atherogenesis. Aging Cell 15(4):766-77. PubMed: 27135421 MGI: J:234787
Duewell P; Kono H; Rayner KJ; Sirois CM; Vladimer G; Bauernfeind FG; Abela GS; Franchi L; Nunez G; Schnurr M; Espevik T; Lien E; Fitzgerald KA; Rock KL; Moore KJ; Wright SD; Hornung V; Latz E. 2010. NLRP3 inflammasomes are required for atherogenesis and activated by cholesterol crystals. Nature 464(7293):1357-61. PubMed: 20428172 MGI: J:159453
Dullens SP; Mensink RP; Bragt MC; Kies AK; Plat J. 2008. Effects of emulsified policosanols with different chain lengths on cholesterol metabolism in heterozygous LDL receptor-deficient mice. J Lipid Res 49(4):790-6. PubMed: 18162663 MGI: J:133589
Dupasquier CM; Dibrov E; Kneesh AL; Cheung PK; Lee KG; Alexander HK; Yeganeh BK; Moghadasian MH; Pierce GN. 2007. Dietary flaxseed inhibits atherosclerosis in the LDL receptor-deficient mouse in part through antiproliferative and anti-inflammatory actions. Am J Physiol Heart Circ Physiol 293(4):H2394-402. PubMed: 17616740 MGI: J:126120
Eberle C; Merki E; Yamashita T; Johnson S; Armando AM; Quehenberger O; Napoli C; Palinski W. 2012. Maternal immunization affects in utero programming of insulin resistance and type 2 diabetes. PLoS One 7(9):e45361. PubMed: 23028961 MGI: J:192004
Egan KM; Lawson JA; Fries S; Koller B; Rader DJ; Smyth EM; Fitzgerald GA. 2004. COX-2-derived prostacyclin confers atheroprotection on female mice. Science 306(5703):1954-7. PubMed: 15550624 MGI: J:105640
Elder GA; Cho JY; English DF; Franciosi S; Schmeidler J; Sosa MA; Gasperi RD; Fisher EA; Mathews PM; Haroutunian V; Buxbaum JD. 2007. Elevated plasma cholesterol does not affect brain Abeta in mice lacking the low-density lipoprotein receptor. J Neurochem 102(4):1220-31. PubMed: 17472705 MGI: J:124132
Elder GA; Ragnauth A; Dorr N; Franciosi S; Schmeidler J; Haroutunian V; Buxbaum JD. 2008. Increased locomotor activity in mice lacking the low-density lipoprotein receptor. Behav Brain Res 191(2):256-265. PubMed: 18466986 MGI: J:135078
Ellison S; Gabunia K; Kelemen SE; England RN; Scalia R; Richards JM; Orr AW; Traylor JG Jr; Rogers T; Cornwell W; Berglund LM; Goncalves I; Gomez MF; Autieri MV. 2013. Attenuation of experimental atherosclerosis by interleukin-19. Arterioscler Thromb Vasc Biol 33(10):2316-24. PubMed: 23950143 MGI: J:224123
Erickson RP; Bhattacharyya A; Hunter RJ; Heidenreich RA; Cherrington NJ. 2005. Liver disease with altered bile acid transport in Niemann-Pick C mice on a high-fat, 1% cholesterol diet. Am J Physiol Gastrointest Liver Physiol 289(2):G300-7. PubMed: 15790756 MGI: J:100351
Erickson RP; Kiela M; Garver WS; Krishnan K; Heidenreich RA. 2001. Cholesterol signaling at the endoplasmic reticulum occurs in npc1(-/-) but not in npc1(-/-), LDLR(-/-) mice. Biochem Biophys Res Commun 284(2):326-30. PubMed: 11394880 MGI: J:69915
Eriksson EE; Xie X; Werr J; Thoren P; Lindbom L. 2001. Importance of primary capture and L-selectin-dependent secondary capture in leukocyte accumulation in inflammation and atherosclerosis in vivo. J Exp Med 194(2):205-18. PubMed: 11457895 MGI: J:118726
Eriksson EE; Xie X; Werr J; Thoren P; Lindbom L. 2001. Direct viewing of atherosclerosis in vivo: plaque invasion by leukocytes is initiated by the endothelial selectins. FASEB J 15(7):1149-57. PubMed: 11344083 MGI: J:120455
Espirito Santo SM; Pires NM; Boesten LS; Gerritsen G; Bovenschen N; van Dijk KW; Jukema JW; Princen HM; Bensadoun A; Li WP; Herz J; Havekes LM; van Vlijmen BJ. 2004. Hepatic low-density lipoprotein receptor-related protein deficiency in mice increases atherosclerosis independent of plasma cholesterol. Blood 103(10):3777-82. PubMed: 14739216 MGI: J:90547
Estrada-Smith D; Collins AR; Wang X; Crockett C; Castellani L; Lusis AJ; Davis RC. 2006. Impact of chromosome 2 obesity loci on cardiovascular complications of insulin resistance in LDL receptor-deficient C57BL/6 mice. Diabetes 55(8):2265-71. PubMed: 16873689 MGI: J:116503
Fan J; Stukas S; Wong C; Chan J; May S; Devalle N; Hirsch-Reinshagen V; Wilkinson A; Oda MN; Wellington CL. 2011. An ABCA1-independent pathway for recycling a poorly lipidated 8.1 nm apolipoprotein E particle from glia. J Lipid Res 52(9):1605-16. PubMed: 21705806 MGI: J:175557
Farris SD; Hu JH; Krishnan R; Emery I; Chu T; Du L; Kremen M; Dichek HL; Gold E; Ramsey SA; Dichek DA. 2011. Mechanisms of urokinase plasminogen activator (uPA)-mediated atherosclerosis: role of the uPA receptor and S100A8/A9 proteins. J Biol Chem 286(25):22665-77. PubMed: 21536666 MGI: J:174810
Fazio S; Babaev VR; Burleigh ME; Major AS; Hasty AH; Linton MF. 2002. Physiological expression of macrophage apoE in the artery wall reduces atherosclerosis in severely hyperlipidemic mice. J Lipid Res 43(10):1602-9. PubMed: 12364544 MGI: J:79439
Fazio S; Hasty AH; Carter KJ; Murray AB; Price JO; Linton MF. 1997. Leukocyte low density lipoprotein receptor (LDL-R) does not contribute to LDL clearance in vivo: bone marrow transplantation studies in the mouse. J Lipid Res 38(2):391-400. PubMed: 9162757 MGI: J:38840
Feig JE; Parathath S; Rong JX; Mick SL; Vengrenyuk Y; Grauer L; Young SG; Fisher EA. 2011. Reversal of hyperlipidemia with a genetic switch favorably affects the content and inflammatory state of macrophages in atherosclerotic plaques. Circulation 123(9):989-98. PubMed: 21339485 MGI: J:183750
Feig JE; Pineda-Torra I; Sanson M; Bradley MN; Vengrenyuk Y; Bogunovic D; Gautier EL; Rubinstein D; Hong C; Liu J; Wu C; van Rooijen N; Bhardwaj N; Garabedian M; Tontonoz P; Fisher EA. 2010. LXR promotes the maximal egress of monocyte-derived cells from mouse aortic plaques during atherosclerosis regression. J Clin Invest 120(12):4415-24. PubMed: 21041949 MGI: J:171875
Feng Y; Schouteden S; Geenens R; Van Duppen V; Herijgers P; Holvoet P; Van Veldhoven PP; Verfaillie CM. 2012. Hematopoietic stem/progenitor cell proliferation and differentiation is differentially regulated by high-density and low-density lipoproteins in mice. PLoS One 7(11):e47286. PubMed: 23144813 MGI: J:194860
Fernandez-Ruiz I; Puchalska P; Narasimhulu CA; Sengupta B; Parthasarathy S. 2016. Differential lipid metabolism in monocytes and macrophages: influence of cholesterol loading. J Lipid Res 57(4):574-86. PubMed: 26839333 MGI: J:231628
Ferreira DF; Fiamoncini J; Prist IH; Ariga SK; de Souza HP; de Lima TM. 2015. Novel role of TLR4 in NAFLD development: Modulation of metabolic enzymes expression. Biochim Biophys Acta 1851(10):1353-9. PubMed: 26172853 MGI: J:231242
Findeisen HM; Gizard F; Zhao Y; Cohn D; Heywood EB; Jones KL; Lovett DH; Howatt DA; Daugherty A; Bruemmer D. 2011. Telomerase deficiency in bone marrow-derived cells attenuates angiotensin II-induced abdominal aortic aneurysm formation. Arterioscler Thromb Vasc Biol 31(2):253-60. PubMed: 21088250 MGI: J:184181
Foks AC; Ran IA; Frodermann V; Bot I; van Santbrink PJ; Kuiper J; van Puijvelde GH. 2013. Agonistic anti-TIGIT treatment inhibits T cell responses in LDLr deficient mice without affecting atherosclerotic lesion development. PLoS One 8(12):e83134. PubMed: 24376654 MGI: J:211124
Foks AC; Ran IA; Wasserman L; Frodermann V; Ter Borg MN; de Jager SC; van Santbrink PJ; Yagita H; Akiba H; Bot I; Kuiper J; van Puijvelde GH. 2013. T-cell immunoglobulin and mucin domain 3 acts as a negative regulator of atherosclerosis. Arterioscler Thromb Vasc Biol 33(11):2558-65. PubMed: 23990206 MGI: J:222219
Foks AC; van Puijvelde GH; Bot I; ter Borg MN; Habets KL; Johnson JL; Yagita H; van Berkel TJ; Kuiper J. 2013. Interruption of the OX40-OX40 ligand pathway in LDL receptor-deficient mice causes regression of atherosclerosis. J Immunol 191(9):4573-80. PubMed: 24068673 MGI: J:206243
Fond AM; Lee CS; Schulman IG; Kiss RS; Ravichandran KS. 2015. Apoptotic cells trigger a membrane-initiated pathway to increase ABCA1. J Clin Invest 125(7):2748-58. PubMed: 26075824 MGI: J:224549
Fontana K; Campos GE; Staron RS; da Cruz-Hofling MA. 2013. Effects of anabolic steroids and high-intensity aerobic exercise on skeletal muscle of transgenic mice. PLoS One 8(11):e80909. PubMed: 24260508 MGI: J:209673
Forte TM; Subbanagounder G; Berliner JA; Blanche PJ; Clermont AO; Jia Z; Oda MN; Krauss RM; Bielicki JK. 2002. Altered activities of anti-atherogenic enzymes LCAT, paraoxonase, and platelet-activating factor acetylhydrolase in atherosclerosis-susceptible mice. J Lipid Res 43(3):477-85. PubMed: 11893784 MGI: J:75568
Fougerat A; Gayral S; Gourdy P; Schambourg A; Ruckle T; Schwarz MK; Rommel C; Hirsch E; Arnal JF; Salles JP; Perret B; Breton-Douillon M; Wymann MP; Laffargue M. 2008. Genetic and pharmacological targeting of phosphoinositide 3-kinase-gamma reduces atherosclerosis and favors plaque stability by modulating inflammatory processes. Circulation 117(10):1310-7. PubMed: 18268153 MGI: J:148451
Franco C; Ahmad PJ; Hou G; Wong E; Bendeck MP. 2010. Increased cell and matrix accumulation during atherogenesis in mice with vessel wall-specific deletion of discoidin domain receptor 1. Circ Res 106(11):1775-83. PubMed: 20448217 MGI: J:172702
Franco C; Britto K; Wong E; Hou G; Zhu SN; Chen M; Cybulsky MI; Bendeck MP. 2009. Discoidin domain receptor 1 on bone marrow-derived cells promotes macrophage accumulation during atherogenesis. Circ Res 105(11):1141-8. PubMed: 19834008 MGI: J:170145
Franco C; Hou G; Ahmad PJ; Fu EY; Koh L; Vogel WF; Bendeck MP. 2008. Discoidin domain receptor 1 (ddr1) deletion decreases atherosclerosis by accelerating matrix accumulation and reducing inflammation in low-density lipoprotein receptor-deficient mice. Circ Res 102(10):1202-11. PubMed: 18451340 MGI: J:149015
Francone OL; Royer L; Boucher G; Haghpassand M; Freeman A; Brees D; Aiello RJ. 2005. Increased cholesterol deposition, expression of scavenger receptors, and response to chemotactic factors in Abca1-deficient macrophages. Arterioscler Thromb Vasc Biol 25(6):1198-205. PubMed: 15831807 MGI: J:114227
Freeman L; Amar MJ; Shamburek R; Paigen B; Brewer HB Jr; Santamarina-Fojo S; Gonzalez-Navarro H. 2007. Lipolytic and ligand-binding functions of hepatic lipase protect against atherosclerosis in LDL receptor-deficient mice. J Lipid Res 48(1):104-13. PubMed: 17071916 MGI: J:117481
Freigang S; Ampenberger F; Weiss A; Kanneganti TD; Iwakura Y; Hersberger M; Kopf M. 2013. Fatty acid-induced mitochondrial uncoupling elicits inflammasome-independent IL-1alpha and sterile vascular inflammation in atherosclerosis. Nat Immunol 14(10):1045-53. PubMed: 23995233 MGI: J:208219
Freigang S; Landais E; Zadorozhny V; Kain L; Yoshida K; Liu Y; Deng S; Palinski W; Savage PB; Bendelac A; Teyton L. 2012. Scavenger receptors target glycolipids for natural killer T cell activation. J Clin Invest 122(11):3943-54. PubMed: 23064364 MGI: J:193547
Freigang S; Zadorozhny V; McKinney MK; Krebs P; Herro R; Pawlak J; Kain L; Schrantz N; Masuda K; Liu Y; Savage PB; Bendelac A; Cravatt BF; Teyton L. 2010. Fatty acid amide hydrolase shapes NKT cell responses by influencing the serum transport of lipid antigen in mice. J Clin Invest 120(6):1873-84. PubMed: 20484813 MGI: J:161640
Fryer JD; Demattos RB; McCormick LM; O'Dell MA; Spinner ML; Bales KR; Paul SM; Sullivan PM; Parsadanian M; Bu G; Holtzman DM. 2005. The low density lipoprotein receptor regulates the level of central nervous system human and murine apolipoprotein E but does not modify amyloid plaque pathology in PDAPP mice. J Biol Chem 280(27):25754-9. PubMed: 15888448 MGI: J:100836
Fu D; Yu JY; Yang S; Wu M; Hammad SM; Connell AR; Du M; Chen J; Lyons TJ. 2016. Survival or death: a dual role for autophagy in stress-induced pericyte loss in diabetic retinopathy. Diabetologia 59(10):2251-61. PubMed: 27475954 MGI: J:237049
Fukuda D; Aikawa E; Swirski FK; Novobrantseva TI; Kotelianski V; Gorgun CZ; Chudnovskiy A; Yamazaki H; Croce K; Weissleder R; Aster JC; Hotamisligil GS; Yagita H; Aikawa M. 2012. Notch ligand Delta-like 4 blockade attenuates atherosclerosis and metabolic disorders. Proc Natl Acad Sci U S A 109(27):E1868-77. PubMed: 22699504 MGI: J:186429
Furbee JW Jr; Francone O; Parks JS. 2001. Alteration of plasma HDL cholesteryl ester composition with transgenic expression of a point mutation (E149A) of human LCAT. J Lipid Res 42(10):1626-35. PubMed: 11590219 MGI: J:124250
Furbee JW Jr; Francone O; Parks JS. 2002. In vivo contribution of LCAT to apolipoprotein B lipoprotein cholesteryl esters in LDL receptor and apolipoprotein E knockout mice. J Lipid Res 43(3):428-37. PubMed: 11893779 MGI: J:75567
Furbee JW Jr; Sawyer JK; Parks JS. 2002. Lecithin:cholesterol acyltransferase deficiency increases atherosclerosis in the low density lipoprotein receptor and apolipoprotein E knockout mice. J Biol Chem 277(5):3511-9. PubMed: 11719520 MGI: J:74315
Gabunia K; Ellison S; Kelemen S; Kako F; Cornwell WD; Rogers TJ; Datta PK; Ouimet M; Moore KJ; Autieri MV. 2016. IL-19 Halts Progression of Atherosclerotic Plaque, Polarizes, and Increases Cholesterol Uptake and Efflux in Macrophages. Am J Pathol 186(5):1361-74. PubMed: 26952642 MGI: J:231915
Garcia RA; Yan M; Search D; Zhang R; Carson NL; Ryan CS; Smith-Monroy C; Zheng J; Chen J; Kong Y; Tang H; Hellings SE; Wardwell-Swanson J; Dinchuk JE; Psaltis GC; Gordon DA; Glunz PW; Gargalovic PS. 2014. P2Y6 receptor potentiates pro-inflammatory responses in macrophages and exhibits differential roles in atherosclerotic lesion development. PLoS One 9(10):e111385. PubMed: 25360548 MGI: J:223087
Gaudreault N; Kumar N; Posada JM; Stephens KB; Reyes de Mochel NS; Eberle D; Olivas VR; Kim RY; Harms MJ; Johnson S; Messina LM; Rapp JH; Raffai RL. 2012. ApoE suppresses atherosclerosis by reducing lipid accumulation in circulating monocytes and the expression of inflammatory molecules on monocytes and vascular endothelium. Arterioscler Thromb Vasc Biol 32(2):264-72. PubMed: 22053073 MGI: J:195610
Gayral S; Garnotel R; Castaing-Berthou A; Blaise S; Fougerat A; Berge E; Montheil A; Malet N; Wymann MP; Maurice P; Debelle L; Martiny L; Martinez LO; Pshezhetsky AV; Duca L; Laffargue M. 2014. Elastin-derived peptides potentiate atherosclerosis through the immune Neu1-PI3Kgamma pathway. Cardiovasc Res 102(1):118-27. PubMed: 24357053 MGI: J:229142
Ge S; Hertel B; Koltsova EK; Sorensen-Zender I; Kielstein JT; Ley K; Haller H; von Vietinghoff S. 2013. Increased atherosclerotic lesion formation and vascular leukocyte accumulation in renal impairment are mediated by interleukin-17A. Circ Res 113(8):965-74. PubMed: 23908345 MGI: J:213467
Gendron ME; Theoret JF; Mamarbachi AM; Drouin A; Nguyen A; Bolduc V; Thorin-Trescases N; Merhi Y; Thorin E. 2010. Late chronic catechin antioxidant treatment is deleterious to the endothelial function in aging mice with established atherosclerosis. Am J Physiol Heart Circ Physiol 298(6):H2062-70. PubMed: 20382853 MGI: J:160434
George J; Afek A; Shaish A; Levkovitz H; Bloom N; Cyrus T; Zhao L; Funk CD; Sigal E; Harats D. 2001. 12/15-Lipoxygenase gene disruption attenuates atherogenesis in LDL receptor-deficient mice. Circulation 104(14):1646-50. PubMed: 11581143 MGI: J:86385
George J; Shoenfeld Y; Harats D. 1999. The involvement of beta2-glycoprotein I (beta2-GPI) in human and murine atherosclerosis. J Autoimmun 13(1):57-60. PubMed: 10441168 MGI: J:56653
German DC; Quintero EM; Liang C; Xie C; Dietschy JM. 2001. Degeneration of neurons and glia in the Niemann-Pick C mouse is unrelated to the low-density lipoprotein receptor. Neuroscience 105(4):999-1005. PubMed: 11530237 MGI: J:126474
Gessner DK; Ringseis R; Moller C; Eder K. 2012. Increased plasma thyroid hormone concentrations in LDL receptor deficient mice may be explained by inhibition of aryl hydrocarbon receptor-dependent expression of hepatic UDP-glucuronosyltransferases. Biochim Biophys Acta 1820(4):495-502. PubMed: 22185956 MGI: J:182449
Ghazalpour A; Wang X; Lusis AJ; Mehrabian M. 2006. Complex inheritance of the 5-lipoxygenase locus influencing atherosclerosis in mice. Genetics 173(2):943-51. PubMed: 16624897 MGI: J:109792
Ghesquiere SA; Gijbels MJ; Anthonsen M; van Gorp PJ; van der Made I; Johansen B; Hofker MH; de Winther MP. 2005. Macrophage-specific overexpression of group IIa sPLA2 increases atherosclerosis and enhances collagen deposition. J Lipid Res 46(2):201-10. PubMed: 15576846 MGI: J:136941
Girod WG; Jones SP; Sieber N; Aw TY; Lefer DJ. 1999. Effects of hypercholesterolemia on myocardial ischemia-reperfusion injury in LDL receptor-deficient mice. Arterioscler Thromb Vasc Biol 19(11):2776-81. PubMed: 10559025 MGI: J:129258
Gistera A; Robertson AK; Andersson J; Ketelhuth DF; Ovchinnikova O; Nilsson SK; Lundberg AM; Li MO; Flavell RA; Hansson GK. 2013. Transforming growth factor-beta signaling in T cells promotes stabilization of atherosclerotic plaques through an interleukin-17-dependent pathway. Sci Transl Med 5(196):196ra100. PubMed: 23903754 MGI: J:213468
Gitlin JM; Homeister JW; Bulgrien J; Counselman J; Curtiss LK; Lowe JB; Boisvert WA. 2009. Disruption of tissue-specific fucosyltransferase VII, an enzyme necessary for selectin ligand synthesis, suppresses atherosclerosis in mice. Am J Pathol 174(1):343-50. PubMed: 19056851 MGI: J:144237
Goel R; Schrank BR; Arora S; Boylan B; Fleming B; Miura H; Newman PJ; Molthen RC; Newman DK. 2008. Site-specific effects of PECAM-1 on atherosclerosis in LDL receptor-deficient mice. Arterioscler Thromb Vasc Biol 28(11):1996-2002. PubMed: 18669884 MGI: J:159801
Goldberg IJ; Hu Y; Noh HL; Wei J; Huggins LA; Rackmill MG; Hamai H; Reid BN; Blaner WS; Huang LS. 2008. Decreased lipoprotein clearance is responsible for increased cholesterol in LDL receptor knockout mice with streptozotocin-induced diabetes. Diabetes 57(6):1674-82. PubMed: 18346984 MGI: J:136922
Goldberg IJ; Huang LS; Huggins LA; Yu S; Nagareddy PR; Scanlan TS; Ehrenkranz JR. 2012. Thyroid hormone reduces cholesterol via a non-LDL receptor-mediated pathway. Endocrinology 153(11):5143-9. PubMed: 22948212 MGI: J:192913
Gonon AT; Bulhak A; Broijersen A; Pernow J. 2005. Cardioprotective effect of an endothelin receptor antagonist during ischaemia/reperfusion in the severely atherosclerotic mouse heart. Br J Pharmacol 144(6):860-6. PubMed: 15685207 MGI: J:110052
Gonzales JC; Gordts PL; Foley EM; Esko JD. 2013. Apolipoproteins E and AV mediate lipoprotein clearance by hepatic proteoglycans. J Clin Invest 123(6):2742-51. PubMed: 23676495 MGI: J:201440
Goossens P; Gijbels MJ; Zernecke A; Eijgelaar W; Vergouwe MN; van der Made I; Vanderlocht J; Beckers L; Buurman WA; Daemen MJ; Kalinke U; Weber C; Lutgens E; de Winther MP. 2010. Myeloid type I interferon signaling promotes atherosclerosis by stimulating macrophage recruitment to lesions. Cell Metab 12(2):142-53. PubMed: 20674859 MGI: J:163078
Goossens P; Vergouwe MN; Gijbels MJ; Curfs DM; van Woezik JH; Hoeksema MA; Xanthoulea S; Leenen PJ; Rupec RA; Hofker MH; de Winther MP. 2011. Myeloid IkappaBalpha Deficiency Promotes Atherogenesis by Enhancing Leukocyte Recruitment to the Plaques. PLoS One 6(7):e22327. PubMed: 21814576 MGI: J:174920
Gordts PL; Nock R; Son NH; Ramms B; Lew I; Gonzales JC; Thacker BE; Basu D; Lee RG; Mullick AE; Graham MJ; Goldberg IJ; Crooke RM; Witztum JL; Esko JD. 2016. ApoC-III inhibits clearance of triglyceride-rich lipoproteins through LDL family receptors. J Clin Invest 126(8):2855-66. PubMed: 27400128 MGI: J:237124
Gordts PL; Reekmans S; Lauwers A; Van Dongen A; Verbeek L; Roebroek AJ. 2009. Inactivation of the LRP1 intracellular NPxYxxL motif in LDLR-deficient mice enhances postprandial dyslipidemia and atherosclerosis. Arterioscler Thromb Vasc Biol 29(9):1258-64. PubMed: 19667105 MGI: J:167801
Gordts SC; Van Craeyveld E; Muthuramu I; Singh N; Jacobs F; De Geest B. 2012. Lipid lowering and HDL raising gene transfer increase endothelial progenitor cells, enhance myocardial vascularity, and improve diastolic function. PLoS One 7(10):e46849. PubMed: 23056485 MGI: J:191934
Graham MJ; Lee RG; Bell TA 3rd; Fu W; Mullick AE; Alexander VJ; Singleton W; Viney N; Geary R; Su J; Baker BF; Burkey J; Crooke ST; Crooke RM. 2013. Antisense oligonucleotide inhibition of apolipoprotein C-III reduces plasma triglycerides in rodents, nonhuman primates, and humans. Circ Res 112(11):1479-90. PubMed: 23542898 MGI: J:213303
Grainger DJ; Reckless J; McKilligin E. 2004. Apolipoprotein E modulates clearance of apoptotic bodies in vitro and in vivo, resulting in a systemic proinflammatory state in apolipoprotein E-deficient mice. J Immunol 173(10):6366-75. PubMed: 15528376 MGI: J:94282
Gruber S; Hendrikx T; Tsiantoulas D; Ozsvar-Kozma M; Goderle L; Mallat Z; Witztum JL; Shiri-Sverdlov R; Nitschke L; Binder CJ. 2016. Sialic Acid-Binding Immunoglobulin-like Lectin G Promotes Atherosclerosis and Liver Inflammation by Suppressing the Protective Functions of B-1 Cells. Cell Rep 14(10):2348-61. PubMed: 26947073 MGI: J:234347
Gu L; Okada Y; Clinton SK; Gerard C; Sukhova GK; Libby P; Rollins BJ. 1998. Absence of monocyte chemoattractant protein-1 reduces atherosclerosis in low density lipoprotein receptor-deficient mice. Mol Cell 2(2):275-81. PubMed: 9734366 MGI: J:75837
Guo W; Wong S; Bhasin S. 2013. AAV-mediated administration of myostatin pro-peptide mutant in adult Ldlr null mice reduces diet-induced hepatosteatosis and arteriosclerosis. PLoS One 8(8):e71017. PubMed: 23936482 MGI: J:205772
Gupte AA; Minze LJ; Reyes M; Ren Y; Wang X; Brunner G; Ghosn M; Cordero-Reyes AM; Ding K; Pratico D; Morrisett J; Shi ZZ; Hamilton DJ; Lyon CJ; Hsueh WA. 2013. High-fat feeding-induced hyperinsulinemia increases cardiac glucose uptake and mitochondrial function despite peripheral insulin resistance. Endocrinology 154(8):2650-62. PubMed: 23709089 MGI: J:201180
Haeusler RA; Pratt-Hyatt M; Welch CL; Klaassen CD; Accili D. 2012. Impaired generation of 12-hydroxylated bile acids links hepatic insulin signaling with dyslipidemia. Cell Metab 15(1):65-74. PubMed: 22197325 MGI: J:182348
Hager L; Li L; Pun H; Liu L; Hossain MA; Maguire GF; Naples M; Baker C; Magomedova L; Tam J; Adeli K; Cummins CL; Connelly PW; Ng DS. 2012. Lecithin:cholesterol acyltransferase deficiency protects against cholesterol-induced hepatic endoplasmic reticulum stress in mice. J Biol Chem 287(24):20755-68. PubMed: 22500017 MGI: J:186520
Hamers AA; Vos M; Rassam F; Marinkovic G; Kurakula K; van Gorp PJ; de Winther MP; Gijbels MJ; de Waard V; de Vries CJ. 2012. Bone marrow-specific deficiency of nuclear receptor Nur77 enhances atherosclerosis. Circ Res 110(3):428-38. PubMed: 22194623 MGI: J:192703
Han CY; Subramanian S; Chan CK; Omer M; Chiba T; Wight TN; Chait A. 2007. Adipocyte-derived serum amyloid A3 and hyaluronan play a role in monocyte recruitment and adhesion. Diabetes 56(9):2260-73. PubMed: 17563062 MGI: J:126587
Han L; Tang MX; Ti Y; Wang ZH; Wang J; Ding WY; Wang H; Zhang Y; Zhang W; Zhong M. 2013. Overexpressing STAMP2 improves insulin resistance in diabetic ApoE(-)/(-)/LDLR(-)/(-) mice via macrophage polarization shift in adipose tissues. PLoS One 8(11):e78903. PubMed: 24236066 MGI: J:209316
Han S; Liang CP; DeVries-Seimon T; Ranalletta M; Welch CL; Collins-Fletcher K; Accili D; Tabas I; Tall AR. 2006. Macrophage insulin receptor deficiency increases ER stress-induced apoptosis and necrotic core formation in advanced atherosclerotic lesions. Cell Metab 3(4):257-66. PubMed: 16581003 MGI: J:129653
Han S; Liang CP; Westerterp M; Senokuchi T; Welch CL; Wang Q; Matsumoto M; Accili D; Tall AR. 2009. Hepatic insulin signaling regulates VLDL secretion and atherogenesis in mice. J Clin Invest 119(4):1029-41. PubMed: 19273907 MGI: J:149755
Han Y; Qi R; Liu G. 2015. Reduced high density lipoprotein cholesterol in severe hypertriglyceridemic ApoCIII transgenic mice via lowered hepatic ApoAI synthesis. Biochem Biophys Res Commun 462(4):420-5. PubMed: 25969427 MGI: J:228456
Hanna RN; Shaked I; Hubbeling HG; Punt JA; Wu R; Herrley E; Zaugg C; Pei H; Geissmann F; Ley K; Hedrick CC. 2012. NR4A1 (Nur77) deletion polarizes macrophages toward an inflammatory phenotype and increases atherosclerosis. Circ Res 110(3):416-27. PubMed: 22194622 MGI: J:192704
Hara S; Kobayashi N; Sakamoto K; Ueno T; Manabe S; Takashima Y; Hamada J; Pastan I; Fukamizu A; Matsusaka T; Nagata M. 2015. Podocyte injury-driven lipid peroxidation accelerates the infiltration of glomerular foam cells in focal segmental glomerulosclerosis. Am J Pathol 185(8):2118-31. PubMed: 26072030 MGI: J:225648
Harada-Shiba M; Takagi A; Marutsuka K; Moriguchi S; Yagyu H; Ishibashi S; Asada Y; Yokoyama S. 2004. Disruption of autosomal recessive hypercholesterolemia gene shows different phenotype in vitro and in vivo. Circ Res 95(9):945-52. PubMed: 15472122 MGI: J:102291
Harats D; Shaish A; George J; Mulkins M; Kurihara H; Levkovitz H; Sigal E. 2000. Overexpression of 15-lipoxygenase in vascular endothelium accelerates early atherosclerosis in LDL receptor-deficient mice. Arterioscler Thromb Vasc Biol 20(9):2100-5. PubMed: 10978255 MGI: J:127953
Hartman HB; Lai K; Evans MJ. 2009. Loss of small heterodimer partner expression in the liver protects against dyslipidemia. J Lipid Res 50(2):193-203. PubMed: 18820241 MGI: J:149005
Hartvigsen K; Binder CJ; Hansen LF; Rafia A; Juliano J; Horkko S; Steinberg D; Palinski W; Witztum JL; Li AC. 2007. A diet-induced hypercholesterolemic murine model to study atherogenesis without obesity and metabolic syndrome. Arterioscler Thromb Vasc Biol 27(4):878-85. PubMed: 17255537 MGI: J:148155
Hasty AH; Shimano H; Osuga Ji; Namatame I; Takahashi A; Yahagi N; Perrey S; Iizuka Y; Tamura Y; Amemiya-Kudo M; Yoshikawa T; Okazaki H; Ohashi K; Harada K; Matsuzaka T; Sone H; Gotoda T; Nagai R; Ishibashi S; Yamada N. 2001. Severe hypercholesterolemia, hypertriglyceridemia, and atherosclerosis in mice lacking both leptin and the low density lipoprotein receptor. J Biol Chem 276(40):37402-8. PubMed: 11445560 MGI: J:72027
Hauer AD; Uyttenhove C; de Vos P; Stroobant V; Renauld JC; van Berkel TJ; van Snick J; Kuiper J. 2005. Blockade of interleukin-12 function by protein vaccination attenuates atherosclerosis. Circulation 112(7):1054-62. PubMed: 16103256 MGI: J:117550
Heikkila HM; Trosien J; Metso J; Jauhiainen M; Pentikainen MO; Kovanen PT; Lindstedt KA. 2010. Mast cells promote atherosclerosis by inducing both an atherogenic lipid profile and vascular inflammation. J Cell Biochem 109(3):615-23. PubMed: 20024959 MGI: J:161254
Heinonen SE; Leppanen P; Kholova I; Lumivuori H; Hakkinen SK; Bosch F; Laakso M; Yla-Herttuala S. 2007. Increased atherosclerotic lesion calcification in a novel mouse model combining insulin resistance, hyperglycemia, and hypercholesterolemia. Circ Res 101(10):1058-67. PubMed: 17872464 MGI: J:141333
Hemdahl AL; Falk E; Thoren P; Hansson GK. 2004. Thrombin inhibitor reduces myocardial infarction in apoE-/- x LDLR-/- mice. Am J Physiol Heart Circ Physiol 287(2):H872-7. PubMed: 15031124 MGI: J:95598
Hendrikx T; Bieghs V; Walenbergh SM; van Gorp PJ; Verheyen F; Jeurissen ML; Steinbusch MM; Vaes N; Binder CJ; Koek GH; Stienstra R; Netea MG; Hofker MH; Shiri-Sverdlov R. 2013. Macrophage specific caspase-1/11 deficiency protects against cholesterol crystallization and hepatic inflammation in hyperlipidemic mice. PLoS One 8(12):e78792. PubMed: 24312444 MGI: J:209749
Henninger DD; Gerritsen ME; Granger DN. 1997. Low-density lipoprotein receptor knockout mice exhibit exaggerated microvascular responses to inflammatory stimuli. Circ Res 81(2):274-81. PubMed: 9242189 MGI: J:42527
Herijgers N; Van Eck M; Korporaal SJ; Hoogerbrugge PM; Van Berkel TJ. 2000. Relative importance of the LDL receptor and scavenger receptor class B in the beta-VLDL-induced uptake and accumulation of cholesteryl esters by peritoneal macrophages J Lipid Res 41(7):1163-71. PubMed: 10884299 MGI: J:63449
Herijgers N; de Winther MP; Van Eck M; Havekes LM; Hofker MH; Hoogerbrugge PM; Van Berkel TJ. 2000. Effect of human scavenger receptor class A overexpression in bone marrow-derived cells on lipoprotein metabolism and atherosclerosis in low density lipoprotein receptor knockout mice J Lipid Res 41(9):1402-9. PubMed: 10974047 MGI: J:64891
Herz J; Qiu SQ; Oesterle A; DeSilva HV; Shafi S; Havel RJ. 1995. Initial hepatic removal of chylomicron remnants is unaffected but endocytosis is delayed in mice lacking the low density lipoprotein receptor. Proc Natl Acad Sci U S A 92(10):4611-5. PubMed: 7753850 MGI: J:25195
Hilgendorf I; Theurl I; Gerhardt LM; Robbins CS; Weber GF; Gonen A; Iwamoto Y; Degousee N; Holderried TA; Winter C; Zirlik A; Lin HY; Sukhova GK; Butany J; Rubin BB; Witztum JL; Libby P; Nahrendorf M; Weissleder R; Swirski FK. 2014. Innate response activator B cells aggravate atherosclerosis by stimulating T helper-1 adaptive immunity. Circulation 129(16):1677-87. PubMed: 24488984 MGI: J:221696
Hime NJ; Black AS; Bulgrien JJ; Curtiss LK. 2008. Leukocyte-derived hepatic lipase increases HDL and decreases en face aortic atherosclerosis in LDLr-/- mice expressing CETP. J Lipid Res 49(10):2113-23. PubMed: 18599739 MGI: J:140426
Hockings PD; Roberts T; Galloway GJ; Reid DG; Harris DA; Vidgeon-Hart M; Groot PH; Suckling KE; Benson GM. 2002. Repeated three-dimensional magnetic resonance imaging of atherosclerosis development in innominate arteries of low-density lipoprotein receptor-knockout mice. Circulation 106(13):1716-21. PubMed: 12270868 MGI: J:103222
Hoeksema MA; Gijbels MJ; Van den Bossche J; van der Velden S; Sijm A; Neele AE; Seijkens T; Stoger JL; Meiler S; Boshuizen MC; Dallinga-Thie GM; Levels JH; Boon L; Mullican SE; Spann NJ; Cleutjens JP; Glass CK; Lazar MA; de Vries CJ; Biessen EA; Daemen MJ; Lutgens E; de Winther MP. 2014. Targeting macrophage Histone deacetylase 3 stabilizes atherosclerotic lesions. EMBO Mol Med 6(9):1124-32. PubMed: 25007801 MGI: J:232468
Hoekstra M; Stitzinger M; van Wanrooij EJ; Michon IN; Kruijt JK; Kamphorst J; Van Eck M; Vreugdenhil E; Van Berkel TJ; Kuiper J. 2006. Microarray analysis indicates an important role for FABP5 and putative novel FABPs on a Western-type diet. J Lipid Res 47(10):2198-207. PubMed: 16885566 MGI: J:116502
Hoekstra M; Van Eck M. 2016. HDL is redundant for adrenal steroidogenesis in LDLR knockout mice with a human-like lipoprotein profile. J Lipid Res 57(4):631-7. PubMed: 26891738 MGI: J:231607
Holdt LM; Thiery J; Breslow JL; Teupser D. 2008. Increased ADAM17 mRNA expression and activity is associated with atherosclerosis resistance in LDL-receptor deficient mice. Arterioscler Thromb Vasc Biol 28(6):1097-103. PubMed: 18356551 MGI: J:149028
Hu C; Dandapat A; Sun L; Chen J; Marwali MR; Romeo F; Sawamura T; Mehta JL. 2008. LOX-1 deletion decreases collagen accumulation in atherosclerotic plaque in low-density lipoprotein receptor knockout mice fed a high-cholesterol diet. Cardiovasc Res 79(2):287-93. PubMed: 18453637 MGI: J:161897
Hu L; Boesten LS; May P; Herz J; Bovenschen N; Huisman MV; Berbee JF; Havekes LM; van Vlijmen BJ; Tamsma JT. 2006. Macrophage low-density lipoprotein receptor-related protein deficiency enhances atherosclerosis in ApoE/LDLR double knockout mice. Arterioscler Thromb Vasc Biol 26(12):2710-5. PubMed: 17038633 MGI: J:129557
Hu L; van der Hoogt CC; Espirito Santo SM; Out R; Kypreos KE; van Vlijmen BJ; Van Berkel TJ; Romijn JA; Havekes LM; van Dijk KW; Rensen PC. 2008. The hepatic uptake of VLDL in lrp-ldlr-/-vldlr-/- mice is regulated by LPL activity and involves proteoglycans and SR-BI. J Lipid Res 49(7):1553-61. PubMed: 18367731 MGI: J:138462
Huang F; Thompson JC; Wilson PG; Aung HH; Rutledge JC; Tannock LR. 2008. Angiotensin II increases vascular proteoglycan content preceding and contributing to atherosclerosis development. J Lipid Res 49(3):521-30. PubMed: 18033753 MGI: J:133289
Huang Y; Liu XQ; Rall SC Jr; Taylor JM; von Eckardstein A; Assmann G; Mahley RW. 1998. Overexpression and accumulation of apolipoprotein E as a cause of hypertriglyceridemia. J Biol Chem 273(41):26388-93. PubMed: 9756870 MGI: J:115206
Huang Y; Rall SC Jr; Mahley RW. 1997. Genetic factors precipitating type III hyperlipoproteinemia in hypolipidemic transgenic mice expressing human apolipoprotein E2. Arterioscler Thromb Vasc Biol 17(11):2817-24. PubMed: 9409260 MGI: J:45728
Hui Y; Ricciotti E; Crichton I; Yu Z; Wang D; Stubbe J; Wang M; Pure E; FitzGerald GA. 2010. Targeted deletions of cyclooxygenase-2 and atherogenesis in mice. Circulation 121(24):2654-60. PubMed: 20530000 MGI: J:178670
Hulsmans M; Geeraert B; Arnould T; Tsatsanis C; Holvoet P. 2013. PPAR agonist-induced reduction of Mcp1 in atherosclerotic plaques of obese, insulin-resistant mice depends on adiponectin-induced Irak3 expression. PLoS One 8(4):e62253. PubMed: 23620818 MGI: J:200636
Huszar D; Varban ML; Rinninger F; Feeley R; Arai T; Fairchild-Huntress V; Donovan MJ; Tall AR. 2000. Increased LDL cholesterol and atherosclerosis in LDL receptor-deficient mice with attenuated expression of scavenger receptor B1. Arterioscler Thromb Vasc Biol 20(4):1068-73. PubMed: 10764675 MGI: J:62371
Igbavboa U; Avdulov NA; Chochina SV; Wood WG. 1997. Transbilayer distribution of cholesterol is modified in brain synaptic plasma membranes of knockout mice deficient in the low-density lipoprotein receptor, apolipoprotein E, or both proteins. J Neurochem 69(4):1661-7. PubMed: 9326295 MGI: J:43043
Iqbal J; Rudel LL; Hussain MM. 2008. Microsomal triglyceride transfer protein enhances cellular cholesteryl esterification by relieving product inhibition. J Biol Chem 283(29):19967-80. PubMed: 18502767 MGI: J:138737
Ishibashi S; Goldstein JL; Brown MS; Herz J; Burns DK. 1994. Massive xanthomatosis and atherosclerosis in cholesterol-fed low density lipoprotein receptor-negative mice. J Clin Invest 93(5):1885-93. PubMed: 8182121 MGI: J:77012
Ishibashi S; Hammer RE; Herz J. 1994. Asialoglycoprotein receptor deficiency in mice lacking the minor receptor subunit. J Biol Chem 269(45):27803-6. PubMed: 7961705 MGI: J:21380
Ishibashi S; Herz J; Maeda N; Goldstein JL; Brown MS. 1994. The two-receptor model of lipoprotein clearance: tests of the hypothesis in knockout mice lacking the low density lipoprotein receptor, apolipoprotein E, or both proteins. Proc Natl Acad Sci U S A 91(10):4431-5. PubMed: 8183926 MGI: J:18138
Ishibashi S; Perrey S; Chen Z; Osuga Ji; Shimada M; Ohashi K; Harada K; Yazaki Y; Yamada N. 1996. Role of the low density lipoprotein (LDL) receptor pathway in the metabolism of chylomicron remnants. A quantitative study in knockout mice lacking the LDL receptor, apolipoprotein E, or both. J Biol Chem 271(37):22422-7. PubMed: 8798405 MGI: J:35377
Ishikawa K; Sugawara D; Wang Xp; Suzuki K; Itabe H; Maruyama Y; Lusis AJ. 2001. Heme oxygenase-1 inhibits atherosclerotic lesion formation in ldl-receptor knockout mice. Circ Res 88(5):506-12. PubMed: 11249874 MGI: J:115392
Iwaki T; Donahue DL; Castellino FJ. 2007. High levels of LDL-cholesterol rescue the neonatal mortality associated with afibrinogenemia in mice. J Thromb Haemost 5(3):624-6. PubMed: 17155952 MGI: J:135942
Iwaki T; Sandoval-Cooper MJ; Brechmann M; Ploplis VA; Castellino FJ. 2006. A fibrinogen deficiency accelerates the initiation of LDL cholesterol-driven atherosclerosis via thrombin generation and platelet activation in genetically predisposed mice. Blood 107(10):3883-91. PubMed: 16434491 MGI: J:132734
Jagavelu K; Tietge UJ; Gaestel M; Drexler H; Schieffer B; Bavendiek U. 2007. Systemic deficiency of the MAP kinase-activated protein kinase 2 reduces atherosclerosis in hypercholesterolemic mice. Circ Res 101(11):1104-12. PubMed: 17885219 MGI: J:142788
Jeong Ts; Schissel SL; Tabas I; Pownall HJ; Tall AR; Jiang X. 1998. Increased sphingomyelin content of plasma lipoproteins in apolipoprotein E knockout mice reflects combined production and catabolic defects and enhances reactivity with mammalian sphingomyelinase. J Clin Invest 101(4):905-12. PubMed: 9466986 MGI: J:46009
Jiang XC; Qin S; Qiao C; Kawano K; Lin M; Skold A; Xiao X; Tall AR. 2001. Apolipoprotein B secretion and atherosclerosis are decreased in mice with phospholipid-transfer protein deficiency. Nat Med 7(7):847-52. PubMed: 11433351 MGI: J:70250
Jiang XC; Tall AR; Qin S; Lin M; Schneider M; Lalanne F; Deckert V; Desrumaux C; Athias A; Witztum JL; Lagrost L. 2002. Phospholipid transfer protein deficiency protects circulating lipoproteins from oxidation due to the enhanced accumulation of vitamin E. J Biol Chem 277(35):31850-6. PubMed: 12105225 MGI: J:120468
Johansson F; Kramer F; Barnhart S; Kanter JE; Vaisar T; Merrill RD; Geng L; Oka K; Chan L; Chait A; Heinecke JW; Bornfeldt KE. 2008. Type 1 diabetes promotes disruption of advanced atherosclerotic lesions in LDL receptor-deficient mice. Proc Natl Acad Sci U S A 105(6):2082-7. PubMed: 18252823 MGI: J:143961
Johnson LA; Altenburg MK; Walzem RL; Scanga LT; Maeda N. 2008. Absence of hyperlipidemia in LDL receptor-deficient mice having apolipoprotein B100 without the putative receptor-binding sequences. Arterioscler Thromb Vasc Biol 28(10):1745-52. PubMed: 18617647 MGI: J:159802
Johnson LA; Arbones-Mainar JM; Fox RG; Pendse AA; Altenburg MK; Kim HS; Maeda N. 2011. Apolipoprotein E4 exaggerates diabetic dyslipidemia and atherosclerosis in mice lacking the LDL receptor. Diabetes 60(9):2285-94. PubMed: 21810592 MGI: J:189275
Johnson LA; Olsen RH; Merkens LS; DeBarber A; Steiner RD; Sullivan PM; Maeda N; Raber J. 2014. Apolipoprotein E-low density lipoprotein receptor interaction affects spatial memory retention and brain ApoE levels in an isoform-dependent manner. Neurobiol Dis 64:150-62. PubMed: 24412220 MGI: J:211613
Jones C; Garuti R; Michaely P; Li WP; Maeda N; Cohen JC; Herz J; Hobbs HH. 2007. Disruption of LDL but not VLDL clearance in autosomal recessive hypercholesterolemia. J Clin Invest 117(1):165-74. PubMed: 17200716 MGI: J:117439
Jones C; Hammer RE; Li WP; Cohen JC; Hobbs HH; Herz J. 2003. Normal sorting but defective endocytosis of the low density lipoprotein receptor in mice with autosomal recessive hypercholesterolemia. J Biol Chem 278(31):29024-30. PubMed: 12746448 MGI: J:84694
Jong MC; Dahlmans VE; van Gorp PJ; van Dijk KW; Breuer ML; Hofker MH; Havekes LM. 1996. In the absence of the low density lipoprotein receptor, human apolipoprotein C1 overexpression in transgenic mice inhibits the hepatic uptake of very low density lipoproteins via a receptor-associated protein-sensitive pathway. J Clin Invest 98(10):2259-67. PubMed: 8941642 MGI: J:65146
Joseph SB; McKilligin E; Pei L; Watson MA; Collins AR; Laffitte BA; Chen M; Noh G; Goodman J; Hagger GN; Tran J; Tippin TK; Wang X; Lusis AJ; Hsueh WA; Law RE; Collins JL; Willson TM; Tontonoz P. 2002. Synthetic LXR ligand inhibits the development of atherosclerosis in mice. Proc Natl Acad Sci U S A 99(11):7604-9. PubMed: 12032330 MGI: J:76860
Joyce CW; Wagner EM; Basso F; Amar MJ; Freeman LA; Shamburek RD; Knapper CL; Syed J; Wu J; Vaisman BL; Fruchart-Najib J; Billings EM; Paigen B; Remaley AT; Santamarina-Fojo S; Brewer HB Jr. 2006. ABCA1 overexpression in the liver of LDLr-KO mice leads to accumulation of pro-atherogenic lipoproteins and enhanced atherosclerosis. J Biol Chem 281(44):33053-65. PubMed: 16928680 MGI: J:117282
Kadl A; Meher AK; Sharma PR; Lee MY; Doran AC; Johnstone SR; Elliott MR; Gruber F; Han J; Chen W; Kensler T; Ravichandran KS; Isakson BE; Wamhoff BR; Leitinger N. 2010. Identification of a novel macrophage phenotype that develops in response to atherogenic phospholipids via Nrf2. Circ Res 107(6):737-46. PubMed: 20651288 MGI: J:175024
Kanter JE; Kramer F; Barnhart S; Averill MM; Vivekanandan-Giri A; Vickery T; Li LO; Becker L; Yuan W; Chait A; Braun KR; Potter-Perigo S; Sanda S; Wight TN; Pennathur S; Serhan CN; Heinecke JW; Coleman RA; Bornfeldt KE. 2012. Diabetes promotes an inflammatory macrophage phenotype and atherosclerosis through acyl-CoA synthetase 1. Proc Natl Acad Sci U S A 109(12):E715-24. PubMed: 22308341 MGI: J:182631
Kanter JE; Tang C; Oram JF; Bornfeldt KE. 2012. Acyl-CoA synthetase 1 is required for oleate and linoleate mediated inhibition of cholesterol efflux through ATP-binding cassette transporter A1 in macrophages. Biochim Biophys Acta 1821(3):358-64. PubMed: 22020260 MGI: J:182368
Kanters E; Gijbels MJ; van der Made I; Vergouwe MN; Heeringa P; Kraal G; Hofker MH; de Winther MP. 2004. Hematopoietic NF-kappaB1 deficiency results in small atherosclerotic lesions with an inflammatory phenotype. Blood 103(3):934-40. PubMed: 14512319 MGI: J:87639
Kanters E; Pasparakis M; Gijbels MJ; Vergouwe MN; Partouns-Hendriks I; Fijneman RJ; Clausen BE; Forster I; Kockx MM; Rajewsky K; Kraal G; Hofker MH; de Winther MP. 2003. Inhibition of NF-kappaB activation in macrophages increases atherosclerosis in LDL receptor-deficient mice. J Clin Invest 112(8):1176-85. PubMed: 14561702 MGI: J:86163
Kappus MS; Murphy AJ; Abramowicz S; Ntonga V; Welch CL; Tall AR; Westerterp M. 2014. Activation of liver X receptor decreases atherosclerosis in Ldlr(-)/(-) mice in the absence of ATP-binding cassette transporters A1 and G1 in myeloid cells. Arterioscler Thromb Vasc Biol 34(2):279-84. PubMed: 24311381 MGI: J:222827
Karagiannides I; Abdou R; Tzortzopoulou A; Voshol PJ; Kypreos KE. 2008. Apolipoprotein E predisposes to obesity and related metabolic dysfunctions in mice. FEBS J 275(19):4796-809. PubMed: 18754772 MGI: J:142460
Karasawa T; Takahashi A; Saito R; Sekiya M; Igarashi M; Iwasaki H; Miyahara S; Koyasu S; Nakagawa Y; Ishii K; Matsuzaka T; Kobayashi K; Yahagi N; Takekoshi K; Sone H; Yatoh S; Suzuki H; Yamada N; Shimano H. 2011. Sterol regulatory element-binding protein-1 determines plasma remnant lipoproteins and accelerates atherosclerosis in low-density lipoprotein receptor-deficient mice. Arterioscler Thromb Vasc Biol 31(8):1788-95. PubMed: 21546605 MGI: J:191862
Karavia EA; Papachristou DJ; Kotsikogianni I; Giopanou I; Kypreos KE. 2011. Deficiency in apolipoprotein E has a protective effect on diet-induced nonalcoholic fatty liver disease in mice. FEBS J 278(17):3119-29. PubMed: 21740524 MGI: J:190789
Kassel KM; Sullivan BP; Cui W; Copple BL; Luyendyk JP. 2012. Therapeutic administration of the direct thrombin inhibitor argatroban reduces hepatic inflammation in mice with established Fatty liver disease. Am J Pathol 181(4):1287-95. PubMed: 22841818 MGI: J:188704
Kassim SH; Li H; Vandenberghe LH; Hinderer C; Bell P; Marchadier D; Wilson A; Cromley D; Redon V; Yu H; Wilson JM; Rader DJ. 2010. Gene therapy in a humanized mouse model of familial hypercholesterolemia leads to marked regression of atherosclerosis. PLoS One 5(10):e13424. PubMed: 20976059 MGI: J:166224
Katsouri L; Georgopoulos S. 2011. Lack of LDL receptor enhances amyloid deposition and decreases glial response in an Alzheimer's disease mouse model. PLoS One 6(7):e21880. PubMed: 21755005 MGI: J:174945
Kaufmann BA; Carr CL; Belcik JT; Xie A; Yue Q; Chadderdon S; Caplan ES; Khangura J; Bullens S; Bunting S; Lindner JR. 2010. Molecular imaging of the initial inflammatory response in atherosclerosis: implications for early detection of disease. Arterioscler Thromb Vasc Biol 30(1):54-9. PubMed: 19834105 MGI: J:171802
Kawashiri Ma; Zhang Y; Usher D; Reilly M; Pure E; Rader DJ. 2001. Effects of coexpression of the LDL receptor and apoE on cholesterol metabolism and atherosclerosis in LDL receptor-deficient mice. J Lipid Res 42(6):943-50. PubMed: 11369802 MGI: J:69834
Kennedy A; Gruen ML; Gutierrez DA; Surmi BK; Orr JS; Webb CD; Hasty AH. 2012. Impact of macrophage inflammatory protein-1alpha deficiency on atherosclerotic lesion formation, hepatic steatosis, and adipose tissue expansion. PLoS One 7(2):e31508. PubMed: 22359597 MGI: J:185223
Kennedy DJ; Kuchibhotla S; Westfall KM; Silverstein RL; Morton RE; Febbraio M. 2011. A CD36-dependent pathway enhances macrophage and adipose tissue inflammation and impairs insulin signalling. Cardiovasc Res 89(3):604-13. PubMed: 21088116 MGI: J:186882
Kennedy DJ; Kuchibhotla SD; Guy E; Park YM; Nimako G; Vanegas D; Morton RE; Febbraio M. 2009. Dietary cholesterol plays a role in CD36-mediated atherogenesis in LDLR-knockout mice. Arterioscler Thromb Vasc Biol 29(10):1481-7. PubMed: 19608973 MGI: J:167807
Keren P; George J; Shaish A; Levkovitz H; Janakovic Z; Afek A; Goldberg I; Kopolovic J; Keren G; Harats D. 2000. Effect of hyperglycemia and hyperlipidemia on atherosclerosis in LDL receptor-deficient mice: establishment of a combined model and association with heat shock protein 65 immunity. Diabetes 49(6):1064-9. PubMed: 10866061 MGI: J:62295
Khan OM; Akula MK; Skalen K; Karlsson C; Stahlman M; Young SG; Boren J; Bergo MO. 2013. Targeting GGTase-I activates RHOA, increases macrophage reverse cholesterol transport, and reduces atherosclerosis in mice. Circulation 127(7):782-90. PubMed: 23334894 MGI: J:210275
Khanicheh E; Mitterhuber M; Xu L; Haeuselmann SP; Kuster GM; Kaufmann BA. 2013. Noninvasive ultrasound molecular imaging of the effect of statins on endothelial inflammatory phenotype in early atherosclerosis. PLoS One 8(3):e58761. PubMed: 23554922 MGI: J:200169
Khoo LH; Thiam CH; Soh SY; Angeli V. 2015. Splenic extrafollicular reactions and BM plasma cells sustain IgM response associated with hypercholesterolemia. Eur J Immunol 45(5):1300-12. PubMed: 25639537 MGI: J:229268
Kim HS; Ullevig SL; Zamora D; Lee CF; Asmis R. 2012. Redox regulation of MAPK phosphatase 1 controls monocyte migration and macrophage recruitment. Proc Natl Acad Sci U S A 109(41):E2803-12. PubMed: 22991462 MGI: J:190103
King LM; Francomano CA. 2001. Characterization of a human gene encoding nucleosomal binding protein nsbp1. Genomics 71(2):163-73. PubMed: 11161810 MGI: J:67578
King VL; Cassis LA; Daugherty A. 2007. Interleukin-4 does not influence development of hypercholesterolemia or angiotensin II-induced atherosclerotic lesions in mice. Am J Pathol 171(6):2040-7. PubMed: 18055554 MGI: J:128948
King VL; Szilvassy SJ; Daugherty A. 2002. Interleukin-4 deficiency promotes gallstone formation. J Lipid Res 43(5):768-71. PubMed: 11971948 MGI: J:76258
King VL; Szilvassy SJ; Daugherty A. 2002. Interleukin-4 deficiency decreases atherosclerotic lesion formation in a site-specific manner in female LDL receptor-/- mice. Arterioscler Thromb Vasc Biol 22(3):456-61. PubMed: 11884290 MGI: J:103308
Kinnunen K; Heinonen SE; Kalesnykas G; Laidinen S; Uusitalo-Jarvinen H; Uusitalo H; Yla-Herttuala S. 2013. LDLR-/-ApoB100/100 mice with insulin-like growth factor II overexpression reveal a novel form of retinopathy with photoreceptor atrophy and altered morphology of the retina. Mol Vis 19:1723-33. PubMed: 23922490 MGI: J:205300
Kitamoto S; Sukhova GK; Sun J; Yang M; Libby P; Love V; Duramad P; Sun C; Zhang Y; Yang X; Peters C; Shi GP. 2007. Cathepsin L deficiency reduces diet-induced atherosclerosis in low-density lipoprotein receptor-knockout mice. Circulation 115(15):2065-75. PubMed: 17404153 MGI: J:135371
Kjolby M; Andersen OM; Breiderhoff T; Fjorback AW; Pedersen KM; Madsen P; Jansen P; Heeren J; Willnow TE; Nykjaer A. 2010. Sort1, encoded by the cardiovascular risk locus 1p13.3, is a regulator of hepatic lipoprotein export. Cell Metab 12(3):213-23. PubMed: 20816088 MGI: J:166369
Klingenberg R; Gerdes N; Badeau RM; Gistera A; Strodthoff D; Ketelhuth DF; Lundberg AM; Rudling M; Nilsson SK; Olivecrona G; Zoller S; Lohmann C; Luscher TF; Jauhiainen M; Sparwasser T; Hansson GK. 2013. Depletion of FOXP3+ regulatory T cells promotes hypercholesterolemia and atherosclerosis. J Clin Invest 123(3):1323-34. PubMed: 23426179 MGI: J:196393
Knouff C; Briand O; Lestavel S; Clavey V; Altenburg M; Maeda N. 2004. Defective VLDL metabolism and severe atherosclerosis in mice expressing human apolipoprotein E isoforms but lacking the LDL receptor. Biochim Biophys Acta 1684(1-3):8-17. PubMed: 15450205 MGI: J:92554
Ko KW; Paul A; Ma K; Li L; Chan L. 2005. Endothelial lipase modulates HDL but has no effect on atherosclerosis development in apoE-/- and LDLR-/- mice. J Lipid Res 46(12):2586-94. PubMed: 16199802 MGI: J:106132
Kobayashi K; Oka K; Forte T; Ishida B; Teng B; Ishimura-Oka K; Nakamuta M; Chan L. 1996. Reversal of hypercholesterolemia in low density lipoprotein receptor knockout mice by adenovirus-mediated gene transfer of the very low density lipoprotein receptor. J Biol Chem 271(12):6852-60. PubMed: 8636110 MGI: J:32102
Koltsova EK; Kim G; Lloyd KM; Saris CJ; von Vietinghoff S; Kronenberg M; Ley K. 2012. Interleukin-27 receptor limits atherosclerosis in Ldlr-/- mice. Circ Res 111(10):1274-85. PubMed: 22927332 MGI: J:212625
Kovacs A; Tornvall P; Nilsson R; Tegner J; Hamsten A; Bjorkegren J. 2007. Human C-reactive protein slows atherosclerosis development in a mouse model with human-like hypercholesterolemia. Proc Natl Acad Sci U S A 104(34):13768-73. PubMed: 17702862 MGI: J:124095
Koya T; Miyazaki T; Watanabe T; Shichiri M; Atsumi T; Kim-Kaneyama JR; Miyazaki A. 2012. Salusin-beta accelerates inflammatory responses in vascular endothelial cells via NF-kappaB signaling in LDL receptor-deficient mice in vivo and HUVECs in vitro. Am J Physiol Heart Circ Physiol 303(1):H96-105. PubMed: 22561298 MGI: J:189056
Kozarsky KF; Donahee MH; Glick JM; Krieger M; Rader DJ. 2000. Gene transfer and hepatic overexpression of the HDL receptor SR-BI reduces atherosclerosis in the cholesterol-fed LDL receptor-deficient mouse. Arterioscler Thromb Vasc Biol 20(3):721-7. PubMed: 10712397 MGI: J:61288
Kraemer FB; Shen WJ; Patel S; Osuga J; Ishibashi S; Azhar S. 2007. The LDL receptor is not necessary for acute adrenal steroidogenesis in mouse adrenocortical cells. Am J Physiol Endocrinol Metab 292(2):E408-12. PubMed: 16985254 MGI: J:143674
Krishack PA; Sontag TJ; Getz GS; Reardon CA. 2016. Serum amyloid A regulates monopoiesis in hyperlipidemic Ldlr(-/-) mice. FEBS Lett 590(16):2650-60. PubMed: 27339627 MGI: J:235225
Krishna SM; Seto SW; Moxon JV; Rush C; Walker PJ; Norman PE; Golledge J. 2012. Fenofibrate increases high-density lipoprotein and sphingosine 1 phosphate concentrations limiting abdominal aortic aneurysm progression in a mouse model. Am J Pathol 181(2):706-18. PubMed: 22698985 MGI: J:186431
Kruit JK; Kremer PH; Dai L; Tang R; Ruddle P; de Haan W; Brunham LR; Verchere CB; Hayden MR. 2010. Cholesterol efflux via ATP-binding cassette transporter A1 (ABCA1) and cholesterol uptake via the LDL receptor influences cholesterol-induced impairment of beta cell function in mice. Diabetologia 53(6):1110-9. PubMed: 20229095 MGI: J:159879
Kuba M; Matsuzaka T; Matsumori R; Saito R; Kaga N; Taka H; Ikehata K; Okada N; Kikuchi T; Ohno H; Han SI; Takeuchi Y; Kobayashi K; Iwasaki H; Yatoh S; Suzuki H; Sone H; Yahagi N; Arakawa Y; Fujimura T; Nakagawa Y; Yamada N; Shimano H. 2015. Absence of Elovl6 attenuates steatohepatitis but promotes gallstone formation in a lithogenic diet-fed Ldlr(-/-) mouse model. Sci Rep 5:17604. PubMed: 26619823 MGI: J:227324
Kubo N; Boisvert WA; Ballantyne CM; Curtiss LK. 2000. Leukocyte CD11b expression is not essential for the development of atherosclerosis in mice J Lipid Res 41(7):1060-6. PubMed: 10884286 MGI: J:63447
Kulinski A; Rustaeus S; Vance JE. 2002. Microsomal Triacylglycerol Transfer Protein Is Required for Lumenal Accretion of Triacylglycerol Not Associated with ApoB, as Well as for ApoB Lipidation. J Biol Chem 277(35):31516-25. PubMed: 12072432 MGI: J:78774
Kumar AP; Piedrafita FJ; Reynolds WF. 2004. Peroxisome proliferator-activated receptor gamma ligands regulate myeloperoxidase expression in macrophages by an estrogen-dependent mechanism involving the -463GA promoter polymorphism. J Biol Chem 279(9):8300-15. PubMed: 14668325 MGI: J:130052
Kunjathoor VV; Chiu DS; O'Brien KD; LeBoeuf RC. 2002. Accumulation of biglycan and perlecan, but not versican, in lesions of murine models of atherosclerosis. Arterioscler Thromb Vasc Biol 22(3):462-8. PubMed: 11884291 MGI: J:103309
Kwak BR; Veillard N; Pelli G; Mulhaupt F; James RW; Chanson M; Mach F. 2003. Reduced connexin43 expression inhibits atherosclerotic lesion formation in low-density lipoprotein receptor-deficient mice. Circulation 107(7):1033-9. PubMed: 12600918 MGI: J:103052
Kypreos KE; Li X; van Dijk KW; Havekes LM; Zannis VI. 2003. Molecular mechanisms of type III hyperlipoproteinemia: The contribution of the carboxy-terminal domain of ApoE can account for the dyslipidemia that is associated with the E2/E2 phenotype. Biochemistry 42(33):9841-53. PubMed: 12924933 MGI: J:115687
Kypreos KE; Zannis VI. 2006. LDL receptor deficiency or apoE mutations prevent remnant clearance and induce hypertriglyceridemia in mice. J Lipid Res 47(3):521-9. PubMed: 16339113 MGI: J:107556
Lagace TA; Curtis DE; Garuti R; McNutt MC; Park SW; Prather HB; Anderson NN; Ho YK; Hammer RE; Horton JD. 2006. Secreted PCSK9 decreases the number of LDL receptors in hepatocytes and inlivers of parabiotic mice. J Clin Invest 116(11):2995-3005. PubMed: 17080197 MGI: J:114949
Lai CF; Seshadri V; Huang K; Shao JS; Cai J; Vattikuti R; Schumacher A; Loewy AP; Denhardt DT; Rittling SR; Towler DA. 2006. An osteopontin-NADPH oxidase signaling cascade promotes pro-matrix metalloproteinase 9 activation in aortic mesenchymal cells. Circ Res 98(12):1479-89. PubMed: 16709900 MGI: J:122625
Lambert G; Jarnoux AL; Pineau T; Pape O; Chetiveaux M; Laboisse C; Krempf M; Costet P. 2006. Fasting induces hyperlipidemia in mice overexpressing proprotein convertase subtilisin kexin type 9: lack of modulation of very-low-density lipoprotein hepatic output by the low-density lipoprotein receptor. Endocrinology 147(10):4985-95. PubMed: 16794006 MGI: J:129548
Lamharzi N; Renard CB; Kramer F; Pennathur S; Heinecke JW; Chait A; Bornfeldt KE. 2004. Hyperlipidemia in concert with hyperglycemia stimulates the proliferation of macrophages in atherosclerotic lesions: potential role of glucose-oxidized LDL. Diabetes 53(12):3217-25. PubMed: 15561953 MGI: J:94609
Lammers B; Chandak PG; Aflaki E; Van Puijvelde GH; Radovic B; Hildebrand RB; Meurs I; Out R; Kuiper J; Van Berkel TJ; Kolb D; Haemmerle G; Zechner R; Levak-Frank S; Van Eck M; Kratky D. 2011. Macrophage adipose triglyceride lipase deficiency attenuates atherosclerotic lesion development in low-density lipoprotein receptor knockout mice. Arterioscler Thromb Vasc Biol 31(1):67-73. PubMed: 21030715 MGI: J:184190
Lammers B; Zhao Y; Foks AC; Hildebrand RB; Kuiper J; Van Berkel TJ; Van Eck M. 2012. Leukocyte ABCA1 remains atheroprotective in splenectomized LDL receptor knockout mice. PLoS One 7(10):e48080. PubMed: 23133551 MGI: J:192253
Lammers B; Zhao Y; Hoekstra M; Hildebrand RB; Ye D; Meurs I; Van Berkel TJ; Van Eck M. 2011. Augmented atherogenesis in LDL receptor deficient mice lacking both macrophage ABCA1 and ApoE. PLoS One 6(10):e26095. PubMed: 22022523 MGI: J:178098
Lampropoulou A; Zannis VI; Kypreos KE. 2012. Pharmacodynamic and pharmacokinetic analysis of apoE4 [L261A, W264A, F265A, L268A, V269A], a recombinant apolipoprotein E variant with improved biological properties. Biochem Pharmacol 84(11):1451-8. PubMed: 22985620 MGI: J:193572
Langheinrich AC; Michniewicz A; Sedding DG; Walker G; Beighley PE; Rau WS; Bohle RM; Ritman EL. 2006. Correlation of vasa vasorum neovascularization and plaque progression in aortas of apolipoprotein E(-/-)/low-density lipoprotein(-/-) double knockout mice. Arterioscler Thromb Vasc Biol 26(2):347-52. PubMed: 16293797 MGI: J:127960
Larsson SL; Skogsberg J; Bjorkegren J. 2004. The low density lipoprotein receptor prevents secretion of dense apoB100-containing lipoproteins from the liver. J Biol Chem 279(2):831-6. PubMed: 14583618 MGI: J:124544
Laurila A; Cole SP; Merat S; Obonyo M; Palinski W; Fierer J; Witztum JL. 2001. High-fat, high-cholesterol diet increases the incidence of gastritis in LDL receptor-negative mice. Arterioscler Thromb Vasc Biol 21(6):991-6. PubMed: 11397709 MGI: J:103300
Laurila PP; Soronen J; Kooijman S; Forsstrom S; Boon MR; Surakka I; Kaiharju E; Coomans CP; Van Den Berg SA; Autio A; Sarin AP; Kettunen J; Tikkanen E; Manninen T; Metso J; Silvennoinen R; Merikanto K; Ruuth M; Perttila J; Makela A; Isomi A; Tuomainen AM; Tikka A; Ramadan UA; Seppala I; Lehtimaki T; Eriksson J; Havulinna A; Jula A; Karhunen PJ; Salomaa V; Perola M; Ehnholm C; Lee-Rueckert M; Van Eck M; Roivainen A; Taskinen MR; Peltonen L; Mervaala E; Jalanko A; Hohtola E; Olkkonen VM; Ripatti S; Kovanen P. 2016. USF1 deficiency activates brown adipose tissue and improves cardiometabolic health. Sci Transl Med 8(323):323ra13. PubMed: 26819196 MGI: J:234120
Lauring B; Taggart AK; Tata JR; Dunbar R; Caro L; Cheng K; Chin J; Colletti SL; Cote J; Khalilieh S; Liu J; Luo WL; Maclean AA; Peterson LB; Polis AB; Sirah W; Wu TJ; Liu X; Jin L; Wu K; Boatman PD; Semple G; Behan DP; Connolly DT; Lai E; Wagner JA; Wright SD; Cuffie C; Mitchel YB; Rader DJ; Paolini JF; Waters MG; Plump A. 2012. Niacin Lipid Efficacy Is Independent of Both the Niacin Receptor GPR109A and Free Fatty Acid Suppression. Sci Transl Med 4(148):148ra115. PubMed: 22914621 MGI: J:187220
Le Quang K; Bouchareb R; Lachance D; Laplante MA; El Husseini D; Boulanger MC; Fournier D; Fang XP; Avramoglu RK; Pibarot P; Deshaies Y; Sweeney G; Mathieu P; Marette A. 2014. Early development of calcific aortic valve disease and left ventricular hypertrophy in a mouse model of combined dyslipidemia and type 2 diabetes mellitus. Arterioscler Thromb Vasc Biol 34(10):2283-91. PubMed: 25231636 MGI: J:227165
Lee CH; Chawla A; Urbiztondo N; Liao D; Boisvert WA; Evans RM; Curtiss LK. 2003. Transcriptional repression of atherogenic inflammation: modulation by PPARdelta. Science 302(5644):453-7. PubMed: 12970571 MGI: J:122915
Lee EC; Desai U; Gololobov G; Hong S; Feng X; Yu XC; Gay J; Wilganowski N; Gao C; Du LL; Chen J; Hu Y; Zhao S; Kirkpatrick L; Schneider M; Zambrowicz BP; Landes G; Powell DR; Sonnenburg WK. 2009. Identification of a new functional domain in angiopoietin-like 3 (ANGPTL3) and angiopoietin-like 4 (ANGPTL4) involved in binding and inhibition of lipoprotein lipase (LPL). J Biol Chem 284(20):13735-45. PubMed: 19318355 MGI: J:149912
Lee LL; Aung HH; Wilson DW; Anderson SE; Rutledge JC; Rutkowsky JM. 2017. Triglyceride-rich lipoprotein lipolysis products increase blood-brain barrier transfer coefficient and induce astrocyte lipid droplets and cell stress. Am J Physiol Cell Physiol 312(4):C500-C516. PubMed: 28077357 MGI: J:240699
Lee MR; Lim CJ; Lee YH; Park JG; Sonn SK; Lee MN; Jung IH; Jeong SJ; Jeon S; Lee M; Oh KS; Yang Y; Kim JB; Choi HS; Jeong W; Jeong TS; Yoon WK; Kim HC; Choi JH; Oh GT. 2014. The adipokine Retnla modulates cholesterol homeostasis in hyperlipidemic mice. Nat Commun 5:4410. PubMed: 25022542 MGI: J:221255
Lee RG; Kelley KL; Sawyer JK; Farese RV Jr; Parks JS; Rudel LL. 2004. Plasma cholesteryl esters provided by lecithin:cholesterol acyltransferase and acyl-coenzyme a:cholesterol acyltransferase 2 have opposite atherosclerotic potential. Circ Res 95(10):998-1004. PubMed: 15486318 MGI: J:103854
Lee RG; Shah R; Sawyer JK; Hamilton RL; Parks JS; Rudel LL. 2005. ACAT2 contributes cholesteryl esters to newly secreted VLDL, whereas LCAT adds cholesteryl ester to LDL in mice. J Lipid Res 46(6):1205-12. PubMed: 15805543 MGI: J:128885
Lee RH; Vazquez G. 2015. Reduced size and macrophage content of advanced atherosclerotic lesions in mice with bone marrow specific deficiency of alpha 7 nicotinic acetylcholine receptor. PLoS One 10(3):e0124584. PubMed: 25826262 MGI: J:229565
Lee SJ; Grosskopf I; Choi SY; Cooper AD. 2004. Chylomicron remnant uptake in the livers of mice expressing human apolipoproteins E3, E2 (Arg158->Cys), and E3-Leiden. J Lipid Res 45(12):2199-210. PubMed: 15466367 MGI: J:94176
Lemmens KJ; van de Wier B; Koek GH; Kohler E; Drittij MJ; van der Vijgh WJ; Bast A; Haenen GR. 2015. The flavonoid monoHER promotes the adaption to oxidative stress during the onset of NAFLD. Biochem Biophys Res Commun 456(1):179-82. PubMed: 25462563 MGI: J:220261
Leppanen P; Koota S; Kholova I; Koponen J; Fieber C; Eriksson U; Alitalo K; Yla-Herttuala S. 2005. Gene transfers of vascular endothelial growth factor-A, vascular endothelial growth factor-B, vascular endothelial growth factor-C, and vascular endothelial growth factor-D have no effects on atherosclerosis in hypercholesterolemic low-density lipoprotein-receptor/apolipoprotein B48-deficient mice. Circulation 112(9):1347-52. PubMed: 16129816 MGI: J:118230
Leung VW; Yun S; Botto M; Mason JC; Malik TH; Song W; Paixao-Cavalcante D; Pickering MC; Boyle JJ; Haskard DO. 2009. Decay-accelerating factor suppresses complement C3 activation and retards atherosclerosis in low-density lipoprotein receptor-deficient mice. Am J Pathol 175(4):1757-67. PubMed: 19729477 MGI: J:153060
Levin MC; Jirholt P; Wramstedt A; Johansson ME; Lundberg AM; Trajkovska MG; Stahlman M; Fogelstrand P; Brisslert M; Fogelstrand L; Yan ZQ; Hansson GK; Bjorkbacka H; Olofsson SO; Boren J. 2011. Rip2 deficiency leads to increased atherosclerosis despite decreased inflammation. Circ Res 109(11):1210-8. PubMed: 21959219 MGI: J:196562
Lewis MJ; Malik TH; Ehrenstein MR; Boyle JJ; Botto M; Haskard DO. 2009. Immunoglobulin M is required for protection against atherosclerosis in low-density lipoprotein receptor-deficient mice. Circulation 120(5):417-26. PubMed: 19620499 MGI: J:166420
Li AC; Brown KK; Silvestre MJ; Willson TM; Palinski W; Glass CK. 2000. Peroxisome proliferator-activated receptor gamma ligands inhibit development of atherosclerosis in LDL receptor-deficient mice. J Clin Invest 106(4):523-31. PubMed: 10953027 MGI: J:64040
Li L; Hossain MA; Sadat S; Hager L; Liu L; Tam L; Schroer S; Huogen L; Fantus IG; Connelly PW; Woo M; Ng DS. 2011. Lecithin Cholesterol Acyltransferase Null Mice Are Protected from Diet-induced Obesity and Insulin Resistance in a Gender-specific Manner through Multiple Pathways. J Biol Chem 286(20):17809-20. PubMed: 21454561 MGI: J:172680
Li L; Naples M; Song H; Yuan R; Ye F; Shafi S; Adeli K; Ng DS. 2007. LCAT-null mice develop improved hepatic insulin sensitivity through altered regulation of transcription factors and suppressors of cytokine signaling. Am J Physiol Endocrinol Metab 293(2):E587-94. PubMed: 17551001 MGI: J:123371
Li L; Thompson PA; Kitchens RL. 2008. Infection induces a positive acute phase apolipoprotein E response from a negative acute phase gene: role of hepatic LDL receptors. J Lipid Res 49(8):1782-93. PubMed: 18497424 MGI: J:138430
Li R; Mittelstein D; Kam W; Pakbin P; Du Y; Tintut Y; Navab M; Sioutas C; Hsiai T. 2013. Atmospheric ultrafine particles promote vascular calcification via the NF-kappaB signaling pathway. Am J Physiol Cell Physiol 304(4):C362-9. PubMed: 23242187 MGI: J:194848
Li S; Sun Y; Liang CP; Thorp EB; Han S; Jehle AW; Saraswathi V; Pridgen B; Kanter JE; Li R; Welch CL; Hasty AH; Bornfeldt KE; Breslow JL; Tabas I; Tall AR. 2009. Defective phagocytosis of apoptotic cells by macrophages in atherosclerotic lesions of ob/ob mice and reversal by a fish oil diet. Circ Res 105(11):1072-82. PubMed: 19834009 MGI: J:170144
Li X; Zhu M; Penfold ME; Koenen RR; Thiemann A; Heyll K; Akhtar S; Koyadan S; Wu Z; Gremse F; Kiessling F; van Zandvoort M; Schall TJ; Weber C; Schober A. 2014. Activation of CXCR7 limits atherosclerosis and improves hyperlipidemia by increasing cholesterol uptake in adipose tissue. Circulation 129(11):1244-53. PubMed: 24374972 MGI: J:219310
Li Y; Xu S; Mihaylova MM; Zheng B; Hou X; Jiang B; Park O; Luo Z; Lefai E; Shyy JY; Gao B; Wierzbicki M; Verbeuren TJ; Shaw RJ; Cohen RA; Zang M. 2011. AMPK phosphorylates and inhibits SREBP activity to attenuate hepatic steatosis and atherosclerosis in diet-induced insulin-resistant mice. Cell Metab 13(4):376-88. PubMed: 21459323 MGI: J:172248
Li Z; Basterr MJ; Hailemariam TK; Hojjati MR; Lu S; Liu J; Liu R; Zhou H; Jiang XC. 2005. The effect of dietary sphingolipids on plasma sphingomyelin metabolism and atherosclerosis. Biochim Biophys Acta 1735(2):130-4. PubMed: 15967715 MGI: J:124540
Lian J; Quiroga AD; Li L; Lehner R. 2012. Ces3/TGH deficiency improves dyslipidemia and reduces atherosclerosis in Ldlr(-/-) mice. Circ Res 111(8):982-90. PubMed: 22872154 MGI: J:212633
Liang CP; Han S; Li G; Tabas I; Tall AR. 2012. Impaired MEK signaling and SERCA expression promote ER stress and apoptosis in insulin-resistant macrophages and are reversed by exenatide treatment. Diabetes 61(10):2609-20. PubMed: 22751695 MGI: J:208519
Liao J; Gao M; Wang M; Guo X; Huang W; Liu G. 2015. Spontaneous and diet-aggravated hemolysis and its correction by probucol in SR-BI knockout mice with LDL-R deficiency. Biochem Biophys Res Commun 463(1-2):48-53. PubMed: 25983325 MGI: J:228451
Liao X; Sluimer JC; Wang Y; Subramanian M; Brown K; Pattison JS; Robbins J; Martinez J; Tabas I. 2012. Macrophage autophagy plays a protective role in advanced atherosclerosis. Cell Metab 15(4):545-53. PubMed: 22445600 MGI: J:184210
Lichtman AH; Clinton SK; Iiyama K; Connelly PW; Libby P; Cybulsky MI. 1999. Hyperlipidemia and atherosclerotic lesion development in LDL receptor-deficient mice fed defined semipurified diets with and without cholate. Arterioscler Thromb Vasc Biol 19(8):1938-44. PubMed: 10446074 MGI: J:129810
Lie J; Moerland M; van Gent T; van Haperen R; Scheek L; Sadeghi-Niaraki F; de Crom R; van Tol A. 2006. Sex differences in atherosclerosis in mice with elevated phospholipid transfer protein activity are related to decreased plasma high density lipoproteins and not to increased production of triglycerides. Biochim Biophys Acta 1761(9):1070-7. PubMed: 16935026 MGI: J:116584
Lie J; de Crom R; van Gent T; van Haperen R; Scheek L; Sadeghi-Niaraki F; van Tol A. 2004. Elevation of plasma phospholipid transfer protein increases the risk of atherosclerosis despite lower apolipoprotein B-containing lipoproteins. J Lipid Res 45(5):805-11. PubMed: 14993244 MGI: J:89308
Lieu HD; Withycombe SK; Walker Q; Rong JX; Walzem RL; Wong JS; Hamilton RL; Fisher EA; Young SG. 2003. Eliminating atherogenesis in mice by switching off hepatic lipoprotein secretion. Circulation 107(9):1315-21. PubMed: 12628954 MGI: J:91722
Lightle S; Tosheva R; Lee A; Queen-Baker J; Boyanovsky B; Shedlofsky S; Nikolova-Karakashian M. 2003. Elevation of ceramide in serum lipoproteins during acute phase response in humans and mice: role of serine-palmitoyl transferase. Arch Biochem Biophys 419(2):120-8. PubMed: 14592455 MGI: J:113578
Lillis AP; Greenlee MC; Mikhailenko I; Pizzo SV; Tenner AJ; Strickland DK; Bohlson SS. 2008. Murine low-density lipoprotein receptor-related protein 1 (LRP) is required for phagocytosis of targets bearing LRP ligands but is not required for C1q-triggered enhancement of phagocytosis. J Immunol 181(1):364-73. PubMed: 18566402 MGI: J:137404
Lillis AP; Muratoglu SC; Au DT; Migliorini M; Lee MJ; Fried SK; Mikhailenko I; Strickland DK. 2015. LDL Receptor-Related Protein-1 (LRP1) Regulates Cholesterol Accumulation in Macrophages. PLoS One 10(6):e0128903. PubMed: 26061292 MGI: J:237703
Lim H; Kim YU; Sun H; Lee JH; Reynolds JM; Hanabuchi S; Wu H; Teng BB; Chung Y. 2014. Proatherogenic conditions promote autoimmune T helper 17 cell responses in vivo. Immunity 40(1):153-65. PubMed: 24412615 MGI: J:209392
Lim HY; Thiam CH; Yeo KP; Bisoendial R; Hii CS; McGrath KC; Tan KW; Heather A; Alexander JS; Angeli V. 2013. Lymphatic vessels are essential for the removal of cholesterol from peripheral tissues by SR-BI-mediated transport of HDL. Cell Metab 17(5):671-84. PubMed: 23663736 MGI: J:199273
Lim RS; Suhalim JL; Miyazaki-Anzai S; Miyazaki M; Levi M; Potma EO; Tromberg BJ. 2011. Identification of cholesterol crystals in plaques of atherosclerotic mice using hyperspectral CARS imaging. J Lipid Res 52(12):2177-86. PubMed: 21949051 MGI: J:178544
Lim WS; Timmins JM; Seimon TA; Sadler A; Kolodgie FD; Virmani R; Tabas I. 2008. Signal transducer and activator of transcription-1 is critical for apoptosis in macrophages subjected to endoplasmic reticulum stress in vitro and in advanced atherosclerotic lesions in vivo. Circulation 117(7):940-51. PubMed: 18227389 MGI: J:145081
Lin J; Li H; Yang M; Ren J; Huang Z; Han F; Huang J; Ma J; Zhang D; Zhang Z; Wu J; Huang D; Qiao M; Jin G; Wu Q; Huang Y; Du J; Han J. 2013. A role of RIP3-mediated macrophage necrosis in atherosclerosis development. Cell Rep 3(1):200-10. PubMed: 23333278 MGI: J:196325
Lin JZ; Martagon AJ; Hsueh WA; Baxter JD; Gustafsson JA; Webb P; Phillips KJ. 2012. Thyroid hormone receptor agonists reduce serum cholesterol independent of the LDL receptor. Endocrinology 153(12):6136-44. PubMed: 23087171 MGI: J:192628
Lingrel JB; Pilcher-Roberts R; Basford JE; Manoharan P; Neumann J; Konaniah ES; Srinivasan R; Bogdanov VY; Hui DY. 2012. Myeloid-specific Kruppel-like factor 2 inactivation increases macrophage and neutrophil adhesion and promotes atherosclerosis. Circ Res 110(10):1294-302. PubMed: 22474254 MGI: J:212516
Linton MF; Babaev VR; Gleaves LA; Fazio S. 1999. A direct role for the macrophage low density lipoprotein receptor in atherosclerotic lesion formation. J Biol Chem 274(27):19204-10. PubMed: 10383427 MGI: J:56080
Lipinski MJ; Campbell KA; Duong SQ; Welch TJ; Garmey JC; Doran AC; Skaflen MD; Oldham SN; Kelly KA; McNamara CA. 2012. Loss of Id3 increases VCAM-1 expression, macrophage accumulation, and atherogenesis in Ldlr-/- mice. Arterioscler Thromb Vasc Biol 32(12):2855-61. PubMed: 23042815 MGI: J:208316
Liu B; Li H; Repa JJ; Turley SD; Dietschy JM. 2008. Genetic variations and treatments that affect the lifespan of the NPC1 mouse. J Lipid Res 49(3):663-9. PubMed: 18077828 MGI: J:133425
Liu B; Xie C; Richardson JA; Turley SD; Dietschy JM. 2007. Receptor-mediated and bulk-phase endocytosis cause macrophage and cholesterol accumulation in Niemann-Pick C disease. J Lipid Res 48(8):1710-23. PubMed: 17476031 MGI: J:123778
Liu J; Huan C; Chakraborty M; Zhang H; Lu D; Kuo MS; Cao G; Jiang XC. 2009. Macrophage sphingomyelin synthase 2 deficiency decreases atherosclerosis in mice. Circ Res 105(3):295-303. PubMed: 19590047 MGI: J:164932
Liu J; Lu H; Howatt DA; Balakrishnan A; Moorleghen JJ; Sorci-Thomas M; Cassis LA; Daugherty A. 2015. Associations of ApoAI and ApoB-containing lipoproteins with AngII-induced abdominal aortic aneurysms in mice. Arterioscler Thromb Vasc Biol 35(8):1826-34. PubMed: 26044581 MGI: J:241810
Lloyd DJ; Helmering J; Kaufman SA; Turk J; Silva M; Vasquez S; Weinstein D; Johnston B; Hale C; Veniant MM. 2011. A Volumetric Method for Quantifying Atherosclerosis in Mice by Using MicroCT: Comparison to En Face. PLoS One 6(4):e18800. PubMed: 21533112 MGI: J:172393
Lloyd DJ; McCormick J; Helmering J; Kim KW; Wang M; Fordstrom P; Kaufman SA; Lindberg RA; Veniant MM. 2008. Generation and characterization of two novel mouse models exhibiting the phenotypes of the metabolic syndrome: Apob48-/-Lepob/ob mice devoid of ApoE or Ldlr. Am J Physiol Endocrinol Metab 294(3):E496-505. PubMed: 18160459 MGI: J:133453
Lo JC; Wang Y; Tumanov AV; Bamji M; Yao Z; Reardon CA; Getz GS; Fu YX. 2007. Lymphotoxin beta receptor-dependent control of lipid homeostasis. Science 316(5822):285-8. PubMed: 17431181 MGI: J:120962
Lo Sasso G; Murzilli S; Salvatore L; D'Errico I; Petruzzelli M; Conca P; Jiang ZY; Calabresi L; Parini P; Moschetta A. 2010. Intestinal specific LXR activation stimulates reverse cholesterol transport and protects from atherosclerosis. Cell Metab 12(2):187-93. PubMed: 20674863 MGI: J:163075
Loeffler B; Heeren J; Blaeser M; Radner H; Kayser D; Aydin B; Merkel M. 2007. Lipoprotein lipase-facilitated uptake of LDL is mediated by the LDL receptor. J Lipid Res 48(2):288-98. PubMed: 17090659 MGI: J:118187
Loeper S; Asa SL; Ezzat S. 2008. Ikaros modulates cholesterol uptake: a link between tumor suppression and differentiation. Cancer Res 68(10):3715-23. PubMed: 18483254 MGI: J:135021
Lombardo E; van Roomen CP; van Puijvelde GH; Ottenhoff R; van Eijk M; Aten J; Kuiper J; Overkleeft HS; Groen AK; Verhoeven AJ; Aerts JM; Bietrix F. 2012. Correction of liver steatosis by a hydrophobic iminosugar modulating glycosphingolipids metabolism. PLoS One 7(10):e38520. PubMed: 23056165 MGI: J:225078
Lowbeer C; Forsberg AM; Tokuno S; Hemdahl AL; Gustafsson SA; Valen G. 2004. Cardiac troponin T content in heart and skeletal muscle and in blood samples from ApoE/LDL receptor double knockout mice. Clin Chim Acta 344(1-2):73-8. PubMed: 15149873 MGI: J:105262
Loyer X; Potteaux S; Vion AC; Guerin CL; Boulkroun S; Rautou PE; Ramkhelawon B; Esposito B; Dalloz M; Paul JL; Julia P; Maccario J; Boulanger CM; Mallat Z; Tedgui A. 2014. Inhibition of microRNA-92a prevents endothelial dysfunction and atherosclerosis in mice. Circ Res 114(3):434-43. PubMed: 24255059 MGI: J:223623
Lu H; Boustany-Kari CM; Daugherty A; Cassis LA. 2007. Angiotensin II increases adipose angiotensinogen expression. Am J Physiol Endocrinol Metab 292(5):E1280-7. PubMed: 17213477 MGI: J:121237
Lu H; Rateri DL; Feldman DL; Jr RJ; Fukamizu A; Ishida J; Oesterling EG; Cassis LA; Daugherty A. 2008. Renin inhibition reduces hypercholesterolemia-induced atherosclerosis in mice. J Clin Invest 118(3):984-93. PubMed: 18274671 MGI: J:135297
Lu J; Cheng H; Atti E; Shih DM; Demer LL; Tintut Y. 2013. Role of paraoxonase-1 in bone anabolic effects of parathyroid hormone in hyperlipidemic mice. Biochem Biophys Res Commun 431(1):19-24. PubMed: 23291186 MGI: J:198076
Lu X; Xia M; Endresz V; Faludi I; Mundkur L; Gonczol E; Chen D; Kakkar VV. 2012. Immunization with a combination of 2 peptides derived from the C5a receptor significantly reduces early atherosclerotic lesion in Ldlr(tm1Her) Apob(tm2Sgy) J mice. Arterioscler Thromb Vasc Biol 32(10):2358-71. PubMed: 22837469 MGI: J:207883
Luchtefeld M; Grothusen C; Gagalick A; Jagavelu K; Schuett H; Tietge UJ; Pabst O; Grote K; Drexler H; Forster R; Schieffer B. 2010. Chemokine receptor 7 knockout attenuates atherosclerotic plaque development. Circulation 122(16):1621-8. PubMed: 20921438 MGI: J:179485
Ludewig B; Jaggi M; Dumrese T; Brduscha-Riem K; Odermatt B; Hengartner H; Zinkernagel RM. 2001. Hypercholesterolemia exacerbates virus-induced immunopathologic liver disease via suppression of antiviral cytotoxic T cell responses. J Immunol 166(5):3369-76. PubMed: 11207293 MGI: J:126478
Lukasova M; Malaval C; Gille A; Kero J; Offermanns S. 2011. Nicotinic acid inhibits progression of atherosclerosis in mice through its receptor GPR109A expressed by immune cells. J Clin Invest 121(3):1163-73. PubMed: 21317532 MGI: J:172039
Lundberg AM; Ketelhuth DF; Johansson ME; Gerdes N; Liu S; Yamamoto M; Akira S; Hansson GK. 2013. Toll-like receptor 3 and 4 signalling through the TRIF and TRAM adaptors in haematopoietic cells promotes atherosclerosis. Cardiovasc Res 99(2):364-73. PubMed: 23417039 MGI: J:218663
Luo N; Liu J; Chung BH; Yang Q; Klein RL; Garvey WT; Fu Y. 2010. Macrophage adiponectin expression improves insulin sensitivity and protects against inflammation and atherosclerosis. Diabetes 59(4):791-9. PubMed: 20350970 MGI: J:164323
Lutgens E; Lievens D; Beckers L; Wijnands E; Soehnlein O; Zernecke A; Seijkens T; Engel D; Cleutjens J; Keller AM; Naik SH; Boon L; Oufella HA; Mallat Z; Ahonen CL; Noelle RJ; de Winther MP; Daemen MJ; Biessen EA; Weber C. 2010. Deficient CD40-TRAF6 signaling in leukocytes prevents atherosclerosis by skewing the immune response toward an antiinflammatory profile. J Exp Med 207(2):391-404. PubMed: 20100871 MGI: J:157760
Ma Y; Wang W; Zhang J; Lu Y; Wu W; Yan H; Wang Y. 2012. Hyperlipidemia and atherosclerotic lesion development in Ldlr-deficient mice on a long-term high-fat diet. PLoS One 7(4):e35835. PubMed: 22558236 MGI: J:187279
MacArthur JM; Bishop JR; Stanford KI; Wang L; Bensadoun A; Witztum JL; Esko JD. 2007. Liver heparan sulfate proteoglycans mediate clearance of triglyceride-rich lipoproteins independently of LDL receptor family members. J Clin Invest 117(1):153-64. PubMed: 17200715 MGI: J:117455
MacDonald ML; Singaraja RR; Bissada N; Ruddle P; Watts R; Karasinska JM; Gibson WT; Fievet C; Vance JE; Staels B; Hayden MR. 2008. Absence of stearoyl-CoA desaturase-1 ameliorates features of the metabolic syndrome in LDLR-deficient mice. J Lipid Res 49(1):217-29. PubMed: 17960025 MGI: J:130278
MacDonald ML; van Eck M; Hildebrand RB; Wong BW; Bissada N; Ruddle P; Kontush A; Hussein H; Pouladi MA; Chapman MJ; Fievet C; van Berkel TJ; Staels B; McManus BM; Hayden MR. 2009. Despite antiatherogenic metabolic characteristics, SCD1-deficient mice have increased inflammation and atherosclerosis. Arterioscler Thromb Vasc Biol 29(3):341-7. PubMed: 19095997 MGI: J:160858
MacDougall ED; Kramer F; Polinsky P; Barnhart S; Askari B; Johansson F; Varon R; Rosenfeld ME; Oka K; Chan L; Schwartz SM; Bornfeldt KE. 2006. Aggressive very low-density lipoprotein (VLDL) and LDL lowering by gene transfer of the VLDL receptor combined with a low-fat diet regimen induces regression and reduces macrophage content in advanced atherosclerotic lesions in LDL receptor-deficient mice. Am J Pathol 168(6):2064-73. PubMed: 16723719 MGI: J:109123
Mach F; Sukhova GK; Michetti M; Libby P; Michetti P. 2002. Influence of Helicobacter pylori infection during atherogenesis in vivo in mice. Circ Res 90(1):E1-4. PubMed: 11786527 MGI: J:109711
Machado RM; Stefano JT; Oliveira CP; Mello ES; Ferreira FD; Nunes VS; de Lima VM; Quintao EC; Catanozi S; Nakandakare ER; Lottenberg AM. 2010. Intake of trans fatty acids causes nonalcoholic steatohepatitis and reduces adipose tissue fat content. J Nutr 140(6):1127-32. PubMed: 20357081 MGI: J:160756
Madenspacher JH; Draper DW; Smoak KA; Li H; Griffiths GL; Suratt BT; Wilson MD; Rudel LL; Fessler MB. 2010. Dyslipidemia induces opposing effects on intrapulmonary and extrapulmonary host defense through divergent TLR response phenotypes. J Immunol 185(3):1660-9. PubMed: 20581153 MGI: J:162471
Maganto-Garcia E; Tarrio ML; Grabie N; Bu DX; Lichtman AH. 2011. Dynamic changes in regulatory T cells are linked to levels of diet-induced hypercholesterolemia. Circulation 124(2):185-95. PubMed: 21690490 MGI: J:186295
Magnusson LU; Lundqvist A; Karlsson MN; Skalen K; Levin M; Wiklund O; Boren J; Hulten LM. 2012. Arachidonate 15-lipoxygenase type B knockdown leads to reduced lipid accumulation and inflammation in atherosclerosis. PLoS One 7(8):e43142. PubMed: 22912809 MGI: J:225091
Major AS; Fazio S; Linton MF. 2002. B-lymphocyte deficiency increases atherosclerosis in LDL receptor-null mice. Arterioscler Thromb Vasc Biol 22(11):1892-8. PubMed: 12426221 MGI: J:103218
Malik TH; Cortini A; Carassiti D; Boyle JJ; Haskard DO; Botto M. 2010. The alternative pathway is critical for pathogenic complement activation in endotoxin- and diet-induced atherosclerosis in low-density lipoprotein receptor-deficient mice. Circulation 122(19):1948-56. PubMed: 20974996 MGI: J:179480
Mallat Z; Gojova A; Sauzeau V; Brun V; Silvestre JS; Esposito B; Merval R; Groux H; Loirand G; Tedgui A. 2003. Rho-associated protein kinase contributes to early atherosclerotic lesion formation in mice. Circ Res 93(9):884-8. PubMed: 14525807 MGI: J:115653
Malloy SI; Altenburg MK; Knouff C; Lanningham-Foster L; Parks JS; Maeda N. 2004. Harmful effects of increased LDLR expression in mice with human APOE*4 but not APOE*3. Arterioscler Thromb Vasc Biol 24(1):91-7. PubMed: 12969990 MGI: J:146721
Marquart TJ; Wu J; Lusis AJ; Baldan A. 2013. Anti-miR-33 therapy does not alter the progression of atherosclerosis in low-density lipoprotein receptor-deficient mice. Arterioscler Thromb Vasc Biol 33(3):455-8. PubMed: 23288159 MGI: J:216897
Marsh MM; Walker VR; Curtiss LK; Banka CL. 1999. Protection against atherosclerosis by estrogen is independent of plasma cholesterol levels in LDL receptor-deficient mice. J Lipid Res 40(5):893-900. PubMed: 10224158 MGI: J:54588
Martens GW; Vallerskog T; Kornfeld H. 2012. Hypercholesterolemic LDL receptor-deficient mice mount a neutrophilic response to tuberculosis despite the timely expression of protective immunity. J Leukoc Biol 91(6):849-57. PubMed: 22227965 MGI: J:184951
Martins IJ; Hone E; Chi C; Seydel U; Martins RN; Redgrave TG. 2000. Relative roles of LDLr and LRP in the metabolism of chylomicron remnants in genetically manipulated mice. J Lipid Res 41(2):205-13. PubMed: 10681404 MGI: J:120545
Masucci-Magoulas L; Goldberg IJ; Bisgaier CL; Serajuddin H; Francone OL ; Breslow JL ; Tall AR. 1997. A mouse model with features of familial combined hyperlipidemia. Science 275(5298):391-4. PubMed: 8994037 MGI: J:37861
Masucci-Magoulas L; Plump A; Jiang XC; Walsh A; Breslow JL; Tall AR. 1996. Profound induction of hepatic cholesteryl ester transfer protein transgene expression in apolipoprotein E and low density lipoprotein receptor gene knockout mice. A novel mechanism signals changes in plasma cholesterol levels. J Clin Invest 97(1):154-61. PubMed: 8550828 MGI: J:111394
Matasconi M; Parini P; Angelin B; Rudling M. 2005. Pituitary control of cholesterol metabolism in normal and LDL receptor knock-out mice: effects of hypophysectomy and growth hormone treatment. Biochim Biophys Acta 1736(3):221-7. PubMed: 16185916 MGI: J:102525
Matt U; Sharif O; Martins R; Furtner T; Langeberg L; Gawish R; Elbau I; Zivkovic A; Lakovits K; Oskolkova O; Doninger B; Vychytil A; Perkmann T; Schabbauer G; Binder CJ; Bochkov VN; Scott JD; Knapp S. 2013. WAVE1 mediates suppression of phagocytosis by phospholipid-derived DAMPs. J Clin Invest 123(7):3014-24. PubMed: 23934128 MGI: J:201609
Matthijsen RA; de Winther MP; Kuipers D; van der Made I; Weber C; Herias MV; Gijbels MJ; Buurman WA. 2009. Macrophage-specific expression of mannose-binding lectin controls atherosclerosis in low-density lipoprotein receptor-deficient mice. Circulation 119(16):2188-95. PubMed: 19380618 MGI: J:166493
McCaffrey TA; Fu C; Du B; Eksinar S; Kent KC; Bush H Jr; Kreiger K; Rosengart T; Cybulsky MI; Silverman ES; Collins T. 2000. High-level expression of Egr-1 and Egr-1-inducible genes in mouse and human atherosclerosis [see comments] J Clin Invest 105(5):653-62. PubMed: 10712437 MGI: J:60968
McGillicuddy CJ; Carrier MJ; Weinberg PD. 2001. Distribution of lipid deposits around aortic branches of mice lacking LDL receptors and apolipoprotein E. Arterioscler Thromb Vasc Biol 21(7):1220-5. PubMed: 11451755 MGI: J:103203
McMillen TS; Heinecke JW; LeBoeuf RC. 2005. Expression of human myeloperoxidase by macrophages promotes atherosclerosis in mice. Circulation 111(21):2798-804. PubMed: 15911707 MGI: J:112270
Mehrabian M; Allayee H; Wong J; Shi W; Wang XP; Shaposhnik Z; Funk CD; Lusis AJ. 2002. Identification of 5-lipoxygenase as a major gene contributing to atherosclerosis susceptibility in mice. Circ Res 91(2):120-6. PubMed: 12142344 MGI: J:109703
Mehta JL; Sanada N; Hu CP; Chen J; Dandapat A; Sugawara F; Satoh H; Inoue K; Kawase Y; Jishage K; Suzuki H; Takeya M; Schnackenberg L; Beger R; Hermonat PL; Thomas M; Sawamura T. 2007. Deletion of LOX-1 reduces atherogenesis in LDLR knockout mice fed high cholesterol diet. Circ Res 100(11):1634-42. PubMed: 17478727 MGI: J:130794
Meiler S; Baumer Y; Huang Z; Hoffmann FW; Fredericks GJ; Rose AH; Norton RL; Hoffmann PR; Boisvert WA. 2013. Selenoprotein K is required for palmitoylation of CD36 in macrophages: implications in foam cell formation and atherogenesis. J Leukoc Biol 93(5):771-80. PubMed: 23444136 MGI: J:200795
Meiler S; Baumer Y; McCurdy S; Lee BH; Kitamoto S; Boisvert WA. 2015. Cluster of differentiation 43 deficiency in leukocytes leads to reduced atherosclerosis--brief report. Arterioscler Thromb Vasc Biol 35(2):309-11. PubMed: 25524774 MGI: J:240985
Meiler S; Baumer Y; Toulmin E; Seng K; Boisvert WA. 2015. MicroRNA 302a is a novel modulator of cholesterol homeostasis and atherosclerosis. Arterioscler Thromb Vasc Biol 35(2):323-31. PubMed: 25524771 MGI: J:240987
Melchior JT; Sawyer JK; Kelley KL; Shah R; Wilson MD; Hantgan RR; Rudel LL. 2013. LDL particle core enrichment in cholesteryl oleate increases proteoglycan binding and promotes atherosclerosis. J Lipid Res 54(9):2495-503. PubMed: 23804810 MGI: J:200774
Merat S; Casanada F; Sutphin M; Palinski W; Reaven PD. 1999. Western-type diets induce insulin resistance and hyperinsulinemia in LDL receptor-deficient mice but do not increase aortic atherosclerosis compared with normoinsulinemic mice in which similar plasma cholesterol levels are achieved by a fructose-rich diet. Arterioscler Thromb Vasc Biol 19(5):1223-30. PubMed: 10323773 MGI: J:103205
Merat S; Fruebis J; Sutphin M; Silvestre M; Reaven PD. 2000. Effect of aging on aortic expression of the vascular cell adhesion molecule-1 and atherosclerosis in murine models of atherosclerosis. J Gerontol A Biol Sci Med Sci 55(2):B85-94. PubMed: 10737683 MGI: J:61164
Merched A; Tollefson K; Chan L. 2010. Beta2 integrins modulate the initiation and progression of atherosclerosis in low-density lipoprotein receptor knockout mice. Cardiovasc Res 85(4):853-63. PubMed: 19843511 MGI: J:172548
Merched AJ; Daret D; Li L; Franzl N; Sauvage-Merched M. 2016. Specific autoantigens in experimental autoimmunity-associated atherosclerosis. FASEB J 30(6):2123-34. PubMed: 26891734 MGI: J:239257
Merkel M; Velez-Carrasco W; Hudgins LC; Breslow JL. 2001. Compared with saturated fatty acids, dietary monounsaturated fatty acids and carbohydrates increase atherosclerosis and VLDL cholesterol levels in LDL receptor-deficient, but not apolipoprotein E-deficient, mice. Proc Natl Acad Sci U S A 98(23):13294-9. PubMed: 11606787 MGI: J:72580
Mertens A; Verhamme P; Bielicki JK; Phillips MC; Quarck R; Verreth W; Stengel D; Ninio E; Navab M; Mackness B; Mackness M; Holvoet P. 2003. Increased low-density lipoprotein oxidation and impaired high-density lipoprotein antioxidant defense are associated with increased macrophage homing and atherosclerosis in dyslipidemic obese mice: LCAT gene transfer decreases atherosclerosis. Circulation 107(12):1640-6. PubMed: 12668499 MGI: J:234614
Metghalchi S; Ponnuswamy P; Simon T; Haddad Y; Laurans L; Clement M; Dalloz M; Romain M; Esposito B; Koropoulis V; Lamas B; Paul JL; Cottin Y; Kotti S; Bruneval P; Callebert J; den Ruijter H; Launay JM; Danchin N; Sokol H; Tedgui A; Taleb S; Mallat Z. 2015. Indoleamine 2,3-Dioxygenase Fine-Tunes Immune Homeostasis in Atherosclerosis and Colitis through Repression of Interleukin-10 Production. Cell Metab 22(3):460-71. PubMed: 26235422 MGI: J:228095
Methia N; Andre P; Denis CV; Economopoulos M; Wagner DD. 2001. Localized reduction of atherosclerosis in von Willebrand factor-deficient mice. Blood 98(5):1424-8. PubMed: 11520791 MGI: J:106677
Meurs I; Calpe-Berdiel L; Habets KL; Zhao Y; Korporaal SJ; Mommaas AM; Josselin E; Hildebrand RB; Ye D; Out R; Kuiper J; Van Berkel TJ; Chimini G; Van Eck M. 2012. Effects of deletion of macrophage ABCA7 on lipid metabolism and the development of atherosclerosis in the presence and absence of ABCA1. PLoS One 7(3):e30984. PubMed: 22403608 MGI: J:186854
Meyer JM; Ji A; Cai L; van der Westhuyzen DR. 2014. Minimally oxidized LDL inhibits macrophage selective cholesteryl ester uptake and native LDL-induced foam cell formation. J Lipid Res 55(8):1648-1656. PubMed: 24891335 MGI: J:214992
Mihara K; Spansier M; Rooseboom M; Smit MJ; Dokter W. 2007. Functional replacement of murine CXCR2 by its human homologue in the development of atherosclerosis in LDLR knockout mice. Biol Pharm Bull 30(7):1231-6. PubMed: 17603159 MGI: J:124372
Milanski M; Arruda AP; Coope A; Ignacio-Souza LM; Nunez CE; Roman EA; Romanatto T; Pascoal LB; Caricilli AM; Torsoni MA; Prada PO; Saad MJ; Velloso LA. 2012. Inhibition of hypothalamic inflammation reverses diet-induced insulin resistance in the liver. Diabetes 61(6):1455-62. PubMed: 22522614 MGI: J:196822
Millar JS; Maugeais C; Fuki IV; Rader DJ. 2002. Normal production rate of apolipoprotein B in LDL receptor-deficient mice. Arterioscler Thromb Vasc Biol 22(6):989-94. PubMed: 12067909 MGI: J:103299
Miller JD; Chu Y; Castaneda LE; Serrano KM; Brooks RM; Heistad DD. 2013. Vascular function during prolonged progression and regression of atherosclerosis in mice. Arterioscler Thromb Vasc Biol 33(3):459-65. PubMed: 23307875 MGI: J:216887
Miller JD; Weiss RM; Serrano KM; Brooks RM 2nd; Berry CJ; Zimmerman K; Young SG; Heistad DD. 2009. Lowering plasma cholesterol levels halts progression of aortic valve disease in mice. Circulation 119(20):2693-701. PubMed: 19433756 MGI: J:166428
Milstone DS; Ilyama M; Chen M; O'Donnell P; Davis VM; Plutzky J; Brown JD; Haldar SM; Siu A; Lau AC; Zhu SN; Basheer MF; Collins T; Jongstra-Bilen J; Cybulsky MI. 2015. Differential role of an NF-kappaB transcriptional response element in endothelial versus intimal cell VCAM-1 expression. Circ Res 117(2):166-77. PubMed: 26034041 MGI: J:227109
Minahk C; Kim KW; Nelson R; Trigatti B; Lehner R; Vance DE. 2008. Conversion of low density lipoprotein-associated phosphatidylcholine to triacylglycerol by primary hepatocytes. J Biol Chem 283(10):6449-58. PubMed: 18175806 MGI: J:133757
Missiou A; Kostlin N; Varo N; Rudolf P; Aichele P; Ernst S; Munkel C; Walter C; Stachon P; Sommer B; Pfeifer D; Zirlik K; MacFarlane L; Wolf D; Tsitsikov E; Bode C; Libby P; Zirlik A. 2010. Tumor necrosis factor receptor-associated factor 1 (TRAF1) deficiency attenuates atherosclerosis in mice by impairing monocyte recruitment to the vessel wall. Circulation 121(18):2033-44. PubMed: 20421522 MGI: J:172624
Missiou A; Rudolf P; Stachon P; Wolf D; Varo N; Aichele P; Colberg C; Hoppe N; Ernst S; Munkel C; Walter C; Sommer B; Hilgendorf I; Nakano H; Bode C; Zirlik A. 2010. TRAF5 deficiency accelerates atherogenesis in mice by increasing inflammatory cell recruitment and foam cell formation. Circ Res 107(6):757-66. PubMed: 20651286 MGI: J:175026
Mitchell PL; Karakach TK; Currie DL; McLeod RS. 2012. t-10, c-12 CLA dietary supplementation inhibits atherosclerotic lesion development despite adverse cardiovascular and hepatic metabolic marker profiles. PLoS One 7(12):e52634. PubMed: 23285120 MGI: J:195756
Miyazaki T; Taketomi Y; Takimoto M; Lei XF; Arita S; Kim-Kaneyama JR; Arata S; Ohata H; Ota H; Murakami M; Miyazaki A. 2011. m-Calpain induction in vascular endothelial cells on human and mouse atheromas and its roles in VE-cadherin disorganization and atherosclerosis. Circulation 124(23):2522-32. PubMed: 22064597 MGI: J:193805
Miyazaki T; Tonami K; Hata S; Aiuchi T; Ohnishi K; Lei XF; Kim-Kaneyama JR; Takeya M; Itabe H; Sorimachi H; Kurihara H; Miyazaki A. 2016. Calpain-6 confers atherogenicity to macrophages by dysregulating pre-mRNA splicing. J Clin Invest 126(9):3417-32. PubMed: 27525442 MGI: J:237240
Moerland M; Samyn H; van Gent T; Jauhiainen M; Metso J; van Haperen R; Grosveld F; van Tol A; de Crom R. 2007. Atherogenic, enlarged, and dysfunctional HDL in human PLTP/apoA-I double transgenic mice. J Lipid Res 48(12):2622-31. PubMed: 17761633 MGI: J:129970
Moerland M; Samyn H; van Gent T; van Haperen R; Dallinga-Thie G; Grosveld F; van Tol A; de Crom R. 2008. Acute elevation of plasma PLTP activity strongly increases pre-existing atherosclerosis. Arterioscler Thromb Vasc Biol 28(7):1277-82. PubMed: 18421000 MGI: J:159813
Mollmark J; Ravi S; Sun B; Shipman S; Buitendijk M; Simons M; Mulligan-Kehoe MJ. 2011. Antiangiogenic activity of rPAI-1(23) promotes vasa vasorum regression in hypercholesterolemic mice through a plasmin-dependent mechanism. Circ Res 108(12):1419-28. PubMed: 21546607 MGI: J:185688
Mollmark JI; Park AJ; Kim J; Wang TZ; Katzenell S; Shipman SL; Zagorchev LG; Simons M; Mulligan-Kehoe MJ. 2012. Fibroblast growth factor-2 is required for vasa vasorum plexus stability in hypercholesterolemic mice. Arterioscler Thromb Vasc Biol 32(11):2644-51. PubMed: 22982464 MGI: J:207880
Mooij HL; Bernelot Moens SJ; Gordts PL; Stanford KI; Foley EM; van den Boogert MA; Witjes JJ; Hassing HC; Tanck MW; van de Sande MA; Levels JH; Kastelein JJ; Stroes ES; Dallinga-Thie GM; Esko JD; Nieuwdorp M. 2015. Ext1 heterozygosity causes a modest effect on postprandial lipid clearance in humans. J Lipid Res 56(3):665-73. PubMed: 25568062 MGI: J:220029
Moore RE; Navab M; Millar JS; Zimetti F; Hama S; Rothblat GH; Rader DJ. 2005. Increased atherosclerosis in mice lacking apolipoprotein A-I attributable to both impaired reverse cholesterol transport and increased inflammation. Circ Res 97(8):763-71. PubMed: 16151025 MGI: J:114636
Moreira EL; Aguiar AS Jr; de Carvalho CR; Santos DB; de Oliveira J; de Bem AF; Xikota JC; Walz R; Farina M; Prediger RD. 2013. Effects of lifestyle modifications on cognitive impairments in a mouse model of hypercholesterolemia. Neurosci Lett 541:193-8. PubMed: 23470631 MGI: J:199546
Moreira EL; de Oliveira J; Dutra MF; Santos DB; Goncalves CA; Goldfeder EM; de Bem AF; Prediger RD; Aschner M; Farina M. 2012. Does methylmercury-induced hypercholesterolemia play a causal role in its neurotoxicity and cardiovascular disease? Toxicol Sci 130(2):373-82. PubMed: 22903822 MGI: J:192657
Mori N; Horie Y; Nimura Y; Wolf R; Granger DN. 2000. Hepatic microvascular responses to ischemia-reperfusion in low-density lipoprotein receptor knockout mice. Am J Physiol Gastrointest Liver Physiol 279(6):G1257-64. PubMed: 11093949 MGI: J:108060
Mortimer BC; Beveridge DJ; Martins IJ; Redgrave TG. 1995. Intracellular localization and metabolism of chylomicron remnants in the livers of low density lipoprotein receptor-deficient mice and apoE-deficient mice. Evidence for slow metabolism via an alternative apoE-dependent pathway. J Biol Chem 270(48):28767-76. PubMed: 7499399 MGI: J:29909
Mulder M; Jansen PJ; Janssen BJ; van de Berg WD; van der Boom H; Havekes LM; de Kloet RE; Ramaekers FC; Blokland A. 2004. Low-density lipoprotein receptor-knockout mice display impaired spatial memory associated with a decreased synaptic density in the hippocampus. Neurobiol Dis 16(1):212-9. PubMed: 15207278 MGI: J:120389
Mulder M; Koopmans G; Wassink G; Al Mansouri G; Simard ML; Havekes LM; Prickaerts J; Blokland A. 2007. LDL receptor deficiency results in decreased cell proliferation and presynaptic bouton density in the murine hippocampus. Neurosci Res 59(3):251-6. PubMed: 17720268 MGI: J:127270
Mullick AE; Fu W; Graham MJ; Lee RG; Witchell D; Bell TA; Whipple CP; Crooke RM. 2011. Antisense oligonucleotide reduction of apoB-ameliorated atherosclerosis in LDL receptor-deficient mice. J Lipid Res 52(5):885-96. PubMed: 21343632 MGI: J:180930
Mullick AE; Soldau K; Kiosses WB; Bell TA 3rd; Tobias PS; Curtiss LK. 2008. Increased endothelial expression of Toll-like receptor 2 at sites of disturbed blood flow exacerbates early atherogenic events. J Exp Med 205(2):373-83. PubMed: 18250194 MGI: J:131783
Mullick AE; Tobias PS; Curtiss LK. 2005. Modulation of atherosclerosis in mice by Toll-like receptor 2. J Clin Invest 115(11):3149-56. PubMed: 16211093 MGI: J:102502
Mulvihill EE; Allister EM; Sutherland BG; Telford DE; Sawyez CG; Edwards JY; Markle JM; Hegele RA; Huff MW. 2009. Naringenin prevents dyslipidemia, apolipoprotein B overproduction, and hyperinsulinemia in LDL receptor-null mice with diet-induced insulin resistance. Diabetes 58(10):2198-210. PubMed: 19592617 MGI: J:154397
Mulvihill EE; Assini JM; Lee JK; Allister EM; Sutherland BG; Koppes JB; Sawyez CG; Edwards JY; Telford DE; Charbonneau A; St-Pierre P; Marette A; Huff MW. 2011. Nobiletin Attenuates VLDL Overproduction, Dyslipidemia, and Atherosclerosis in Mice With Diet-Induced Insulin Resistance. Diabetes 60(5):1446-57. PubMed: 21471511 MGI: J:171813
Mundkur L; Mukhopadhyay R; Samson S; Varma M; Kale D; Chen D; Shivaprasad S; Sivanandan H; Soman V; Lu X; Kakkar VV. 2013. Mucosal tolerance to a combination of ApoB and HSP60 peptides controls plaque progression and stabilizes vulnerable plaque in Apob(tm2Sgy)Ldlr(tm1Her)/J mice. PLoS One 8(3):e58364. PubMed: 23505495 MGI: J:199840
Muratoglu SC; Belgrave S; Lillis AP; Migliorini M; Robinson S; Smith E; Zhang L; Strickland DK. 2011. Macrophage LRP1 suppresses neo-intima formation during vascular remodeling by modulating the TGF-beta signaling pathway. PLoS One 6(12):e28846. PubMed: 22174911 MGI: J:182253
Murphy AJ; Akhtari M; Tolani S; Pagler T; Bijl N; Kuo CL; Wang M; Sanson M; Abramowicz S; Welch C; Bochem AE; Kuivenhoven JA; Yvan-Charvet L; Tall AR. 2011. ApoE regulates hematopoietic stem cell proliferation, monocytosis, and monocyte accumulation in atherosclerotic lesions in mice. J Clin Invest 121(10):4138-49. PubMed: 21968112 MGI: J:178453
Murphy AJ; Bijl N; Yvan-Charvet L; Welch CB; Bhagwat N; Reheman A; Wang Y; Shaw JA; Levine RL; Ni H; Tall AR; Wang N. 2013. Cholesterol efflux in megakaryocyte progenitors suppresses platelet production and thrombocytosis. Nat Med 19(5):586-94. PubMed: 23584088 MGI: J:198517
Nagareddy PR; Murphy AJ; Stirzaker RA; Hu Y; Yu S; Miller RG; Ramkhelawon B; Distel E; Westerterp M; Huang LS; Schmidt AM; Orchard TJ; Fisher EA; Tall AR; Goldberg IJ. 2013. Hyperglycemia promotes myelopoiesis and impairs the resolution of atherosclerosis. Cell Metab 17(5):695-708. PubMed: 23663738 MGI: J:199272
Naik SU; Wang X; Da Silva JS; Jaye M; Macphee CH; Reilly MP; Billheimer JT; Rothblat GH; Rader DJ. 2006. Pharmacological activation of liver X receptors promotes reverse cholesterol transport in vivo. Circulation 113(1):90-7. PubMed: 16365197 MGI: J:121508
Nakai Y; Iwabuchi K; Fujii S; Ishimori N; Dashtsoodol N; Watano K; Mishima T; Iwabuchi C; Tanaka S; Bezbradica JS; Nakayama T; Taniguchi M; Miyake S; Yamamura T; Kitabatake A; Joyce S; Van Kaer L; Onoe K. 2004. Natural killer T cells accelerate atherogenesis in mice. Blood 104(7):2051-9. PubMed: 15113755 MGI: J:93754
Nakamura I; Hasegawa K; Wada Y; Hirase T; Node K; Watanabe Y. 2013. Detection of early stage atherosclerotic plaques using PET and CT fusion imaging targeting P-selectin in low density lipoprotein receptor-deficient mice. Biochem Biophys Res Commun 433(1):47-51. PubMed: 23485468 MGI: J:201227
Nakamura T; Ruiz-Lozano P; Lindner V; Yabe D; Taniwaki M; Furukawa Y; Kobuke K; Tashiro K; Lu Z; Andon NL; Schaub R; Matsumori A; Sasayama S; Chien KR; Honjo T. 1999. DANCE, a novel secreted RGD protein expressed in developing, atherosclerotic, and balloon-injured arteries. J Biol Chem 274(32):22476-83. PubMed: 10428823 MGI: J:56624
Nakamuta M; Taniguchi S; Ishida BY; Kobayashi K; Chan L. 1998. Phenotype interaction of apobec-1 and CETP, LDLR, and apoE gene expression in mice: role of apoB mRNA editing in lipoprotein phenotype expression. Arterioscler Thromb Vasc Biol 18(5):747-55. PubMed: 9598833 MGI: J:48202
Nakaya H; Summers BD; Nicholson AC; Gotto AM Jr; Hajjar DP; Han J. 2009. Atherosclerosis in LDLR-knockout mice is inhibited, but not reversed, by the PPARgamma ligand pioglitazone. Am J Pathol 174(6):2007-14. PubMed: 19435790 MGI: J:148764
Nassir F; Xie Y; Patterson BW; Luo J; Davidson NO. 2004. Hepatic secretion of small lipoprotein particles in apobec-1-/- mice is regulated by the LDL receptor. J Lipid Res 45(9):1649-59. PubMed: 15145984 MGI: J:121192
Nathan L; Shi W; Dinh H; Mukherjee TK; Wang X; Lusis AJ; Chaudhuri G. 2001. Testosterone inhibits early atherogenesis by conversion to estradiol: critical role of aromatase. Proc Natl Acad Sci U S A 98(6):3589-93. PubMed: 11248122 MGI: J:80921
Navab M; Hama-Levy S; Van Lenten BJ; Fonarow GC; Cardinez CJ ; Castellani LW ; Brennan ML ; Lusis AJ ; Fogelman AM ; La Du BN. 1997. Mildly oxidized LDL induces an increased apolipoprotein J/paraoxonase ratio [published erratum appears in J Clin Invest 1997 Jun 15;99(12):3043] J Clin Invest 99(8):2005-19. PubMed: 9109446 MGI: J:40285
Nawrocki AR; Hofmann SM; Teupser D; Basford JE; Durand JL; Jelicks LA; Woo CW; Kuriakose G; Factor SM; Tanowitz HB; Hui DY; Tabas I; Scherer PE. 2010. Lack of association between adiponectin levels and atherosclerosis in mice. Arterioscler Thromb Vasc Biol 30(6):1159-65. PubMed: 20299691 MGI: J:180866
Netea MG; Demacker PN; Kullberg BJ; Boerman OC; Verschueren I; Stalenhoef AF; van der Meer JW. 1996. Low-density lipoprotein receptor-deficient mice are protected against lethal endotoxemia and severe gram-negative infections. J Clin Invest 97(6):1366-72. PubMed: 8617867 MGI: J:31997
Netea MG; Joosten LA; Keuter M; Wagener F; Stalenhoef AF; van der Meer JW; Kullberg BJ. 2009. Circulating lipoproteins are a crucial component of host defense against invasive Salmonella typhimurium infection. PLoS One 4(1):e4237. PubMed: 19156198 MGI: J:144972
Ng DS; Xie C; Maguire GF; Zhu X; Ugwu F; Lam E; Connelly PW. 2004. Hypertriglyceridemia in lecithin-cholesterol acyltransferase-deficient mice is associated with hepatic overproduction of triglycerides, increased lipogenesis, and improved glucose tolerance. J Biol Chem 279(9):7636-42. PubMed: 14668345 MGI: J:89015
Ngai YF; Quong WL; Glier MB; Glavas MM; Babich SL; Innis SM; Kieffer TJ; Gibson WT. 2010. Ldlr-/- mice display decreased susceptibility to Western-type diet-induced obesity due to increased thermogenesis. Endocrinology 151(11):5226-36. PubMed: 20881250 MGI: J:168347
Nishina K; Piao W; Yoshida-Tanaka K; Sujino Y; Nishina T; Yamamoto T; Nitta K; Yoshioka K; Kuwahara H; Yasuhara H; Baba T; Ono F; Miyata K; Miyake K; Seth PP; Low A; Yoshida M; Bennett CF; Kataoka K; Mizusawa H; Obika S; Yokota T. 2015. DNA/RNA heteroduplex oligonucleotide for highly efficient gene silencing. Nat Commun 6:7969. PubMed: 26258894 MGI: J:224998
Nishizawa T; Kanter JE; Kramer F; Barnhart S; Shen X; Vivekanandan-Giri A; Wall VZ; Kowitz J; Devaraj S; O'Brien KD; Pennathur S; Tang J; Miyaoka RS; Raines EW; Bornfeldt KE. 2014. Testing the role of myeloid cell glucose flux in inflammation and atherosclerosis. Cell Rep 7(2):356-65. PubMed: 24726364 MGI: J:211813
Nofer JR; Bot M; Brodde M; Taylor PJ; Salm P; Brinkmann V; van Berkel T; Assmann G; Biessen EA. 2007. FTY720, a synthetic sphingosine 1 phosphate analogue, inhibits development of atherosclerosis in low-density lipoprotein receptor-deficient mice. Circulation 115(4):501-8. PubMed: 17242282 MGI: J:130151
Nookaew I; Gabrielsson BG; Holmang A; Sandberg AS; Nielsen J. 2010. Identifying molecular effects of diet through systems biology: influence of herring diet on sterol metabolism and protein turnover in mice. PLoS One 5(8):. PubMed: 20808764 MGI: J:164017
Nuotio-Antar AM; Hachey DL; Hasty AH. 2007. Carbenoxolone treatment attenuates symptoms of metabolic syndrome and atherogenesis in obese, hyperlipidemic mice. Am J Physiol Endocrinol Metab 293(6):E1517-28. PubMed: 17878220 MGI: J:145108
O'Brien KD; McDonald TO; Kunjathoor V; Eng K; Knopp EA; Lewis K; Lopez R; Kirk EA; Chait A; Wight TN; deBeer FC; LeBoeuf RC. 2005. Serum amyloid A and lipoprotein retention in murine models of atherosclerosis. Arterioscler Thromb Vasc Biol 25(4):785-90. PubMed: 15692094 MGI: J:110024
Okamoto R; Gery S; Gombart AF; Wang X; Castellani LW; Akagi T; Chen S; Arditi M; Ho Q; Lusis AJ; Li Q; Koeffler HP. 2014. Deficiency of CCAAT/enhancer binding protein-epsilon reduces atherosclerotic lesions in LDLR-/- mice. PLoS One 9(1):e85341. PubMed: 24489659 MGI: J:211106
Okayasu M; Nakayachi M; Hayashida C; Ito J; Kaneda T; Masuhara M; Suda N; Sato T; Hakeda Y. 2012. Low-density lipoprotein receptor deficiency causes impaired osteoclastogenesis and increased bone mass in mice because of defect in osteoclastic cell-cell fusion. J Biol Chem 287(23):19229-41. PubMed: 22500026 MGI: J:186208
Okazaki H; Tazoe F; Okazaki S; Isoo N; Tsukamoto K; Sekiya M; Yahagi N; Iizuka Y; Ohashi K; Kitamine T; Tozawa R; Inaba T; Yagyu H; Okazaki M; Shimano H; Shibata N; Arai H; Nagai RZ; Kadowaki T; Osuga J; Ishibashi S. 2006. Increased cholesterol biosynthesis and hypercholesterolemia in mice overexpressing squalene synthase in the liver. J Lipid Res 47(9):1950-8. PubMed: 16741291 MGI: J:114485
Oliveira HC; Cosso RG; Alberici LC; Maciel EN; Salerno AG; Dorighello GG; Velho JA; de Faria EC; Vercesi AE. 2005. Oxidative stress in atherosclerosis-prone mouse is due to low antioxidant capacity of mitochondria. FASEB J 19(2):278-80. PubMed: 15569776 MGI: J:105088
Orozco LD; Kapturczak MH; Barajas B; Wang X; Weinstein MM; Wong J; Deshane J; Bolisetty S; Shaposhnik Z; Shih DM; Agarwal A; Lusis AJ; Araujo JA. 2007. Heme oxygenase-1 expression in macrophages plays a beneficial role in atherosclerosis. Circ Res 100(12):1703-11. PubMed: 17495224 MGI: J:137771
Osono Y; Woollett LA; Herz J; Dietschy JM. 1995. Role of the low density lipoprotein receptor in the flux of cholesterol through the plasma and across the tissues of the mouse. J Clin Invest 95(3):1124-32. PubMed: 7883961 MGI: J:23579
Osuga J; Yonemoto M; Yamada N; Shimano H; Yagyu H; Ohashi K; Harada K; Kamei T; Yazaki Y; Ishibashi S. 1998. Cholesterol lowering in low density lipoprotein receptor knockout mice overexpressing apolipoprotein E. J Clin Invest 102(2):386-94. PubMed: 9664080 MGI: J:115142
Ou ZJ; Li L; Liao XL; Wang YM; Hu XX; Zhang QL; Wang ZP; Yu H; Zhang X; Hu P; Xu YQ; Liang QL; Ou JS; Luo G. 2012. Apolipoprotein A-I mimetic peptide inhibits atherosclerosis by altering plasma metabolites in hypercholesterolemia. Am J Physiol Endocrinol Metab 303(6):E683-94. PubMed: 22535745 MGI: J:189438
Ouimet M; Ediriweera HN; Gundra UM; Sheedy FJ; Ramkhelawon B; Hutchison SB; Rinehold K; van Solingen C; Fullerton MD; Cecchini K; Rayner KJ; Steinberg GR; Zamore PD; Fisher EA; Loke P; Moore KJ. 2015. MicroRNA-33-dependent regulation of macrophage metabolism directs immune cell polarization in atherosclerosis. J Clin Invest 125(12):4334-48. PubMed: 26517695 MGI: J:229401
Out R; Hoekstra M; Habets K; Meurs I; de Waard V; Hildebrand RB; Wang Y; Chimini G; Kuiper J; Van Berkel TJ; Van Eck M. 2008. Combined deletion of macrophage ABCA1 and ABCG1 leads to massive lipid accumulation in tissue macrophages and distinct atherosclerosis at relatively low plasma cholesterol levels. Arterioscler Thromb Vasc Biol 28(2):258-64. PubMed: 18006857 MGI: J:147678
Out R; Hoekstra M; Hildebrand RB; Kruit JK; Meurs I; Li Z; Kuipers F; Van Berkel TJ; Van Eck M. 2006. Macrophage ABCG1 deletion disrupts lipid homeostasis in alveolar macrophages and moderately influences atherosclerotic lesion development in LDL receptor-deficient mice. Arterioscler Thromb Vasc Biol 26(10):2295-300. PubMed: 16857950 MGI: J:128052
Overton CD; Yancey PG; Major AS; Linton MF; Fazio S. 2007. Deletion of macrophage LDL receptor-related protein increases atherogenesis in the mouse. Circ Res 100(5):670-7. PubMed: 17303763 MGI: J:133698
Owens AP 3rd; Passam FH; Antoniak S; Marshall SM; McDaniel AL; Rudel L; Williams JC; Hubbard BK; Dutton JA; Wang J; Tobias PS; Curtiss LK; Daugherty A; Kirchhofer D; Luyendyk JP; Moriarty PM; Nagarajan S; Furie BC; Furie B; Johns DG; Temel RE; Mackman N. 2012. Monocyte tissue factor-dependent activation of coagulation in hypercholesterolemic mice and monkeys is inhibited by simvastatin. J Clin Invest 122(2):558-68. PubMed: 22214850 MGI: J:184381
Owens AP 3rd; Rateri DL; Howatt DA; Moore KJ; Tobias PS; Curtiss LK; Lu H; Cassis LA; Daugherty A. 2011. MyD88 deficiency attenuates angiotensin II-induced abdominal aortic aneurysm formation independent of signaling through Toll-like receptors 2 and 4. Arterioscler Thromb Vasc Biol 31(12):2813-9. PubMed: 21960563 MGI: J:191452
Paim BA; Velho JA; Castilho RF; Oliveira HC; Vercesi AE. 2008. Oxidative stress in hypercholesterolemic LDL (low-density lipoprotein) receptor knockout mice is associated with low content of mitochondrial NADP-linked substrates and is partially reversed by citrate replacement. Free Radic Biol Med 44(3):444-51. PubMed: 17991444 MGI: J:130348
Pan JH; Sukhova GK; Yang JT; Wang B; Xie T; Fu H; Zhang Y; Satoskar AR; David JR; Metz CN; Bucala R; Fang K; Simon DI; Chapman HA; Libby P; Shi GP. 2004. Macrophage migration inhibitory factor deficiency impairs atherosclerosis in low-density lipoprotein receptor-deficient mice. Circulation 109(25):3149-53. PubMed: 15197138 MGI: J:102201
Pan X; Jiang XC; Hussain MM. 2013. Impaired cholesterol metabolism and enhanced atherosclerosis in clock mutant mice. Circulation 128(16):1758-69. PubMed: 24014832 MGI: J:218726
Parathath S; Grauer L; Huang LS; Sanson M; Distel E; Goldberg IJ; Fisher EA. 2011. Diabetes adversely affects macrophages during atherosclerotic plaque regression in mice. Diabetes 60(6):1759-69. PubMed: 21562077 MGI: J:177946
Park SH; Sui Y; Gizard F; Xu J; Rios-Pilier J; Helsley RN; Han SS; Zhou C. 2012. Myeloid-specific IkappaB kinase beta deficiency decreases atherosclerosis in low-density lipoprotein receptor-deficient mice. Arterioscler Thromb Vasc Biol 32(12):2869-76. PubMed: 23023371 MGI: J:207877
Parks BW; Gambill GP; Lusis AJ; Kabarowski JH. 2005. Loss of G2A promotes macrophage accumulation in atherosclerotic lesions of low density lipoprotein receptor-deficient mice. J Lipid Res 46(7):1405-15. PubMed: 15834123 MGI: J:100498
Parks BW; Lusis AJ; Kabarowski JH. 2006. Loss of the lysophosphatidylcholine effector, G2A, ameliorates aortic atherosclerosis in low-density lipoprotein receptor knockout mice. Arterioscler Thromb Vasc Biol 26(12):2703-9. PubMed: 16990555 MGI: J:128044
Parks BW; Srivastava R; Yu S; Kabarowski JH. 2009. ApoE-dependent modulation of HDL and atherosclerosis by G2A in LDL receptor-deficient mice independent of bone marrow-derived cells. Arterioscler Thromb Vasc Biol 29(4):539-47. PubMed: 19164809 MGI: J:159778
Paulson KE; Zhu SN; Chen M; Nurmohamed S; Jongstra-Bilen J; Cybulsky MI. 2010. Resident intimal dendritic cells accumulate lipid and contribute to the initiation of atherosclerosis. Circ Res 106(2):383-90. PubMed: 19893012 MGI: J:170071
Persson L; Boren J; Nicoletti A; Hansson GK; Pekna M. 2005. Immunoglobulin treatment reduces atherosclerosis in apolipoprotein E-/- low-density lipoprotein receptor-/- mice via the complement system. Clin Exp Immunol 142(3):441-5. PubMed: 16297155 MGI: J:107602
Persson L; Boren J; Robertson AK; Wallenius V; Hansson GK; Pekna M. 2004. Lack of complement factor C3, but not factor B, increases hyperlipidemia and atherosclerosis in apolipoprotein E-/- low-density lipoprotein receptor-/- mice. Arterioscler Thromb Vasc Biol 24(6):1062-7. PubMed: 15059809 MGI: J:102339
Petri MH; Laguna-Fernandez A; Gonzalez-Diez M; Paulsson-Berne G; Hansson GK; Back M. 2015. The role of the FPR2/ALX receptor in atherosclerosis development and plaque stability. Cardiovasc Res 105(1):65-74. PubMed: 25341894 MGI: J:230313
Picataggi A; Lim GF; Kent AP; Millar JS; Rader DJ; Stylianou IM. 2013. A coding variant in SR-BI (I179N) significantly increases atherosclerosis in mice. Mamm Genome :. PubMed: 23722970 MGI: J:199101
Pinkaew D; Hutadilok-Towatana N; Teng BB; Mahabusarakam W; Fujise K. 2012. Morelloflavone, a biflavonoid inhibitor of migration-related kinases, ameliorates atherosclerosis in mice. Am J Physiol Heart Circ Physiol 302(2):H451-8. PubMed: 22058152 MGI: J:181657
Pinkaew D; Le RJ; Chen Y; Eltorky M; Teng BB; Fujise K. 2013. Fortilin reduces apoptosis in macrophages and promotes atherosclerosis. Am J Physiol Heart Circ Physiol 305(10):H1519-29. PubMed: 24043250 MGI: J:204609
Plat J; Beugels I; Gijbels MJ; de Winther MP; Mensink RP. 2006. Plant sterol or stanol esters retard lesion formation in LDL receptor-deficient mice independent of changes in serum plant sterols. J Lipid Res 47(12):2762-71. PubMed: 16957178 MGI: J:117204
Plump AS; Masucci-Magoulas L; Bruce C; Bisgaier CL; Breslow JL; Tall AR. 1999. Increased atherosclerosis in ApoE and LDL receptor gene knock-out mice as a result of human cholesteryl ester transfer protein transgene expression. Arterioscler Thromb Vasc Biol 19(4):1105-10. PubMed: 10195942 MGI: J:55980
Podrez EA; Byzova TV; Febbraio M; Salomon RG; Ma Y; Valiyaveettil M; Poliakov E; Sun M; Finton PJ; Curtis BR; Chen J; Zhang R; Silverstein RL; Hazen SL. 2007. Platelet CD36 links hyperlipidemia, oxidant stress and a prothrombotic phenotype. Nat Med 13(9):1086-95. PubMed: 17721545 MGI: J:125153
Poduri A; Owens AP 3rd; Howatt DA; Moorleghen JJ; Balakrishnan A; Cassis LA; Daugherty A. 2012. Regional variation in aortic AT1b receptor mRNA abundance is associated with contractility but unrelated to atherosclerosis and aortic aneurysms. PLoS One 7(10):e48462. PubMed: 23119030 MGI: J:192277
Pols TW; Nomura M; Harach T; Lo Sasso G; Oosterveer MH; Thomas C; Rizzo G; Gioiello A; Adorini L; Pellicciari R; Auwerx J; Schoonjans K. 2011. TGR5 activation inhibits atherosclerosis by reducing macrophage inflammation and lipid loading. Cell Metab 14(6):747-57. PubMed: 22152303 MGI: J:179660
Postea O; Vasina EM; Cauwenberghs S; Projahn D; Liehn EA; Lievens D; Theelen W; Kramp BK; Butoi ED; Soehnlein O; Heemskerk JW; Ludwig A; Weber C; Koenen RR. 2012. Contribution of platelet CX(3)CR1 to platelet-monocyte complex formation and vascular recruitment during hyperlipidemia. Arterioscler Thromb Vasc Biol 32(5):1186-93. PubMed: 22383701 MGI: J:196930
Potteaux S; Esposito B; van Oostrom O; Brun V; Ardouin P; Groux H; Tedgui A; Mallat Z. 2004. Leukocyte-derived interleukin 10 is required for protection against atherosclerosis in low-density lipoprotein receptor knockout mice. Arterioscler Thromb Vasc Biol 24(8):1474-8. PubMed: 15178562 MGI: J:102225
Poupel L; Boissonnas A; Hermand P; Dorgham K; Guyon E; Auvynet C; Charles FS; Lesnik P; Deterre P; Combadiere C. 2013. Pharmacological inhibition of the chemokine receptor, CX3CR1, reduces atherosclerosis in mice. Arterioscler Thromb Vasc Biol 33(10):2297-305. PubMed: 23887641 MGI: J:222227
Powell-Braxton L; Veniant M; Latvala RD; Hirano KI; Won WB; Ross J; Dybdal N; Zlot CH; Young SG; Davidson NO. 1998. A mouse model of human familial hypercholesterolemia: markedly elevated low density lipoprotein cholesterol levels and severe atherosclerosis on a low-fat chow diet [see comments] Nat Med 4(8):934-8. PubMed: 9701246 MGI: J:49125
Pratico D; Cyrus T; Li H; FitzGerald GA. 2000. Endogenous biosynthesis of thromboxane and prostacyclin in 2 distinct murine models of atherosclerosis Blood 96(12):3823-6. PubMed: 11090066 MGI: J:66258
Pratico D; Rokach J; Tangirala RK. 1999. Brains of aged apolipoprotein E-deficient mice have increased levels of F2-isoprostanes, in vivo markers of lipid peroxidation. J Neurochem 73(2):736-41. PubMed: 10428071 MGI: J:111985
Pratico D; Tillmann C; Zhang ZB; Li H; FitzGerald GA. 2001. Acceleration of atherogenesis by COX-1-dependent prostanoid formation in low density lipoprotein receptor knockout mice. Proc Natl Acad Sci U S A 98(6):3358-63. PubMed: 11248083 MGI: J:68091
Preusch MR; Rattazzi M; Albrecht C; Merle U; Tuckermann J; Schutz G; Blessing E; Zoppellaro G; Pauletto P; Krempien R; Rosenfeld ME; Katus HA; Bea F. 2008. Critical role of macrophages in glucocorticoid driven vascular calcification in a mouse-model of atherosclerosis. Arterioscler Thromb Vasc Biol 28(12):2158-64. PubMed: 18787189 MGI: J:159796
Qian YW; Schmidt RJ; Zhang Y; Chu S; Lin A; Wang H; Wang X; Beyer TP; Bensch WR; Li W; Ehsani ME; Lu D; Konrad RJ; Eacho PI; Moller DE; Karathanasis SK; Cao G. 2007. Secreted PCSK9 downregulates low density lipoprotein receptor through receptor-mediated endocytosis. J Lipid Res 48(7):1488-98. PubMed: 17449864 MGI: J:122491
Qiang L; Lin HV; Kim-Muller JY; Welch CL; Gu W; Accili D. 2011. Proatherogenic abnormalities of lipid metabolism in SirT1 transgenic mice are mediated through Creb deacetylation. Cell Metab 14(6):758-67. PubMed: 22078933 MGI: J:179674
Qiang L; Tsuchiya K; Kim-Muller JY; Lin HV; Welch C; Accili D. 2012. Increased atherosclerosis and endothelial dysfunction in mice bearing constitutively deacetylated alleles of Foxo1 gene. J Biol Chem 287(17):13944-51. PubMed: 22389493 MGI: J:184477
Qiu H; Gabrielsen A; Agardh HE; Wan M; Wetterholm A; Wong CH; Hedin U; Swedenborg J; Hansson GK; Samuelsson B; Paulsson-Berne G; Haeggstrom JZ. 2006. Expression of 5-lipoxygenase and leukotriene A4 hydrolase in human atherosclerotic lesions correlates with symptoms of plaque instability. Proc Natl Acad Sci U S A 103(21):8161-6. PubMed: 16698924 MGI: J:110208
Qu A; Shah YM; Manna SK; Gonzalez FJ. 2012. Disruption of endothelial peroxisome proliferator-activated receptor gamma accelerates diet-induced atherogenesis in LDL receptor-null mice. Arterioscler Thromb Vasc Biol 32(1):65-73. PubMed: 22015658 MGI: J:195979
Quan G; Xie C; Dietschy JM; Turley SD. 2003. Ontogenesis and regulation of cholesterol metabolism in the central nervous system of the mouse. Brain Res Dev Brain Res 146(1-2):87-98. PubMed: 14643015 MGI: J:86935
Radonjic M; Wielinga PY; Wopereis S; Kelder T; Goelela VS; Verschuren L; Toet K; van Duyvenvoorde W; van der Werff van der Vat B; Stroeve JH; Cnubben N; Kooistra T; van Ommen B; Kleemann R. 2013. Differential effects of drug interventions and dietary lifestyle in developing type 2 diabetes and complications: a systems biology analysis in LDLr-/- mice. PLoS One 8(2):e56122. PubMed: 23457508 MGI: J:198285
Raikwar NS; Cho WK; Bowen RF; Deeg MA. 2006. Glycosylphosphatidylinositol-specific phospholipase D influences triglyceride-rich lipoprotein metabolism. Am J Physiol Endocrinol Metab 290(3):E463-70. PubMed: 16219662 MGI: J:106052
Ramirez C; Sierra S; Tercero I; Vazquez JA; Pineda A; Manrique T; Burgos JS. 2011. ApoB100/LDLR-/- hypercholesterolaemic mice as a model for mild cognitive impairment and neuronal damage. PLoS One 6(7):e22712. PubMed: 21829488 MGI: J:175834
Ramsey SA; Vengrenyuk Y; Menon P; Podolsky I; Feig JE; Aderem A; Fisher EA; Gold ES. 2014. Epigenome-guided analysis of the transcriptome of plaque macrophages during atherosclerosis regression reveals activation of the Wnt signaling pathway. PLoS Genet 10(12):e1004828. PubMed: 25474352 MGI: J:222183
Rashid S; Curtis DE; Garuti R; Anderson NN; Bashmakov Y; Ho YK; Hammer RE; Moon YA; Horton JD. 2005. Decreased plasma cholesterol and hypersensitivity to statins in mice lacking Pcsk9. Proc Natl Acad Sci U S A 102(15):5374-9. PubMed: 15805190 MGI: J:97836
Rateri DL; Davis FM; Balakrishnan A; Howatt DA; Moorleghen JJ; O'Connor WN; Charnigo R; Cassis LA; Daugherty A. 2014. Angiotensin II induces region-specific medial disruption during evolution of ascending aortic aneurysms. Am J Pathol 184(9):2586-95. PubMed: 25038458 MGI: J:213954
Rateri DL; Moorleghen JJ; Balakrishnan A; Owens AP 3rd; Howatt DA; Subramanian V; Poduri A; Charnigo R; Cassis LA; Daugherty A. 2011. Endothelial Cell-Specific Deficiency of Ang II Type 1a Receptors Attenuates Ang II-Induced Ascending Aortic Aneurysms in LDL Receptor-/- Mice. Circ Res 108(5):574-81. PubMed: 21252156 MGI: J:170230
Rateri DL; Moorleghen JJ; Knight V; Balakrishnan A; Howatt DA; Cassis LA; Daugherty A. 2012. Depletion of endothelial or smooth muscle cell-specific angiotensin II type 1a receptors does not influence aortic aneurysms or atherosclerosis in LDL receptor deficient mice. PLoS One 7(12):e51483. PubMed: 23236507 MGI: J:195549
Ratliff EP; Gutierrez A; Davis RA. 2006. Transgenic expression of CYP7A1 in LDL receptor-deficient mice blocks diet-induced hypercholesterolemia. J Lipid Res 47(7):1513-20. PubMed: 16609145 MGI: J:112052
Rayner KJ; Suarez Y; Davalos A; Parathath S; Fitzgerald ML; Tamehiro N; Fisher EA; Moore KJ; Fernandez-Hernando C. 2010. MiR-33 contributes to the regulation of cholesterol homeostasis. Science 328(5985):1570-3. PubMed: 20466885 MGI: J:160971
Recinos A rd; Carr BK; Bartos DB; Boldogh I; Carmical JR; Belalcazar LM; Brasier AR. 2004. Liver gene expression associated with diet and lesion development in atherosclerosis-prone mice: induction of components of alternative complement pathway. Physiol Genomics 19(1):131-42. PubMed: 15238619 MGI: J:106239
Reddy ST; Nguyen JT; Grijalva V; Hough G; Hama S; Navab M; Fogelman AM. 2004. Potential role for mitogen-activated protein kinase phosphatase-1 in the development of atherosclerotic lesions in mouse models. Arterioscler Thromb Vasc Biol 24(9):1676-81. PubMed: 15242861 MGI: J:102220
Reiterer G; MacDonald R; Browning JD; Morrow J; Matveev SV; Daugherty A; Smart E; Toborek M; Hennig B. 2005. Zinc deficiency increases plasma lipids and atherosclerotic markers in LDL-receptor-deficient mice. J Nutr 135(9):2114-8. PubMed: 16140885 MGI: J:106652
Renard CB; Kramer F; Johansson F; Lamharzi N; Tannock LR; von Herrath MG; Chait A; Bornfeldt KE. 2004. Diabetes and diabetes-associated lipid abnormalities have distinct effects on initiation and progression of atherosclerotic lesions. J Clin Invest 114(5):659-68. PubMed: 15343384 MGI: J:92597
Rensen SS; Bieghs V; Xanthoulea S; Arfianti E; Bakker JA; Shiri-Sverdlov R; Hofker MH; Greve JW; Buurman WA. 2012. Neutrophil-derived myeloperoxidase aggravates non-alcoholic steatohepatitis in low-density lipoprotein receptor-deficient mice. PLoS One 7(12):e52411. PubMed: 23285030 MGI: J:195762
Rensing KL; de Jager SC; Stroes ES; Vos M; Twickler MT; Dallinga-Thie GM; de Vries CJ; Kuiper J; Bot I; von der Thusen JH. 2014. Akt2/LDLr double knockout mice display impaired glucose tolerance and develop more complex atherosclerotic plaques than LDLr knockout mice. Cardiovasc Res 101(2):277-87. PubMed: 24220638 MGI: J:219538
Repa JJ; Li H; Frank-Cannon TC; Valasek MA; Turley SD; Tansey MG; Dietschy JM. 2007. Liver X receptor activation enhances cholesterol loss from the brain, decreases neuroinflammation, and increases survival of the NPC1 mouse. J Neurosci 27(52):14470-80. PubMed: 18160655 MGI: J:130969
Repa JJ; Turley SD; Quan G; Dietschy JM. 2005. Delineation of molecular changes in intrahepatic cholesterol metabolism resulting from diminished cholesterol absorption. J Lipid Res 46(4):779-89. PubMed: 15654122 MGI: J:98574
Rinninger F; Heine M; Singaraja R; Hayden M; Brundert M; Ramakrishnan R; Heeren J. 2014. High density lipoprotein metabolism in low density lipoprotein receptor-deficient mice. J Lipid Res 55(9):1914-24. PubMed: 24954421 MGI: J:214973
Robbins CS; Chudnovskiy A; Rauch PJ; Figueiredo JL; Iwamoto Y; Gorbatov R; Etzrodt M; Weber GF; Ueno T; van Rooijen N; Mulligan-Kehoe MJ; Libby P; Nahrendorf M; Pittet MJ; Weissleder R; Swirski FK. 2012. Extramedullary hematopoiesis generates Ly-6C(high) monocytes that infiltrate atherosclerotic lesions. Circulation 125(2):364-74. PubMed: 22144566 MGI: J:193795
Robbins CS; Hilgendorf I; Weber GF; Theurl I; Iwamoto Y; Figueiredo JL; Gorbatov R; Sukhova GK; Gerhardt LM; Smyth D; Zavitz CC; Shikatani EA; Parsons M; van Rooijen N; Lin HY; Husain M; Libby P; Nahrendorf M; Weissleder R; Swirski FK. 2013. Local proliferation dominates lesional macrophage accumulation in atherosclerosis. Nat Med 19(9):1166-72. PubMed: 23933982 MGI: J:201890
Rogers L; Burchat S; Gage J; Hasu M; Thabet M; Wilcox L; Ramsamy TA; Whitman SC. 2008. Deficiency of invariant V alpha 14 natural killer T cells decreases atherosclerosis in LDL receptor null mice. Cardiovasc Res 78(1):167-74. PubMed: 18192239 MGI: J:140276
Rohlmann A; Gotthardt M; Hammer RE; Herz J. 1998. Inducible inactivation of hepatic LRP gene by cre-mediated recombination confirms role of LRP in clearance of chylomicron remnants. J Clin Invest 101(3):689-95. PubMed: 9449704 MGI: J:67929
Romeo GR; Moulton KS; Kazlauskas A. 2007. Attenuated expression of profilin-1 confers protection from atherosclerosis in the LDL receptor null mouse. Circ Res 101(4):357-67. PubMed: 17615372 MGI: J:140294
Rong S; Cao Q; Liu M; Seo J; Jia L; Boudyguina E; Gebre AK; Colvin PL; Smith TL; Murphy RC; Mishra N; Parks JS. 2012. Macrophage 12/15 lipoxygenase expression increases plasma and hepatic lipid levels and exacerbates atherosclerosis. J Lipid Res 53(4):686-95. PubMed: 22279185 MGI: J:184947
Roselaar SE; Kakkanathu PX; Daugherty A. 1996. Lymphocyte populations in atherosclerotic lesions of apoE -/- and LDL receptor -/- mice. Decreasing density with disease progression. Arterioscler Thromb Vasc Biol 16(8):1013-8. PubMed: 8696940 MGI: J:111962
Rotllan N; Chamorro-Jorganes A; Araldi E; Wanschel AC; Aryal B; Aranda JF; Goedeke L; Salerno AG; Ramirez CM; Sessa WC; Suarez Y; Fernandez-Hernando C. 2015. Hematopoietic Akt2 deficiency attenuates the progression of atherosclerosis. FASEB J 29(2):597-610. PubMed: 25392271 MGI: J:218205
Roubtsova A; Chamberland A; Marcinkiewicz J; Essalmani R; Fazel A; Bergeron JJ; Seidah NG; Prat A. 2015. PCSK9 deficiency unmasks a sex- and tissue-specific subcellular distribution of the LDL and VLDL receptors in mice. J Lipid Res 56(11):2133-42. PubMed: 26323289 MGI: J:227085
Roubtsova A; Munkonda MN; Awan Z; Marcinkiewicz J; Chamberland A; Lazure C; Cianflone K; Seidah NG; Prat A. 2011. Circulating proprotein convertase subtilisin/kexin 9 (PCSK9) regulates VLDLR protein and triglyceride accumulation in visceral adipose tissue. Arterioscler Thromb Vasc Biol 31(4):785-91. PubMed: 21273557 MGI: J:184166
Rousselet E; Marcinkiewicz J; Kriz J; Zhou A; Hatten ME; Prat A; Seidah NG. 2011. PCSK9 reduces the protein levels of the LDL receptor in mouse brain during development and after ischemic stroke. J Lipid Res 52(7):1383-91. PubMed: 21518694 MGI: J:174826
Rudling M; Angelin B. 2001. Growth hormone reduces plasma cholesterol in LDL receptor-deficient mice. FASEB J 15(8):1350-6. PubMed: 11387232 MGI: J:120519
Rudolf M; Winkler B; Aherrahou Z; Doehring LC; Kaczmarek P; Schmidt-Erfurth U. 2005. Increased expression of vascular endothelial growth factor associated with accumulation of lipids in Bruch's membrane of LDL receptor knockout mice. Br J Ophthalmol 89(12):1627-30. PubMed: 16299144 MGI: J:116908
Ruotsalainen AK; Inkala M; Partanen ME; Lappalainen JP; Kansanen E; Makinen PI; Heinonen SE; Laitinen HM; Heikkila J; Vatanen T; Horkko S; Yamamoto M; Yla-Herttuala S; Jauhiainen M; Levonen AL. 2013. The absence of macrophage Nrf2 promotes early atherogenesis. Cardiovasc Res 98(1):107-15. PubMed: 23341579 MGI: J:210429
Sag D; Cekic C; Wu R; Linden J; Hedrick CC. 2015. The cholesterol transporter ABCG1 links cholesterol homeostasis and tumour immunity. Nat Commun 6:6354. PubMed: 25724068 MGI: J:221785
Sage AP; Murphy D; Maffia P; Masters LM; Sabir SR; Baker LL; Cambrook H; Finigan AJ; Ait-Oufella H; Grassia G; Harrison JE; Ludewig B; Reith W; Hansson GK; Reizis B; Hugues S; Mallat Z. 2014. MHC Class II-restricted antigen presentation by plasmacytoid dendritic cells drives proatherogenic T cell immunity. Circulation 130(16):1363-73. PubMed: 25223984 MGI: J:234151
Sage AP; Nus M; Baker LL; Finigan AJ; Masters LM; Mallat Z. 2015. Regulatory B cell-specific interleukin-10 is dispensable for atherosclerosis development in mice. Arterioscler Thromb Vasc Biol 35(8):1770-3. PubMed: 26088575 MGI: J:241912
Saito R; Matsuzaka T; Karasawa T; Sekiya M; Okada N; Igarashi M; Matsumori R; Ishii K; Nakagawa Y; Iwasaki H; Kobayashi K; Yatoh S; Takahashi A; Sone H; Suzuki H; Yahagi N; Yamada N; Shimano H. 2011. Macrophage Elovl6 deficiency ameliorates foam cell formation and reduces atherosclerosis in low-density lipoprotein receptor-deficient mice. Arterioscler Thromb Vasc Biol 31(9):1973-9. PubMed: 21817094 MGI: J:191842
Sakai K; Tiebel O; Ljungberg MC; Sullivan M; Lee HJ; Terashima T; Li R; Kobayashi K; Lu HC; Chan L; Oka K. 2009. A neuronal VLDLR variant lacking the third complement-type repeat exhibits high capacity binding of apoE containing lipoproteins. Brain Res 1276:11-21. PubMed: 19393635 MGI: J:157221
Sakamoto N; Rosenberg AS. 2011. Apolipoprotein B binding domains: evidence that they are cell-penetrating peptides that efficiently deliver antigenic peptide for cross-presentation of cytotoxic T cells. J Immunol 186(8):5004-11. PubMed: 21402897 MGI: J:172521
Samyn H; Moerland M; van Gent T; van Haperen R; Metso J; Grosveld F; Jauhiainen M; van Tol A; de Crom R. 2008. Plasma phospholipid transfer activity is essential for increased atherogenesis in PLTP transgenic mice: a mutation-inactivation study. J Lipid Res 49(12):2504-12. PubMed: 18711210 MGI: J:142969
Sanan DA; Newland DL; Tao R; Marcovina S; Wang J; Mooser V; Hammer RE; Hobbs HH. 1998. Low density lipoprotein receptor-negative mice expressing human apolipoprotein B-100 develop complex atherosclerotic lesions on a chow diet: no accentuation by apolipoprotein(a). Proc Natl Acad Sci U S A 95(8):4544-9. PubMed: 9539774 MGI: J:47464
Saraswathi V; Morrow JD; Hasty AH. 2009. Dietary fish oil exerts hypolipidemic effects in lean and insulin sensitizing effects in obese LDLR-/- mice. J Nutr 139(12):2380-6. PubMed: 19864403 MGI: J:154774
Sasaki M; Terao Y; Ayaori M; Uto-Kondo H; Iizuka M; Yogo M; Hagisawa K; Takiguchi S; Yakushiji E; Nakaya K; Ogura M; Komatsu T; Ikewaki K. 2014. Hepatic overexpression of idol increases circulating protein convertase subtilisin/kexin type 9 in mice and hamsters via dual mechanisms: sterol regulatory element-binding protein 2 and low-density lipoprotein receptor-dependent pathways. Arterioscler Thromb Vasc Biol 34(6):1171-8. PubMed: 24675665 MGI: J:222901
Schiller NK; Black AS; Bradshaw GP; Bonnet DJ; Curtiss LK. 2004. Participation of macrophages in atherosclerotic lesion morphology in LDLr-/- mice. J Lipid Res 45(8):1398-409. PubMed: 15175354 MGI: J:91367
Schiller NK; Boisvert WA; Curtiss LK. 2002. Inflammation in atherosclerosis: lesion formation in LDL receptor-deficient mice with perforin and Lyst(beige) mutations. Arterioscler Thromb Vasc Biol 22(8):1341-6. PubMed: 12171798 MGI: J:103214
Schmidt-Erfurth U; Rudolf M; Funk M; Hofmann-Rummelt C; Franz-Haas NS; Aherrahrou Z; Schlotzer-Schrehardt U. 2008. Ultrastructural changes in a murine model of graded Bruch membrane lipoidal degeneration and corresponding VEGF164 detection. Invest Ophthalmol Vis Sci 49(1):390-8. PubMed: 18172117 MGI: J:132498
Schneider F; Sukhova GK; Aikawa M; Canner J; Gerdes N; Tang SM; Shi GP; Apte SS; Libby P. 2008. Matrix-metalloproteinase-14 deficiency in bone-marrow-derived cells promotes collagen accumulation in mouse atherosclerotic plaques. Circulation 117(7):931-9. PubMed: 18250269 MGI: J:145079
Schneider JG; Finck BN; Ren J; Standley KN; Takagi M; Maclean KH; Bernal-Mizrachi C; Muslin AJ; Kastan MB; Semenkovich CF. 2006. ATM-dependent suppression of stress signaling reduces vascular disease in metabolic syndrome. Cell Metab 4(5):377-89. PubMed: 17084711 MGI: J:129761
Schonbeck U; Sukhova GK; Shimizu K; Mach F; Libby P. 2000. Inhibition of CD40 signaling limits evolution of established atherosclerosis in mice [see comments] Proc Natl Acad Sci U S A 97(13):7458-63. PubMed: 10861012 MGI: J:63076
Schreyer SA; Vick C; Lystig TC; Mystkowski P; LeBoeuf RC. 2002. LDL receptor but not apolipoprotein E deficiency increases diet-induced obesity and diabetes in mice. Am J Physiol Endocrinol Metab 282(1):E207-14. PubMed: 11739102 MGI: J:75609
Schroeter MR; Leifheit-Nestler M; Hubert A; Schumann B; Gluckermann R; Eschholz N; Kruger N; Lutz S; Hasenfuss G; Konstantinides S; Schafer K. 2013. Leptin promotes neointima formation and smooth muscle cell proliferation via NADPH oxidase activation and signalling in caveolin-rich microdomains. Cardiovasc Res 99(3):555-65. PubMed: 23723060 MGI: J:218655
Segura-Puimedon M; Mergia E; Al-Hasani J; Aherrahrou R; Stoelting S; Kremer F; Freyer J; Koesling D; Erdmann J; Schunkert H; de Wit C; Aherrahrou Z. 2016. Proatherosclerotic Effect of the alpha1-Subunit of Soluble Guanylyl Cyclase by Promoting Smooth Muscle Phenotypic Switching. Am J Pathol 186(8):2220-31. PubMed: 27315776 MGI: J:234282
Sehayek E; Ono JG; Duncan EM; Batta AK; Salen G; Shefer S; Neguyen LB; Yang K; Lipkin M; Breslow JL. 2001. Hyodeoxycholic acid efficiently suppresses atherosclerosis formation and plasma cholesterol levels in mice. J Lipid Res 42(8):1250-6. PubMed: 11483626 MGI: J:70721
Seidelmann SB; Kuo C; Pleskac N; Molina J; Sayers S; Li R; Zhou J; Johnson P; Braun K; Chan C; Teupser D; Breslow JL; Wight TN; Tall AR; Welch CL. 2008. Athsq1 is an atherosclerosis modifier locus with dramatic effects on lesion area and prominent accumulation of versican. Arterioscler Thromb Vasc Biol 28(12):2180-6. PubMed: 18818413 MGI: J:159792
Seimon TA; Nadolski MJ; Liao X; Magallon J; Nguyen M; Feric NT; Koschinsky ML; Harkewicz R; Witztum JL; Tsimikas S; Golenbock D; Moore KJ; Tabas I. 2010. Atherogenic lipids and lipoproteins trigger CD36-TLR2-dependent apoptosis in macrophages undergoing endoplasmic reticulum stress. Cell Metab 12(5):467-82. PubMed: 21035758 MGI: J:167910
Sekiya M; Osuga J; Nagashima S; Ohshiro T; Igarashi M; Okazaki H; Takahashi M; Tazoe F; Wada T; Ohta K; Takanashi M; Kumagai M; Nishi M; Takase S; Yahagi N; Yagyu H; Ohashi K; Nagai R; Kadowaki T; Furukawa Y; Ishibashi S. 2009. Ablation of neutral cholesterol ester hydrolase 1 accelerates atherosclerosis. Cell Metab 10(3):219-28. PubMed: 19723498 MGI: J:152385
Semenkovich CF; Coleman T; Daugherty A. 1998. Effects of heterozygous lipoprotein lipase deficiency on diet-induced atherosclerosis in mice. J Lipid Res 39(6):1141-51. PubMed: 9643345 MGI: J:48030
Senokuchi T; Liang CP; Seimon TA; Han S; Matsumoto M; Banks AS; Paik JH; DePinho RA; Accili D; Tabas I; Tall AR. 2008. Forkhead transcription factors (FoxOs) promote apoptosis of insulin-resistant macrophages during cholesterol-induced endoplasmic reticulum stress. Diabetes 57(11):2967-76. PubMed: 18728232 MGI: J:142468
Shah Z; Kampfrath T; Deiuliis JA; Zhong J; Pineda C; Ying Z; Xu X; Lu B; Moffatt-Bruce S; Durairaj R; Sun Q; Mihai G; Maiseyeu A; Rajagopalan S. 2011. Long-term dipeptidyl-peptidase 4 inhibition reduces atherosclerosis and inflammation via effects on monocyte recruitment and chemotaxis. Circulation 124(21):2338-49. PubMed: 22007077 MGI: J:189450
Shao JS; Sierra OL; Cohen R; Mecham RP; Kovacs A; Wang J; Distelhorst K; Behrmann A; Halstead LR; Towler DA. 2011. Vascular calcification and aortic fibrosis: a bifunctional role for osteopontin in diabetic arteriosclerosis. Arterioscler Thromb Vasc Biol 31(8):1821-33. PubMed: 21597007 MGI: J:191858
Shaposhnik Z; Wang X; Lusis AJ. 2010. Arterial colony stimulating factor-1 influences atherosclerotic lesions by regulating monocyte migration and apoptosis. J Lipid Res 51(7):1962-70. PubMed: 20194110 MGI: J:162834
Shaposhnik Z; Wang X; Weinstein M; Bennett BJ; Lusis AJ. 2007. Granulocyte macrophage colony-stimulating factor regulates dendritic cell content of atherosclerotic lesions. Arterioscler Thromb Vasc Biol 27(3):621-7. PubMed: 17158354 MGI: J:130538
Sharabi Y; Grossman E; Sherer Y; Shaish A; Levkovitz H; Bitzur R; Harats D. 2000. The effect of renin-angiotensin axis inhibition on early atherogenesis in LDL-receptor-deficient mice. Pathobiology 68(6):270-4. PubMed: 11493760 MGI: J:71167
Sherer Y; Shoenfeld Y; Shaish A; Levkovitz H; Bitzur R; Harats D. 2000. Suppression of atherogenesis in female low-density lipoprotein receptor knockout mice following magnesium fortification of drinking water: the importance of diet. Pathobiology 68(2):93-8. PubMed: 10878506 MGI: J:63520
Shewale SV; Brown AL; Bi X; Boudyguina E; Sawyer JK; Alexander-Miller MA; Parks JS. 2017. In vivo activation of leukocyte GPR120/FFAR4 by PUFAs has minimal impact on atherosclerosis in LDL receptor knockout mice. J Lipid Res 58(1):236-246. PubMed: 27811230 MGI: J:237924
Shi W; Wang X; Wong J; Hedrick CC; Wong H; Castellani LW; Lusis AJ. 2004. Effect of macrophage-derived apolipoprotein E on hyperlipidemia and atherosclerosis of LDLR-deficient mice. Biochem Biophys Res Commun 317(1):223-9. PubMed: 15047172 MGI: J:88891
Shih DM; Shaposhnik Z; Meng Y; Rosales M; Wang X; Wu J; Ratiner B; Zadini F; Zadini G; Lusis AJ. 2013. Hyodeoxycholic acid improves HDL function and inhibits atherosclerotic lesion formation in LDLR-knockout mice. FASEB J 27(9):3805-17. PubMed: 23752203 MGI: J:201179
Shih DM; Xia YR; Wang XP; Wang SS; Bourquard N; Fogelman AM; Lusis AJ; Reddy ST. 2007. Decreased obesity and atherosclerosis in human paraoxonase 3 transgenic mice. Circ Res 100(8):1200-7. PubMed: 17379834 MGI: J:135375
Shimada M; Ishibashi S; Inaba T; Yagyu H; Harada K; Osuga JI; Ohashi K; Yazaki Y; Yamada N. 1996. Suppression of diet-induced atherosclerosis in low density lipoprotein receptor knockout mice overexpressing lipoprotein lipase. Proc Natl Acad Sci U S A 93(14):7242-6. PubMed: 8692976 MGI: J:34082
Sigel S; Bunk S; Meergans T; Doninger B; Stich K; Stulnig T; Derfler K; Hoffmann J; Deininger S; von Aulock S; Knapp S. 2012. Apolipoprotein B100 is a suppressor of Staphylococcus aureus-induced innate immune responses in humans and mice. Eur J Immunol 42(11):2983-9. PubMed: 22806614 MGI: J:188717
Silvola JM; Saraste A; Forsback S; Laine VJ; Saukko P; Heinonen SE; Yla-Herttuala S; Roivainen A; Knuuti J. 2011. Detection of hypoxia by [18F]EF5 in atherosclerotic plaques in mice. Arterioscler Thromb Vasc Biol 31(5):1011-5. PubMed: 21372297 MGI: J:191482
Sims-Robinson C; Bakeman A; Glasser R; Boggs J; Pacut C; Feldman EL. 2016. The role of endoplasmic reticulum stress in hippocampal insulin resistance. Exp Neurol 277:261-7. PubMed: 26775176 MGI: J:229542
Singh I; Sagare AP; Coma M; Perlmutter D; Gelein R; Bell RD; Deane RJ; Zhong E; Parisi M; Ciszewski J; Kasper RT; Deane R. 2013. Low levels of copper disrupt brain amyloid-beta homeostasis by altering its production and clearance. Proc Natl Acad Sci U S A 110(36):14771-6. PubMed: 23959870 MGI: J:200976
Singh U; Zhong S; Xiong M; Li TB; Sniderman A; Teng BB. 2004. Increased plasma non-esterified fatty acids and platelet-activating factor acetylhydrolase are associated with susceptibility to atherosclerosis in mice. Clin Sci (Lond) 106(4):421-32. PubMed: 14717654 MGI: J:105456
Sjoland H; Eitzman DT; Gordon D; Westrick R; Nabel EG; Ginsburg D. 2000. Atherosclerosis progression in LDL receptor-deficient and apolipoprotein E-deficient mice is independent of genetic alterations in plasminogen activator inhibitor-1. Arterioscler Thromb Vasc Biol 20(3):846-52. PubMed: 10712412 MGI: J:61287
Skogsberg J; Dicker A; Ryden M; Astrom G; Nilsson R; Bhuiyan H; Vitols S; Mairal A; Langin D; Alberts P; Walum E; Tegner J; Hamsten A; Arner P; Bjorkegren J. 2008. ApoB100-LDL acts as a metabolic signal from liver to peripheral fat causing inhibition of lipolysis in adipocytes. PLoS One 3(11):e3771. PubMed: 19020660 MGI: J:143905
Skogsberg J; Lundstrom J; Kovacs A; Nilsson R; Noori P; Maleki S; Kohler M; Hamsten A; Tegner J; Bjorkegren J. 2008. Transcriptional profiling uncovers a network of cholesterol-responsive atherosclerosis target genes. PLoS Genet 4(3):e1000036. PubMed: 18369455 MGI: J:136835
Solca C; Pandit B; Yu H; Tint GS; Patel SB. 2007. Loss of apolipoprotein E exacerbates the neonatal lethality of the Smith-Lemli-Opitz syndrome mouse. Mol Genet Metab 91(1):7-14. PubMed: 17197219 MGI: J:121454
Sommerville LJ; Kelemen SE; Autieri MV. 2008. Increased smooth muscle cell activation and neointima formation in response to injury in AIF-1 transgenic mice. Arterioscler Thromb Vasc Biol 28(1):47-53. PubMed: 17991871 MGI: J:147519
Song H; Zhu L; Picardo CM; Maguire G; Leung V; Connelly PW; Ng DS. 2006. Coordinated alteration of hepatic gene expression in fatty acid and triglyceride synthesis in LCAT-null mice is associated with altered PUFA metabolism. Am J Physiol Endocrinol Metab 290(1):E17-E25. PubMed: 16105858 MGI: J:104219
Song L; Leung C; Schindler C. 2001. Lymphocytes are important in early atherosclerosis. J Clin Invest 108(2):251-9. PubMed: 11457878 MGI: J:118405
Sontag TJ; Chellan B; Bhanvadia CV; Getz GS; Reardon CA. 2015. Alginic acid cell entrapment: a novel method for measuring in vivo macrophage cholesterol homeostasis. J Lipid Res 56(2):470-83. PubMed: 25465389 MGI: J:219836
Sontag TJ; Chellan B; Getz GS; Reardon CA. 2013. Differing rates of cholesterol absorption among inbred mouse strains yield differing levels of HDL-cholesterol. J Lipid Res 54(9):2515-24. PubMed: 23812556 MGI: J:200771
Sorci-Thomas MG; Zabalawi M; Bharadwaj MS; Wilhelm AJ; Owen JS; Asztalos BF; Bhat S; Thomas MJ. 2012. Dysfunctional HDL containing L159R ApoA-I leads to exacerbation of atherosclerosis in hyperlipidemic mice. Biochim Biophys Acta 1821(3):502-12. PubMed: 21944998 MGI: J:182370
Souza JC; Vanzela EC; Ribeiro RA; Rezende LF; de Oliveira CA; Carneiro EM; Oliveira HC; Boschero AC. 2013. Cholesterol reduction ameliorates glucose-induced calcium handling and insulin secretion in islets from low-density lipoprotein receptor knockout mice. Biochim Biophys Acta 1831(4):769-75. PubMed: 23298460 MGI: J:199048
Spady DK; Cuthbert JA; Willard MN; Meidell RS. 1998. Overexpression of cholesterol 7alpha-hydroxylase (CYP7A) in mice lacking the low density lipoprotein (LDL) receptor gene. LDL transport and plasma LDL concentrations are reduced. J Biol Chem 273(1):126-32. PubMed: 9417056 MGI: J:45043
Spann NJ; Garmire LX; McDonald JG; Myers DS; Milne SB; Shibata N; Reichart D; Fox JN; Shaked I; Heudobler D; Raetz CR; Wang EW; Kelly SL; Sullards MC; Murphy RC; Merrill AH Jr; Brown HA; Dennis EA; Li AC; Ley K; Tsimikas S; Fahy E; Subramaniam S; Quehenberger O; Russell DW; Glass CK. 2012. Regulated accumulation of desmosterol integrates macrophage lipid metabolism and inflammatory responses. Cell 151(1):138-52. PubMed: 23021221 MGI: J:188262
Stachon P; Missiou A; Walter C; Varo N; Colberg C; Wolf D; Buchner M; von Zur Muhlen C; Zirlik K; Bode C; Zirlik A. 2010. Tumor necrosis factor receptor associated factor 6 is not required for atherogenesis in mice and does not associate with atherosclerosis in humans. PLoS One 5(7):e11589. PubMed: 20644648 MGI: J:163110
Stanford KI; Bishop JR; Foley EM; Gonzales JC; Niesman IR; Witztum JL; Esko JD. 2009. Syndecan-1 is the primary heparan sulfate proteoglycan mediating hepatic clearance of triglyceride-rich lipoproteins in mice. J Clin Invest 119(11):3236-45. PubMed: 19805913 MGI: J:154621
Stanic AK; Stein CM; Morgan AC; Fazio S; Linton MF; Wakeland EK; Olsen NJ; Major AS. 2006. Immune dysregulation accelerates atherosclerosis and modulates plaque composition in systemic lupus erythematosus. Proc Natl Acad Sci U S A 103(18):7018-23. PubMed: 16636270 MGI: J:109461
Staprans I; Pan XM; Rapp JH; Grunfeld C; Feingold KR. 2000. Oxidized cholesterol in the diet accelerates the development of atherosclerosis in LDL receptor- and apolipoprotein E-deficient mice. Arterioscler Thromb Vasc Biol 20(3):708-14. PubMed: 10712395 MGI: J:103278
Steffens S; Burger F; Pelli G; Dean Y; Elson G; Kosco-Vilbois M; Chatenoud L; Mach F. 2006. Short-term treatment with anti-CD3 antibody reduces the development and progression of atherosclerosis in mice. Circulation 114(18):1977-84. PubMed: 17043169 MGI: J:127202
Stein CS; Martins I; Davidson BL. 2000. Long-term reversal of hypercholesterolemia in low density lipoprotein receptor (LDLR)-deficient mice by adenovirus-mediated LDLR gene transfer combined with CD154 blockade J Gene Med 2(1):41-51. PubMed: 10765504 MGI: J:62368
Stein S; Oosterveer MH; Mataki C; Xu P; Lemos V; Havinga R; Dittner C; Ryu D; Menzies KJ; Wang X; Perino A; Houten SM; Melchior F; Schoonjans K. 2014. SUMOylation-dependent LRH-1/PROX1 interaction promotes atherosclerosis by decreasing hepatic reverse cholesterol transport. Cell Metab 20(4):603-13. PubMed: 25176150 MGI: J:215556
Steiner T; Francescut L; Byrne S; Hughes T; Jayanthi A; Guschina I; Harwood J; Cianflone K; Stover C; Francis S. 2014. Protective role for properdin in progression of experimental murine atherosclerosis. PLoS One 9(3):e92404. PubMed: 24667818 MGI: J:215053
Strack AM; Carballo-Jane E; Wang SP; Xue J; Ping X; McNamara LA; Thankappan A; Price O; Wolff M; Wu TJ; Kawka D; Mariano M; Burton C; Chang CH; Chen J; Menke J; Luell S; Zycband EI; Tong X; Raubertas R; Sparrow CP; Hubbard B; Woods J; O'Neill G; Waters MG; Sitlani A. 2013. Nicotinic acid and DP1 blockade: studies in mouse models of atherosclerosis. J Lipid Res 54(1):177-88. PubMed: 23103473 MGI: J:192168
Strom A; Olin AI; Aspberg A; Hultgardh-Nilsson A. 2006. Fibulin-2 is present in murine vascular lesions and is important for smooth muscle cell migration. Cardiovasc Res 69(3):755-63. PubMed: 16409997 MGI: J:105710
Subbaiah PV; Jiang XC; Belikova NA; Aizezi B; Huang ZH; Reardon CA. 2012. Regulation of plasma cholesterol esterification by sphingomyelin: Effect of physiological variations of plasma sphingomyelin on lecithin-cholesterol acyltransferase activity. Biochim Biophys Acta 1821(6):908-13. PubMed: 22370449 MGI: J:185003
Subramanian M; Thorp E; Hansson GK; Tabas I. 2013. Treg-mediated suppression of atherosclerosis requires MYD88 signaling in DCs. J Clin Invest 123(1):179-88. PubMed: 23257360 MGI: J:194509
Subramanian S; Goodspeed L; Wang S; Kim J; Zeng L; Ioannou GN; Haigh WG; Yeh MM; Kowdley KV; O'Brien KD; Pennathur S; Chait A. 2011. Dietary cholesterol exacerbates hepatic steatosis and inflammation in obese LDL receptor-deficient mice. J Lipid Res 52(9):1626-35. PubMed: 21690266 MGI: J:175559
Subramanian S; Han CY; Chiba T; McMillen TS; Wang SA; Haw A rd; Kirk EA; O'Brien KD; Chait A. 2008. Dietary cholesterol worsens adipose tissue macrophage accumulation and atherosclerosis in obese LDL receptor-deficient mice. Arterioscler Thromb Vasc Biol 28(4):685-91. PubMed: 18239153 MGI: J:149038
Subramanian V; Golledge J; Ijaz T; Bruemmer D; Daugherty A. 2010. Pioglitazone-induced reductions in atherosclerosis occur via smooth muscle cell-specific interaction with PPAR{gamma}. Circ Res 107(8):953-8. PubMed: 20798360 MGI: J:178193
Subramanian V; Moorleghen JJ; Balakrishnan A; Howatt DA; Chishti AH; Uchida HA. 2013. Calpain-2 compensation promotes angiotensin II-induced ascending and abdominal aortic aneurysms in calpain-1 deficient mice. PLoS One 8(8):e72214. PubMed: 23977256 MGI: J:206427
Sugiyama E; Tanaka N; Nakajima T; Kamijo Y; Yokoyama S; Li Y; Gonzalez FJ; Aoyama T. 2006. Haploinsufficiency in the PPARalpha and LDL receptor genes leads to gender- and age-specific obesity and hyperinsulinemia. Biochem Biophys Res Commun 350(2):370-6. PubMed: 17011521 MGI: J:116049
Sui Y; Park SH; Xu J; Monette S; Helsley RN; Han SS; Zhou C. 2014. IKKbeta links vascular inflammation to obesity and atherosclerosis. J Exp Med 211(5):869-86. PubMed: 24799533 MGI: J:211281
Sukhova GK; Zhang Y; Pan JH; Wada Y; Yamamoto T; Naito M; Kodama T; Tsimikas S; Witztum JL; Lu ML; Sakara Y; Chin MT; Libby P; Shi GP. 2003. Deficiency of cathepsin S reduces atherosclerosis in LDL receptor-deficient mice. J Clin Invest 111(6):897-906. PubMed: 12639996 MGI: J:82520
Sun H; Samarghandi A; Zhang N; Yao Z; Xiong M; Teng BB. 2012. Proprotein convertase subtilisin/kexin type 9 interacts with apolipoprotein B and prevents its intracellular degradation, irrespective of the low-density lipoprotein receptor. Arterioscler Thromb Vasc Biol 32(7):1585-95. PubMed: 22580899 MGI: J:186176
Sun J; Hartvigsen K; Chou MY; Zhang Y; Sukhova GK; Zhang J; Lopez-Ilasaca M; Diehl CJ; Yakov N; Harats D; George J; Witztum JL; Libby P; Ploegh H; Shi GP. 2010. Deficiency of antigen-presenting cell invariant chain reduces atherosclerosis in mice. Circulation 122(8):808-20. PubMed: 20697023 MGI: J:178588
Sun J; Sukhova GK; Wolters PJ; Yang M; Kitamoto S; Libby P; MacFarlane LA; Mallen-St Clair J; Shi GP. 2007. Mast cells promote atherosclerosis by releasing proinflammatory cytokines. Nat Med 13(6):719-24. PubMed: 17546038 MGI: J:125116
Sun L; Ishida T; Yasuda T; Kojima Y; Honjo T; Yamamoto Y; Yamamoto H; Ishibashi S; Hirata K; Hayashi Y. 2009. RAGE mediates oxidized LDL-induced pro-inflammatory effects and atherosclerosis in non-diabetic LDL receptor-deficient mice. Cardiovasc Res 82(2):371-81. PubMed: 19176597 MGI: J:162198
Surmi BK; Atkinson RD; Gruen ML; Coenen KR; Hasty AH. 2008. The role of macrophage leptin receptor in aortic root lesion formation. Am J Physiol Endocrinol Metab 294(3):E488-95. PubMed: 18182468 MGI: J:133462
Tacken PJ; Teusink B; Jong MC; Harats D; Havekes LM; van Dijk KW; Hofker MH. 2000. LDL receptor deficiency unmasks altered VLDL triglyceride metabolism in VLDL receptor transgenic and knockout mice J Lipid Res 41(12):2055-62. PubMed: 11108739 MGI: J:66431
Tadin-Strapps M; Peterson LB; Cumiskey AM; Rosa RL; Mendoza VH; Castro-Perez J; Puig O; Zhang L; Strapps WR; Yendluri S; Andrews L; Pickering V; Rice J; Luo L; Chen Z; Tep S; Ason B; Somers EP; Sachs AB; Bartz SR; Tian J; Chin J; Hubbard BK; Wong KK; Mitnaul LJ. 2011. siRNA-induced liver ApoB knockdown lowers serum LDL-cholesterol in a mouse model with human-like serum lipids. J Lipid Res 52(6):1084-97. PubMed: 21398511 MGI: J:180925
Takata Y; Liu J; Yin F; Collins AR; Lyon CJ; Lee CH; Atkins AR; Downes M; Barish GD; Evans RM; Hsueh WA; Tangirala RK. 2008. PPARdelta-mediated antiinflammatory mechanisms inhibit angiotensin II-accelerated atherosclerosis. Proc Natl Acad Sci U S A 105(11):4277-82. PubMed: 18337495 MGI: J:133474
Taleb S; Herbin O; Ait-Oufella H; Verreth W; Gourdy P; Barateau V; Merval R; Esposito B; Clement K; Holvoet P; Tedgui A; Mallat Z. 2007. Defective leptin/leptin receptor signaling improves regulatory T cell immune response and protects mice from atherosclerosis. Arterioscler Thromb Vasc Biol 27(12):2691-8. PubMed: 17690315 MGI: J:147531
Taleb S; Romain M; Ramkhelawon B; Uyttenhove C; Pasterkamp G; Herbin O; Esposito B; Perez N; Yasukawa H; Van Snick J; Yoshimura A; Tedgui A; Mallat Z. 2009. Loss of SOCS3 expression in T cells reveals a regulatory role for interleukin-17 in atherosclerosis. J Exp Med 206(10):2067-77. PubMed: 19737863 MGI: J:153361
Taneja D; Thompson J; Wilson P; Brandewie K; Schaefer L; Mitchell B; Tannock LR. 2010. Reversibility of renal injury with cholesterol lowering in hyperlipidemic diabetic mice. J Lipid Res 51(6):1464-70. PubMed: 20110440 MGI: J:161500
Tang EH; Shimizu K; Christen T; Rocha VZ; Shvartz E; Tesmenitsky Y; Sukhova G; Shi GP; Libby P. 2011. Lack of EP4 receptors on bone marrow-derived cells enhances inflammation in atherosclerotic lesions. Cardiovasc Res 89(1):234-43. PubMed: 20736236 MGI: J:167790
Tang EH; Shvartz E; Shimizu K; Rocha VZ; Zheng C; Fukuda D; Shi GP; Sukhova G; Libby P. 2011. Deletion of EP4 on bone marrow-derived cells enhances inflammation and angiotensin II-induced abdominal aortic aneurysm formation. Arterioscler Thromb Vasc Biol 31(2):261-9. PubMed: 21088251 MGI: J:184180
Tang JJ; Li JG; Qi W; Qiu WW; Li PS; Li BL; Song BL. 2011. Inhibition of SREBP by a small molecule, betulin, improves hyperlipidemia and insulin resistance and reduces atherosclerotic plaques. Cell Metab 13(1):44-56. PubMed: 21195348 MGI: J:169478
Tang M; Cyrus T; Yao Y; Vocun L; Pratico D. 2005. Involvement of thromboxane receptor in the proatherogenic effect of isoprostane F2alpha-III: evidence from apolipoprotein E- and LDL receptor-deficient mice. Circulation 112(18):2867-74. PubMed: 16267259 MGI: J:116835
Tang SY; Monslow J; Todd L; Lawson J; Pure E; FitzGerald GA. 2014. Cyclooxygenase-2 in endothelial and vascular smooth muscle cells restrains atherogenesis in hyperlipidemic mice. Circulation 129(17):1761-9. PubMed: 24519928 MGI: J:221694
Tang WH; Stitham J; Jin Y; Liu R; Lee SH; Du J; Atteya G; Gleim S; Spollett G; Martin K; Hwa J. 2014. Aldose reductase-mediated phosphorylation of p53 leads to mitochondrial dysfunction and damage in diabetic platelets. Circulation 129(15):1598-609. PubMed: 24474649 MGI: J:219307
Tangirala RK; Bischoff ED; Joseph SB; Wagner BL; Walczak R; Laffitte BA; Daige CL; Thomas D; Heyman RA; Mangelsdorf DJ; Wang X; Lusis AJ; Tontonoz P; Schulman IG. 2002. Identification of macrophage liver X receptors as inhibitors of atherosclerosis. Proc Natl Acad Sci U S A 99(18):11896-901. PubMed: 12193651 MGI: J:125452
Tangirala RK; Pratico D; FitzGerald GA; Chun S; Tsukamoto K; Maugeais C; Usher DC; Pure E; Rader DJ. 2001. Reduction of isoprostanes and regression of advanced atherosclerosis by apolipoprotein E. J Biol Chem 276(1):261-6. PubMed: 11024044 MGI: J:66833
Tangirala RK; Rubin EM; Palinski W. 1995. Quantitation of atherosclerosis in murine models: correlation between lesions in the aortic origin and in the entire aorta, and differences in the extent of lesions between sexes in LDL receptor-deficient and apolipoprotein E-deficient mice. J Lipid Res 36(11):2320-8. PubMed: 8656070 MGI: J:29950
Tanigawa H; Billheimer JT; Tohyama J; Zhang Y; Rothblat G; Rader DJ. 2007. Expression of cholesteryl ester transfer protein in mice promotes macrophage reverse cholesterol transport. Circulation 116(11):1267-73. PubMed: 17709636 MGI: J:139845
Tao W; Moore R; Meng Y; Smith ER; Xu XX. 2016. Endocytic adaptors Arh and Dab2 control homeostasis of circulatory cholesterol. J Lipid Res 57(5):809-17. PubMed: 27005486 MGI: J:231758
Tavori H; Fan D; Blakemore JL; Yancey PG; Ding L; Linton MF; Fazio S. 2013. Serum proprotein convertase subtilisin/kexin type 9 and cell surface low-density lipoprotein receptor: evidence for a reciprocal regulation. Circulation 127(24):2403-13. PubMed: 23690465 MGI: J:211389
Tennert C; Teupser D; Mueller MA; Wilfert W; Renner-Muller I; Stein O; Stein Y; Sippel AE; Wolf E; Thiery J. 2007. Effect of macrophage ApoE on atherosclerosis in LDL-receptor deficient mice. Biochem Biophys Res Commun 361(3):574-9. PubMed: 17669363 MGI: J:124271
Tep S; Mihaila R; Freeman A; Pickering V; Huyhn F; Tadin-Strapps M; Stracks A; Hubbard B; Caldwell J; Flanagan WM; Kuklin NA; Ason B. 2012. Rescue of Mtp siRNA-induced hepatic steatosis by DGAT2 siRNA silencing. J Lipid Res 53(5):859-67. PubMed: 22355095 MGI: J:184930
Terasaka N; Wang N; Yvan-Charvet L; Tall AR. 2007. High-density lipoprotein protects macrophages from oxidized low-density lipoprotein-induced apoptosis by promoting efflux of 7-ketocholesterol via ABCG1. Proc Natl Acad Sci U S A 104(38):15093-8. PubMed: 17846428 MGI: J:125197
Terasaka N; Yu S; Yvan-Charvet L; Wang N; Mzhavia N; Langlois R; Pagler T; Li R; Welch CL; Goldberg IJ; Tall AR. 2008. ABCG1 and HDL protect against endothelial dysfunction in mice fed a high-cholesterol diet. J Clin Invest 118(11):3701-13. PubMed: 18924609 MGI: J:144580
Terrand J; Bruban V; Zhou L; Gong W; El Asmar Z; May P; Zurhove K; Haffner P; Philippe C; Woldt E; Matz RL; Gracia C; Metzger D; Auwerx J; Herz J; Boucher P. 2009. LRP1 controls intracellular cholesterol storage and fatty acid synthesis through modulation of Wnt signaling. J Biol Chem 284(1):381-8. PubMed: 18990694 MGI: J:146007
Teupser D; Kretzschmar D; Tennert C; Burkhardt R; Wilfert W; Fengler D; Naumann R; Sippel AE; Thiery J. 2008. Effect of macrophage overexpression of murine liver X receptor-alpha (LXR-alpha) on atherosclerosis in LDL-receptor deficient mice. Arterioscler Thromb Vasc Biol 28(11):2009-15. PubMed: 18787185 MGI: J:159797
Teupser D; Pavlides S; Tan M; Gutierrez-Ramos JC; Kolbeck R; Breslow JL. 2004. Major reduction of atherosclerosis in fractalkine (CX3CL1)-deficient mice is at the brachiocephalic artery, not the aortic root. Proc Natl Acad Sci U S A 101(51):17795-800. PubMed: 15596719 MGI: J:95279
Teupser D; Tan M; Persky AD; Breslow JL. 2006. Atherosclerosis quantitative trait loci are sex- and lineage-dependent in an intercross of C57BL/6 and FVB/N low-density lipoprotein receptor-/- mice. Proc Natl Acad Sci U S A 103(1):123-8. PubMed: 16380418 MGI: J:104621
Teupser D; Weber O; Rao TN; Sass K; Thiery J; Fehling HJ. 2011. No reduction of atherosclerosis in C-reactive protein (CRP)-deficient mice. J Biol Chem 286(8):6272-9. PubMed: 21149301 MGI: J:170409
Teusink B; Mensenkamp AR; van der Boom H; Kuipers F; van Dijk KW; Havekes LM. 2001. Stimulation of the in vivo production of very low density lipoproteins by apolipoprotein E is independent of the presence of the low density lipoprotein receptor. J Biol Chem 276(44):40693-7. PubMed: 11546779 MGI: J:119460
Thatcher SE; Zhang X; Howatt DA; Lu H; Gurley SB; Daugherty A; Cassis LA. 2011. Angiotensin-converting enzyme 2 deficiency in whole body or bone marrow-derived cells increases atherosclerosis in low-density lipoprotein receptor-/- mice. Arterioscler Thromb Vasc Biol 31(4):758-65. PubMed: 21252069 MGI: J:184167
Thirumangalakudi L; Prakasam A; Zhang R; Bimonte-Nelson H; Sambamurti K; Kindy MS; Bhat NR. 2008. High cholesterol-induced neuroinflammation and amyloid precursor protein processing correlate with loss of working memory in mice. J Neurochem 106(1):475-85. PubMed: 18410513 MGI: J:137264
Thompson J; Wilson P; Brandewie K; Taneja D; Schaefer L; Mitchell B; Tannock LR. 2011. Renal accumulation of biglycan and lipid retention accelerates diabetic nephropathy. Am J Pathol 179(3):1179-87. PubMed: 21723246 MGI: J:176327
Thorp E; Li G; Seimon TA; Kuriakose G; Ron D; Tabas I. 2009. Reduced apoptosis and plaque necrosis in advanced atherosclerotic lesions of Apoe-/- and Ldlr-/- mice lacking CHOP. Cell Metab 9(5):474-81. PubMed: 19416717 MGI: J:148485
Tian J; Pei H; Sanders JM; Angle JF; Sarembock IJ; Matsumoto AH; Helm GA; Shi W. 2006. Hyperlipidemia is a major determinant of neointimal formation in LDL receptor-deficient mice. Biochem Biophys Res Commun 345(3):1004-9. PubMed: 16712797 MGI: J:109645
Tiebel O; Oka K; Robinson K; Sullivan M; Martinez J; Nakamuta M; Ishimura-Oka K; Chan L. 1999. Mouse very low-density lipoprotein receptor (VLDLR): gene structure, tissue-specific expression and dietary and developmental regulation. Atherosclerosis 145(2):239-51. PubMed: 10488949 MGI: J:59491
Tietge UJ; Pratico D; Ding T; Funk CD; Hildebrand RB; Van Berkel T; Van Eck M. 2005. Macrophage-specific expression of group IIA sPLA2 results in accelerated atherogenesis by increasing oxidative stress. J Lipid Res 46(8):1604-14. PubMed: 15897607 MGI: J:100744
Tilley RE; Pedersen B; Pawlinski R; Sato Y; Erlich JH; Shen Y; Day S; Huang Y; Eitzman DT; Boisvert WA; Curtiss LK; Fay WP; Mackman N. 2006. Atherosclerosis in mice is not affected by a reduction in tissue factor expression. Arterioscler Thromb Vasc Biol 26(3):555-62. PubMed: 16385085 MGI: J:127980
Tokuno S; Hinokiyama K; Tokuno K; Lowbeer C; Hansson LO; Valen G. 2002. Spontaneous ischemic events in the brain and heart adapt the hearts of severely atherosclerotic mice to ischemia. Arterioscler Thromb Vasc Biol 22(6):995-1001. PubMed: 12067910 MGI: J:102937
Towler DA; Bidder M; Latifi T; Coleman T; Semenkovich CF. 1998. Diet-induced diabetes activates an osteogenic gene regulatory program in the aortas of low density lipoprotein receptor-deficient mice. J Biol Chem 273(46):30427-34. PubMed: 9804809 MGI: J:50962
Tozawa R; Ishibashi S; Osuga J; Yagyu H; Oka T; Chen Z; Ohashi K; Perrey S; Shionoiri F; Yahagi N; Harada K; Gotoda T; Yazaki Y; Yamada N. 1999. Embryonic lethality and defective neural tube closure in mice lacking squalene synthase. J Biol Chem 274(43):30843-8. PubMed: 10521476 MGI: J:58231
Truong TQ; Auger A; Denizeau F; Brissette L. 2000. Analysis of low-density lipoprotein catabolism by primary cultures of hepatic cells from normal and low-density lipoprotein receptor knockout mice. Biochim Biophys Acta 1484(2-3):307-15. PubMed: 10760479 MGI: J:61821
Tsai SH; Huang PH; Peng YJ; Chang WC; Tsai HY; Leu HB; Chen JW; Lin SJ. 2013. Zoledronate attenuates angiotensin II-induced abdominal aortic aneurysm through inactivation of Rho/ROCK-dependent JNK and NF-kappaB pathway. Cardiovasc Res 100(3):501-10. PubMed: 24225494 MGI: J:219537
Tsuchiya K; Westerterp M; Murphy AJ; Subramanian V; Ferrante AW Jr; Tall AR; Accili D. 2013. Expanded granulocyte/monocyte compartment in myeloid-specific triple FoxO knockout increases oxidative stress and accelerates atherosclerosis in mice. Circ Res 112(7):992-1003. PubMed: 23420833 MGI: J:213325
Tu P; Bhasin S; Hruz PW; Herbst KL; Castellani LW; Hua N; Hamilton JA; Guo W. 2009. Genetic disruption of myostatin reduces the development of proatherogenic dyslipidemia and atherogenic lesions in Ldlr null mice. Diabetes 58(8):1739-48. PubMed: 19509018 MGI: J:154414
Twisk J; Gillian-Daniel DL; Tebon A; Wang L; Barrett PH; Attie AD. 2000. The role of the LDL receptor in apolipoprotein B secretion. J Clin Invest 105(4):521-32. PubMed: 10683382 MGI: J:60664
Uchida HA; Poduri A; Subramanian V; Cassis LA; Daugherty A. 2011. Urokinase-type plasminogen activator deficiency in bone marrow-derived cells augments rupture of angiotensin II-induced abdominal aortic aneurysms. Arterioscler Thromb Vasc Biol 31(12):2845-52. PubMed: 21868698 MGI: J:191466
Umans L; Overbergh L; Serneels L; Tesseur I; Van Leuven F. 1999. Analysis of expression of genes involved in apolipoprotein E-based lipoprotein metabolism in pregnant mice deficient in the receptor-associated protein, the low density lipoprotein receptor, or apolipoprotein E. Biol Reprod 61(5):1216-25. PubMed: 10529267 MGI: J:107547
Umemoto T; Han CY; Mitra P; Averill MM; Tang C; Goodspeed L; Omer M; Subramanian S; Wang S; Den Hartigh LJ; Wei H; Kim EJ; Kim J; O'Brien KD; Chait A. 2013. Apolipoprotein AI and high-density lipoprotein have anti-inflammatory effects on adipocytes via cholesterol transporters: ATP-binding cassette A-1, ATP-binding cassette G-1, and scavenger receptor B-1. Circ Res 112(10):1345-54. PubMed: 23501697 MGI: J:213314
Vaillant F; Lauzier B; Ruiz M; Shi Y; Lachance D; Rivard ME; Bolduc V; Thorin E; Tardif JC; Des Rosiers C. 2016. Ivabradine and metoprolol differentially affect cardiac glucose metabolism despite similar heart rate reduction in a mouse model of dyslipidemia. Am J Physiol Heart Circ Physiol 311(4):H991-H1003. PubMed: 27496881 MGI: J:236619
Valenta DT; Bulgrien JJ; Bonnet DJ; Curtiss LK. 2008. Macrophage PLTP is atheroprotective in LDLr-deficient mice with systemic PLTP deficiency. J Lipid Res 49(1):24-32. PubMed: 17928634 MGI: J:130081
Van Eck M; Bos IS; Hildebrand RB; Van Rij BT; Van Berkel TJ. 2004. Dual role for scavenger receptor class B, type I on bone marrow-derived cells in atherosclerotic lesion development. Am J Pathol 165(3):785-94. PubMed: 15331403 MGI: J:92320
Van Eck M; Ye D; Hildebrand RB; Kar Kruijt J; de Haan W; Hoekstra M; Rensen PC; Ehnholm C; Jauhiainen M; Van Berkel TJ. 2007. Important role for bone marrow-derived cholesteryl ester transfer protein in lipoprotein cholesterol redistribution and atherosclerotic lesion development in LDL receptor knockout mice. Circ Res 100(5):678-85. PubMed: 17293475 MGI: J:133704
Van den Bergh A; Vanderper A; Vangheluwe P; Desjardins F; Nevelsteen I; Verreth W; Wuytack F; Holvoet P; Flameng W; Balligand JL; Herijgers P. 2008. Dyslipidaemia in type II diabetic mice does not aggravate contractile impairment but increases ventricular stiffness. Cardiovasc Res 77(2):371-9. PubMed: 18006491 MGI: J:161915
VanderLaan PA; Reardon CA; Thisted RA; Getz GS. 2009. VLDL best predicts aortic root atherosclerosis in LDL receptor deficient mice. J Lipid Res 50(3):376-85. PubMed: 18957695 MGI: J:149089
Varadhachary AS; Monestier M; Salgame P. 2001. Reciprocal induction of IL-10 and IL-12 from macrophages by low-density lipoprotein and its oxidized forms. Cell Immunol 213(1):45-51. PubMed: 11747355 MGI: J:115363
Vasandani C; Kafrouni AI; Caronna A; Bashmakov Y; Gotthardt M; Horton JD; Spady DK. 2002. Upregulation of hepatic LDL transport by n-3 fatty acids in LDL receptor knockout mice. J Lipid Res 43(5):772-84. PubMed: 11971949 MGI: J:124748
Veniant MM; Sullivan MA; Kim SK; Ambroziak P; Chu A; Wilson MD; Hellerstein MK; Rudel LL; Walzem RL; Young SG. 2000. Defining the atherogenicity of large and small lipoproteins containing apolipoprotein B100 J Clin Invest 106(12):1501-10. PubMed: 11120757 MGI: J:66424
Veniant MM; Zlot CH; Walzem RL; Pierotti V; Driscoll R; Dichek D ; Herz J ; Young SG. 1998. Lipoprotein clearance mechanisms in LDL receptor-deficient Apo-B48-only and Apo-B100-only mice. J Clin Invest 102(8):1559-68. PubMed: 9788969 MGI: J:51022
Verreth W; De Keyzer D; Pelat M; Verhamme P; Ganame J; Bielicki JK; Mertens A; Quarck R; Benhabiles N; Marguerie G; Mackness B; Mackness M; Ninio E; Herregods MC; Balligand JL; Holvoet P. 2004. Weight-loss-associated induction of peroxisome proliferator-activated receptor-alpha and peroxisome proliferator-activated receptor-gamma correlate with reduced atherosclerosis and improved cardiovascular function in obese insulin-resistant mice. Circulation 110(20):3259-69. PubMed: 15533870 MGI: J:234613
Verschuren L; Kooistra T; Bernhagen J; Voshol PJ; Ouwens DM; van Erk M; de Vries-van der Weij J; Leng L; van Bockel JH; van Dijk KW; Fingerle-Rowson G; Bucala R; Kleemann R. 2009. MIF deficiency reduces chronic inflammation in white adipose tissue and impairs the development of insulin resistance, glucose intolerance, and associated atherosclerotic disease. Circ Res 105(1):99-107. PubMed: 19478200 MGI: J:164757
Vikramadithyan RK; Hu Y; Noh HL; Liang CP; Hallam K; Tall AR; Ramasamy R; Goldberg IJ. 2005. Human aldose reductase expression accelerates diabetic atherosclerosis in transgenic mice. J Clin Invest 115(9):2434-43. PubMed: 16127462 MGI: J:100916
Vikramadithyan RK; Kako Y; Chen G; Hu Y; Arikawa-Hirasawa E; Yamada Y; Goldberg IJ. 2004. Atherosclerosis in perlecan heterozygous mice. J Lipid Res 45(10):1806-12. PubMed: 15258195 MGI: J:93619
Vikstedt R; Ye D; Metso J; Hildebrand RB; Van Berkel TJ; Ehnholm C; Jauhiainen M; Van Eck M. 2007. Macrophage phospholipid transfer protein contributes significantly to total plasma phospholipid transfer activity and its deficiency leads to diminished atherosclerotic lesion development. Arterioscler Thromb Vasc Biol 27(3):578-86. PubMed: 17170377 MGI: J:148673
Von Der Thusen JH; Kuiper J; Fekkes ML; De Vos P; Van Berkel TJ; Biessen EA. 2001. Attenuation of atherogenesis by systemic and local adenovirus-mediated gene transfer of interleukin-10 in LDLr-/- mice. FASEB J 15(14):2730-2. PubMed: 11687507 MGI: J:73161
Voorend M; van der Ven AJ; Mulder M; Lodder J; Steinbusch HW; Bruggeman CA. 2010. Chlamydia pneumoniae infection enhances microglial activation in atherosclerotic mice. Neurobiol Aging 31(10):1766-73. PubMed: 19027992 MGI: J:165244
Vuorio T; Nurmi H; Moulton K; Kurkipuro J; Robciuc MR; Ohman M; Heinonen SE; Samaranayake H; Heikura T; Alitalo K; Yla-Herttuala S. 2014. Lymphatic vessel insufficiency in hypercholesterolemic mice alters lipoprotein levels and promotes atherogenesis. Arterioscler Thromb Vasc Biol 34(6):1162-70. PubMed: 24723556 MGI: J:222899
Wang J; Sjoberg S; Tang TT; Oorni K; Wu W; Liu C; Secco B; Tia V; Sukhova GK; Fernandes C; Lesner A; Kovanen PT; Libby P; Cheng X; Shi GP. 2014. Cathepsin G activity lowers plasma LDL and reduces atherosclerosis. Biochim Biophys Acta 1842(11):2174-83. PubMed: 25092171 MGI: J:218470
Wang M; Gao M; Liao J; Han Y; Wang Y; Liu G. 2015. Dysfunction of lipid metabolism in lipodystrophic Seipin-deficient mice. Biochem Biophys Res Commun 461(2):206-10. PubMed: 25866184 MGI: J:228386
Wang M; Lee E; Song W; Ricciotti E; Rader DJ; Lawson JA; Pure E; FitzGerald GA. 2008. Microsomal prostaglandin E synthase-1 deletion suppresses oxidative stress and angiotensin II-induced abdominal aortic aneurysm formation. Circulation 117(10):1302-9. PubMed: 18285567 MGI: J:148450
Wang M; Zukas AM; Hui Y; Ricciotti E; Pure E; FitzGerald GA. 2006. Deletion of microsomal prostaglandin E synthase-1 augments prostacyclin and retards atherogenesis. Proc Natl Acad Sci U S A 103(39):14507-12. PubMed: 16973753 MGI: J:114545
Wang MD; Kiss RS; Franklin V; McBride HM; Whitman SC; Marcel YL. 2007. Different cellular traffic of LDL-cholesterol and acetylated LDL-cholesterol leads to distinct reverse cholesterol transport pathways. J Lipid Res 48(3):633-45. PubMed: 17148552 MGI: J:120283
Wang S; Zhang M; Liang B; Xu J; Xie Z; Liu C; Viollet B; Yan D; Zou MH. 2010. AMPKalpha2 deletion causes aberrant expression and activation of NAD(P)H oxidase and consequent endothelial dysfunction in vivo: role of 26S proteasomes. Circ Res 106(6):1117-28. PubMed: 20167927 MGI: J:171036
Wang W; Vootukuri S; Meyer A; Ahamed J; Coller BS. 2014. Association between shear stress and platelet-derived transforming growth factor-beta1 release and activation in animal models of aortic valve stenosis. Arterioscler Thromb Vasc Biol 34(9):1924-32. PubMed: 24903096 MGI: J:227102
Wang Y; Gusarova V; Banfi S; Gromada J; Cohen JC; Hobbs HH. 2015. Inactivation of ANGPTL3 reduces hepatic VLDL-triglyceride secretion. J Lipid Res 56(7):1296-307. PubMed: 25954050 MGI: J:224940
Wang Y; Wang GZ; Rabinovitch PS; Tabas I. 2014. Macrophage mitochondrial oxidative stress promotes atherosclerosis and nuclear factor-kappaB-mediated inflammation in macrophages. Circ Res 114(3):421-33. PubMed: 24297735 MGI: J:223619
Wang Z; Nicholls SJ; Rodriguez ER; Kummu O; Horkko S; Barnard J; Reynolds WF; Topol EJ; DiDonato JA; Hazen SL. 2007. Protein carbamylation links inflammation, smoking, uremia and atherogenesis. Nat Med 13(10):1176-84. PubMed: 17828273 MGI: J:129923
Wang ZH; Shang YY; Zhang S; Zhong M; Wang XP; Deng JT; Pan J; Zhang Y; Zhang W. 2012. Silence of TRIB3 suppresses atherosclerosis and stabilizes plaques in diabetic ApoE-/-/LDL receptor-/- mice. Diabetes 61(2):463-73. PubMed: 22275087 MGI: J:196759
Wanschel A; Seibert T; Hewing B; Ramkhelawon B; Ray TD; van Gils JM; Rayner KJ; Feig JE; O'Brien ER; Fisher EA; Moore KJ. 2013. Neuroimmune guidance cue Semaphorin 3E is expressed in atherosclerotic plaques and regulates macrophage retention. Arterioscler Thromb Vasc Biol 33(5):886-93. PubMed: 23430613 MGI: J:217969
Webb NR; Bostrom MA; Szilvassy SJ; van der Westhuyzen DR; Daugherty A; de Beer FC. 2003. Macrophage-expressed group IIA secretory phospholipase A2 increases atherosclerotic lesion formation in LDL receptor-deficient mice. Arterioscler Thromb Vasc Biol 23(2):263-8. PubMed: 12588769 MGI: J:127990
Weber C; Meiler S; Doring Y; Koch M; Drechsler M; Megens RT; Rowinska Z; Bidzhekov K; Fecher C; Ribechini E; van Zandvoort MA; Binder CJ; Jelinek I; Hristov M; Boon L; Jung S; Korn T; Lutz MB; Forster I; Zenke M; Hieronymus T; Junt T; Zernecke A. 2011. CCL17-expressing dendritic cells drive atherosclerosis by restraining regulatory T cell homeostasis in mice. J Clin Invest 121(7):2898-910. PubMed: 21633167 MGI: J:175665
Wei S; Wang H; Zhang G; Lu Y; An X; Ren S; Wang Y; Chen Y; White JG; Zhang C; Simon DI; Wu C; Li Z; Huo Y. 2013. Platelet IkappaB kinase-beta deficiency increases mouse arterial neointima formation via delayed glycoprotein Ibalpha shedding. Arterioscler Thromb Vasc Biol 33(2):241-8. PubMed: 23241410 MGI: J:216903
Weng S; Sprague JE; Oh J; Riek AE; Chin K; Garcia M; Bernal-Mizrachi C. 2013. Vitamin D deficiency induces high blood pressure and accelerates atherosclerosis in mice. PLoS One 8(1):e54625. PubMed: 23349943 MGI: J:195839
Weng S; Zemany L; Standley KN; Novack DV; La Regina M; Bernal-Mizrachi C; Coleman T; Semenkovich CF. 2003. Beta3 integrin deficiency promotes atherosclerosis and pulmonary inflammation in high-fat-fed, hyperlipidemic mice. Proc Natl Acad Sci U S A 100(11):6730-5. PubMed: 12746502 MGI: J:83615
Westerterp M; Koetsveld J; Yu S; Han S; Li R; Goldberg IJ; Welch CL; Tall AR. 2010. Increased atherosclerosis in mice with vascular ATP-binding cassette transporter G1 deficiency--brief report. Arterioscler Thromb Vasc Biol 30(11):2103-5. PubMed: 20705913 MGI: J:183210
Westerterp M; Murphy AJ; Wang M; Pagler TA; Vengrenyuk Y; Kappus MS; Gorman DJ; Nagareddy PR; Zhu X; Abramowicz S; Parks JS; Welch C; Fisher EA; Wang N; Yvan-Charvet L; Tall AR. 2013. Deficiency of ATP-binding cassette transporters A1 and G1 in macrophages increases inflammation and accelerates atherosclerosis in mice. Circ Res 112(11):1456-65. PubMed: 23572498 MGI: J:213300
Westmuckett AD; Moore KL. 2009. Lack of tyrosylprotein sulfotransferase activity in hematopoietic cells drastically attenuates atherosclerosis in Ldlr-/- mice. Arterioscler Thromb Vasc Biol 29(11):1730-6. PubMed: 19679829 MGI: J:167800
Whitman SC; Rateri DL; Szilvassy SJ; Cornicelli JA; Daugherty A. 2002. Macrophage-specific expression of class A scavenger receptors in LDL receptor(-/-) mice decreases atherosclerosis and changes spleen morphology. J Lipid Res 43(8):1201-8. PubMed: 12177164 MGI: J:78922
Wilck N; Fechner M; Dreger H; Hewing B; Arias A; Meiners S; Baumann G; Stangl V; Stangl K; Ludwig A. 2012. Attenuation of early atherogenesis in low-density lipoprotein receptor-deficient mice by proteasome inhibition. Arterioscler Thromb Vasc Biol 32(6):1418-26. PubMed: 22516063 MGI: J:197090
Wilhelm AJ; Zabalawi M; Grayson JM; Weant AE; Major AS; Owen J; Bharadwaj M; Walzem R; Chan L; Oka K; Thomas MJ; Sorci-Thomas MG. 2009. Apolipoprotein A-I and its role in lymphocyte cholesterol homeostasis and autoimmunity. Arterioscler Thromb Vasc Biol 29(6):843-9. PubMed: 19286630 MGI: J:162193
Wilhelm AJ; Zabalawi M; Owen JS; Shah D; Grayson JM; Major AS; Bhat S; Gibbs DP Jr; Thomas MJ; Sorci-Thomas MG. 2010. Apolipoprotein A-I modulates regulatory T cells in autoimmune LDLr-/-, ApoA-I-/- mice. J Biol Chem 285(46):36158-69. PubMed: 20833724 MGI: J:166862
Willecke F; Yuan C; Oka K; Chan L; Hu Y; Barnhart S; Bornfeldt KE; Goldberg IJ; Fisher EA. 2015. Effects of High Fat Feeding and Diabetes on Regression of Atherosclerosis Induced by Low-Density Lipoprotein Receptor Gene Therapy in LDL Receptor-Deficient Mice. PLoS One 10(6):e0128996. PubMed: 26046657 MGI: J:237713
Willnow TE; Armstrong SA; Hammer RE; Herz J. 1995. Functional expression of low density lipoprotein receptor-related protein is controlled by receptor-associated protein in vivo. Proc Natl Acad Sci U S A 92(10):4537-41. PubMed: 7538675 MGI: J:43736
Wilund KR; Yu L; Xu F; Hobbs HH; Cohen JC. 2004. High-level expression of ABCG5 and ABCG8 attenuates diet-induced hypercholesterolemia and atherosclerosis in Ldlr-/- mice. J Lipid Res 45(8):1429-36. PubMed: 15175362 MGI: J:91353
Witting PK; Pettersson K; Ostlund-Lindqvist AM; Westerlund C; Eriksson AW; Stocker R. 1999. Inhibition by a coantioxidant of aortic lipoprotein lipid peroxidation and atherosclerosis in apolipoprotein E and low density lipoprotein receptor gene double knockout mice. FASEB J 13(6):667-75. PubMed: 10094927 MGI: J:54037
Wolfrum C; Poy MN; Stoffel M. 2005. Apolipoprotein M is required for prebeta-HDL formation and cholesterol efflux to HDL and protects against atherosclerosis. Nat Med 11(4):418-22. PubMed: 15793583 MGI: J:97550
Wong CW; Burger F; Pelli G; Mach F; Kwak BR. 2003. Dual benefit of reduced Cx43 on atherosclerosis in LDL receptor-deficient mice. Cell Commun Adhes 10(4-6):395-400. PubMed: 14681047 MGI: J:103076
Wouters K; van Bilsen M; van Gorp PJ; Bieghs V; Lutjohann D; Kerksiek A; Staels B; Hofker MH; Shiri-Sverdlov R. 2010. Intrahepatic cholesterol influences progression, inhibition and reversal of non-alcoholic steatohepatitis in hyperlipidemic mice. FEBS Lett 584(5):1001-5. PubMed: 20114046 MGI: J:157585
Wu D; Yang H; Xiang W; Zhou L; Shi M; Julies G; Laplante JM; Ballard BR; Guo Z. 2005. Heterozygous mutation of ataxia-telangiectasia mutated gene aggravates hypercholesterolemia in apoE-deficient mice. J Lipid Res 46(7):1380-7. PubMed: 15863839 MGI: J:100500
Wu JE; Basso F; Shamburek RD; Amar MJ; Vaisman B; Szakacs G; Joyce C; Tansey T; Freeman L; Paigen BJ; Thomas F; Brewer HB Jr; Santamarina-Fojo S. 2004. Hepatic ABCG5 and ABCG8 overexpression increases hepatobiliary sterol transport but does not alter aortic atherosclerosis in transgenic mice. J Biol Chem 279(22):22913-25. PubMed: 15044450 MGI: J:90718
Wu L; Vikramadithyan R; Yu S; Pau C; Hu Y; Goldberg IJ; Dansky HM. 2006. Addition of dietary fat to cholesterol in the diets of LDL receptor knockout mice: effects on plasma insulin, lipoproteins, and atherosclerosis. J Lipid Res 47(10):2215-22. PubMed: 16840797 MGI: J:116491
Xanthoulea S; Thelen M; Pottgens C; Gijbels MJ; Lutgens E; de Winther MP. 2009. Absence of p55 TNF receptor reduces atherosclerosis, but has no major effect on angiotensin II induced aneurysms in LDL receptor deficient mice. PLoS One 4(7):e6113. PubMed: 19582157 MGI: J:151487
Xia M; Chen D; Endresz V; Faludi I; Szabo A; Gonczol E; Kakkar V; Lu X. 2013. Immunization of Chlamydia pneumoniae (Cpn)-infected Apob(tm2Sgy)Ldlr(tm1Her)/J mice with a combined peptide of Cpn significantly reduces atherosclerotic lesion development. PLoS One 8(12):e81056. PubMed: 24349031 MGI: J:211155
Xia M; Chen D; Endresz V; Lantos I; Szabo A; Kakkar V; Lu X. 2015. Modulation of recombinant antigenic constructs containing multi-epitopes towards effective reduction of atherosclerotic lesion in B6;129S-Ldlr(tm1Her)Apob(tm2Sgy)/J mice. PLoS One 10(4):e0123393. PubMed: 25830298 MGI: J:233433
Xie C; Burns DK; Turley SD; Dietschy JM. 2000. Cholesterol is sequestered in the brains of mice with Niemann-Pick type C disease but turnover is increased. J Neuropathol Exp Neurol 59(12):1106-17. PubMed: 11138930 MGI: J:104996
Xie C; Richardson JA; Turley SD; Dietschy JM. 2006. Cholesterol substrate pools and steroid hormone levels are normal in the face of mutational inactivation of NPC1 protein. J Lipid Res 47(5):953-63. PubMed: 16461760 MGI: J:109000
Xie C; Turley SD; Dietschy JM. 2000. Centripetal cholesterol flow from the extrahepatic organs through the liver is normal in mice with mutated niemann-pick type C protein (NPC1) J Lipid Res 41(8):1278-89. PubMed: 10946016 MGI: J:64028
Xie C; Turley SD; Dietschy JM. 1999. Cholesterol accumulation in tissues of the Niemann-pick type C mouse is determined by the rate of lipoprotein-cholesterol uptake through the coated-pit pathway in each organ. Proc Natl Acad Sci U S A 96(21):11992-7. PubMed: 10518564 MGI: J:76735
Xu J; Wang S; Zhang M; Wang Q; Asfa S; Zou MH. 2012. Tyrosine nitration of PA700 links proteasome activation to endothelial dysfunction in mouse models with cardiovascular risk factors. PLoS One 7(1):e29649. PubMed: 22272240 MGI: J:224068
Xu L; Dai Perrard X; Perrard JL; Yang D; Xiao X; Teng BB; Simon SI; Ballantyne CM; Wu H. 2015. Foamy monocytes form early and contribute to nascent atherosclerosis in mice with hypercholesterolemia. Arterioscler Thromb Vasc Biol 35(8):1787-97. PubMed: 26112011 MGI: J:241910
Xu Y; Arai H; Murayama T; Kita T; Yokode M. 2007. Hypercholesterolemia contributes to the development of atherosclerosis and vascular remodeling by recruiting bone marrow-derived cells in cuff-induced vascular injury. Biochem Biophys Res Commun 363(3):782-7. PubMed: 17897625 MGI: J:127338
Xu Y; Zalzala M; Xu J; Li Y; Yin L; Zhang Y. 2015. A metabolic stress-inducible miR-34a-HNF4alpha pathway regulates lipid and lipoprotein metabolism. Nat Commun 6:7466. PubMed: 26100857 MGI: J:223016
Xue S; Wang J; Zhang X; Shi Y; Li B; Bao Q; Pang W; Ai D; Zhu Y; He J. 2016. Endothelial ATP-binding cassette G1 in mouse endothelium protects against hemodynamic-induced atherosclerosis. Biochem Biophys Res Commun 477(2):247-54. PubMed: 27297110 MGI: J:236494
Yagyu H; Kitamine T; Osuga J; Tozawa R; Chen Z; Kaji Y; Oka T; Perrey S; Tamura Y; Ohashi K; Okazaki H; Yahagi N; Shionoiri F; Iizuka Y; Harada K; Shimano H; Yamashita H; Gotoda T; Yamada N; Ishibashi S. 2000. Absence of ACAT-1 attenuates atherosclerosis but causes dry eye and cutaneous xanthomatosis in mice with congenital hyperlipidemia. J Biol Chem 275(28):21324-30. PubMed: 10777503 MGI: J:63468
Yan D; Jauhiainen M; Hildebrand RB; Willems van Dijk K; Van Berkel TJ; Ehnholm C; Van Eck M; Olkkonen VM. 2007. Expression of human OSBP-related protein 1L in macrophages enhances atherosclerotic lesion development in LDL receptor-deficient mice. Arterioscler Thromb Vasc Biol 27(7):1618-24. PubMed: 17478758 MGI: J:134908
Yan D; Navab M; Bruce C; Fogelman AM; Jiang XC. 2004. PLTP deficiency improves the anti-inflammatory properties of HDL and reduces the ability of LDL to induce monocyte chemotactic activity. J Lipid Res 45(10):1852-8. PubMed: 15258196 MGI: J:93620
Yancey PG; Ding Y; Fan D; Blakemore JL; Zhang Y; Ding L; Zhang J; Linton MF; Fazio S. 2011. Low-density lipoprotein receptor-related protein 1 prevents early atherosclerosis by limiting lesional apoptosis and inflammatory Ly-6Chigh monocytosis: evidence that the effects are not apolipoprotein E dependent. Circulation 124(4):454-64. PubMed: 21730304 MGI: J:186294
Yang X; Peterson L; Thieringer R; Deignan JL; Wang X; Zhu J; Wang S; Zhong H; Stepaniants S; Beaulaurier J; Wang IM; Rosa R; Cumiskey AM; Luo JM; Luo Q; Shah K; Xiao J; Nickle D; Plump A; Schadt EE; Lusis AJ; Lum PY. 2010. Identification and validation of genes affecting aortic lesions in mice. J Clin Invest 120(7):2414-22. PubMed: 20577049 MGI: J:163781
Ye D; Meurs I; Ohigashi M; Calpe-Berdiel L; Habets KL; Zhao Y; Kubo Y; Yamaguchi A; Van Berkel TJ; Nishi T; Van Eck M. 2010. Macrophage ABCA5 deficiency influences cellular cholesterol efflux and increases susceptibility to atherosclerosis in female LDLr knockout mice. Biochem Biophys Res Commun 395(3):387-94. PubMed: 20382126 MGI: J:160341
Ye D; Zhao Y; Hildebrand RB; Singaraja RR; Hayden MR; Van Berkel TJ; Van Eck M. 2011. The dynamics of macrophage infiltration into the arterial wall during atherosclerotic lesion development in low-density lipoprotein receptor knockout mice. Am J Pathol 178(1):413-22. PubMed: 21224078 MGI: J:168077
Yen FT; Roitel O; Bonnard L; Notet V; Pratte D; Stenger C; Magueur E; Bihain BE. 2008. Lipolysis stimulated lipoprotein receptor: a novel molecular link between hyperlipidemia, weight gain, and atherosclerosis in mice. J Biol Chem 283(37):25650-9. PubMed: 18644789 MGI: J:142162
Yokoyama M; Seo T; Park T; Yagyu H; Hu Y; Son NH; Augustus AS; Vikramadithyan RK; Ramakrishnan R; Pulawa LK; Eckel RH; Goldberg IJ. 2007. Effects of lipoprotein lipase and statins on cholesterol uptake into heart and skeletal muscle. J Lipid Res 48(3):646-55. PubMed: 17189607 MGI: J:120271
Yoon J; Subramanian S; Ding Y; Wang S; Goodspeed L; Sullivan B; Kim J; O'Brien KD; Chait A. 2011. Chronic insulin therapy reduces adipose tissue macrophage content in LDL-receptor-deficient mice. Diabetologia :. PubMed: 21327868 MGI: J:169596
Yoshimatsu M; Terasaki Y; Sakashita N; Kiyota E; Sato H; van der Laan LJ; Takeya M. 2004. Induction of macrophage scavenger receptor MARCO in nonalcoholic steatohepatitis indicates possible involvement of endotoxin in its pathogenic process. Int J Exp Pathol 85(6):335-43. PubMed: 15566430 MGI: J:104609
Yu F; Du F; Wang Y; Huang S; Miao R; Major AS; Murphy EA; Fu M; Fan D. 2013. Bone marrow deficiency of MCPIP1 results in severe multi-organ inflammation but diminishes atherogenesis in hyperlipidemic mice. PLoS One 8(11):e80089. PubMed: 24223214 MGI: J:209217
Yu KC; Chen W; Cooper AD. 2001. LDL receptor-related protein mediates cell-surface clustering and hepatic sequestration of chylomicron remnants in LDLR-deficient mice. J Clin Invest 107(11):1387-94. PubMed: 11390420 MGI: J:69912
Yu KC; Jiang Y; Chen W; Cooper AD. 2000. Rapid initial removal of chylomicron remnants by the mouse liver does not require hepatically localized apolipoprotein E J Lipid Res 41(11):1715-27. PubMed: 11060341 MGI: J:65695
Yu Y; Lucitt MB; Stubbe J; Cheng Y; Friis UG; Hansen PB; Jensen BL; Smyth EM; FitzGerald GA. 2009. Prostaglandin F2alpha elevates blood pressure and promotes atherosclerosis. Proc Natl Acad Sci U S A 106(19):7985-90. PubMed: 19416858 MGI: J:148401
Yun TJ; Lee JS; Machmach K; Shim D; Choi J; Wi YJ; Jang HS; Jung IH; Kim K; Yoon WK; Miah MA; Li B; Chang J; Bego MG; Pham TN; Loschko J; Fritz JH; Krug AB; Lee SP; Keler T; Guimond JV; Haddad E; Cohen EA; Sirois MG; El-Hamamsy I; Colonna M; Oh GT; Choi JH; Cheong C. 2016. Indoleamine 2,3-Dioxygenase-Expressing Aortic Plasmacytoid Dendritic Cells Protect against Atherosclerosis by Induction of Regulatory T Cells. Cell Metab 23(5):852-66. PubMed: 27166946 MGI: J:235369
Yvan-Charvet L; Pagler T; Gautier EL; Avagyan S; Siry RL; Han S; Welch CL; Wang N; Randolph GJ; Snoeck HW; Tall AR. 2010. ATP-binding cassette transporters and HDL suppress hematopoietic stem cell proliferation. Science 328(5986):1689-93. PubMed: 20488992 MGI: J:161310
Yvan-Charvet L; Ranalletta M; Wang N; Han S; Terasaka N; Li R; Welch C; Tall AR. 2007. Combined deficiency of ABCA1 and ABCG1 promotes foam cell accumulation and accelerates atherosclerosis in mice. J Clin Invest 117(12):3900-8. PubMed: 17992262 MGI: J:130777
Zabalawi M; Bharadwaj M; Horton H; Cline M; Willingham M; Thomas MJ; Sorci-Thomas MG. 2007. Inflammation and skin cholesterol in LDLr-/-, apoA-I-/- mice: link between cholesterol homeostasis and self-tolerance? J Lipid Res 48(1):52-65. PubMed: 17071966 MGI: J:117480
Zabalawi M; Bhat S; Loughlin T; Thomas MJ; Alexander E; Cline M; Bullock B; Willingham M; Sorci-Thomas MG. 2003. Induction of fatal inflammation in LDL receptor and ApoA-I double-knockout mice fed dietary fat and cholesterol. Am J Pathol 163(3):1201-13. PubMed: 12937162 MGI: J:85174
Zaid A; Roubtsova A; Essalmani R; Marcinkiewicz J; Chamberland A; Hamelin J; Tremblay M; Jacques H; Jin W; Davignon J; Seidah NG; Prat A. 2008. Proprotein convertase subtilisin/kexin type 9 (PCSK9): hepatocyte-specific low-density lipoprotein receptor degradation and critical role in mouse liver regeneration. Hepatology 48(2):646-54. PubMed: 18666258 MGI: J:169834
Zernecke A; Bot I; Djalali-Talab Y; Shagdarsuren E; Bidzhekov K; Meiler S; Krohn R; Schober A; Sperandio M; Soehnlein O; Bornemann J; Tacke F; Biessen EA; Weber C. 2008. Protective role of CXC receptor 4/CXC ligand 12 unveils the importance of neutrophils in atherosclerosis. Circ Res 102(2):209-17. PubMed: 17991882 MGI: J:145593
Zhang C; An J; Strickland DK; Yepes M. 2009. The low-density lipoprotein receptor-related protein 1 mediates tissue-type plasminogen activator-induced microglial activation in the ischemic brain. Am J Pathol 174(2):586-94. PubMed: 19147818 MGI: J:144185
Zhang D; Fang P; Jiang X; Nelson J; Moore JK; Kruger WD; Berretta RM; Houser SR; Yang X; Wang H. 2012. Severe hyperhomocysteinemia promotes bone marrow-derived and resident inflammatory monocyte differentiation and atherosclerosis in LDLr/CBS-deficient mice. Circ Res 111(1):37-49. PubMed: 22628578 MGI: J:212656
Zhang WJ; Bird KE; McMillen TS; LeBoeuf RC; Hagen TM; Frei B. 2008. Dietary alpha-lipoic acid supplementation inhibits atherosclerotic lesion development in apolipoprotein E-deficient and apolipoprotein E/low-density lipoprotein receptor-deficient mice. Circulation 117(3):421-8. PubMed: 18158360 MGI: J:145089
Zhang X; Thatcher SE; Rateri DL; Bruemmer D; Charnigo R; Daugherty A; Cassis LA. 2012. Transient exposure of neonatal female mice to testosterone abrogates the sexual dimorphism of abdominal aortic aneurysms. Circ Res 110(11):e73-85. PubMed: 22539767 MGI: J:212660
Zhang Y; Breevoort SR; Angdisen J; Fu M; Schmidt DR; Holmstrom SR; Kliewer SA; Mangelsdorf DJ; Schulman IG. 2012. Liver LXRalpha expression is crucial for whole body cholesterol homeostasis and reverse cholesterol transport in mice. J Clin Invest 122(5):1688-99. PubMed: 22484817 MGI: J:184536
Zhang Y; Wang X; Vales C; Lee FY; Lee H; Lusis AJ; Edwards PA. 2006. FXR deficiency causes reduced atherosclerosis in Ldlr-/- mice. Arterioscler Thromb Vasc Biol 26(10):2316-21. PubMed: 16825595 MGI: J:128055
Zhao B; Song J; Chow WN; St Clair RW; Rudel LL; Ghosh S. 2007. Macrophage-specific transgenic expression of cholesteryl ester hydrolase significantly reduces atherosclerosis and lesion necrosis in Ldlr mice. J Clin Invest 117(10):2983-92. PubMed: 17885686 MGI: J:127535
Zhao L; Cuff CA; Moss E; Wille U; Cyrus T; Klein EA; Pratico D; Rader DJ; Hunter CA; Pure E; Funk CD. 2002. Selective interleukin-12 synthesis defect in 12/15-lipoxygenase-deficient macrophages associated with reduced atherosclerosis in a mouse model of familial hypercholesterolemia. J Biol Chem 277(38):35350-6. PubMed: 12122008 MGI: J:79120
Zhao Y; Pennings M; Hildebrand RB; Ye D; Calpe-Berdiel L; Out R; Kjerrulf M; Hurt-Camejo E; Groen AK; Hoekstra M; Jessup W; Chimini G; Van Berkel TJ; Van Eck M. 2010. Enhanced foam cell formation, atherosclerotic lesion development, and inflammation by combined deletion of ABCA1 and SR-BI in Bone marrow-derived cells in LDL receptor knockout mice on western-type diet. Circ Res 107(12):e20-31. PubMed: 21071707 MGI: J:178508
Zhao Y; Su B; Jacobs RL; Kennedy B; Francis GA; Waddington E; Brosnan JT; Vance JE; Vance DE. 2009. Lack of phosphatidylethanolamine N-methyltransferase alters plasma VLDL phospholipids and attenuates atherosclerosis in mice. Arterioscler Thromb Vasc Biol 29(9):1349-55. PubMed: 19520976 MGI: J:167813
Zhao Y; Ye D; Wang J; Calpe-Berdiel L; Azzis SB; Van Berkel TJ; Van Eck M. 2011. Stage-specific remodeling of atherosclerotic lesions upon cholesterol lowering in LDL receptor knockout mice. Am J Pathol 179(3):1522-32. PubMed: 21741939 MGI: J:179953
Zhou C; Pridgen B; King N; Xu J; Breslow JL. 2011. Hyperglycemic Ins2AkitaLdlr-/- mice show severely elevated lipid levels and increased atherosclerosis: a model of type 1 diabetic macrovascular disease. J Lipid Res 52(8):1483-93. PubMed: 21606463 MGI: J:174983
Zhou L; Choi HY; Li WP; Xu F; Herz J. 2009. LRP1 controls cPLA2 phosphorylation, ABCA1 expression and cellular cholesterol export. PLoS One 4(8):e6853. PubMed: 19718435 MGI: J:152391
Zhou L; Takayama Y; Boucher P; Tallquist MD; Herz J. 2009. LRP1 regulates architecture of the vascular wall by controlling PDGFRbeta-dependent phosphatidylinositol 3-kinase activation. PLoS One 4(9):e6922. PubMed: 19742316 MGI: J:153626
Zhou L; Yang H; Lin X; Okoro EU; Guo Z. 2012. Cholecystokinin elevates mouse plasma lipids. PLoS One 7(12):e51011. PubMed: 23300532 MGI: J:195734
Zhou L; Yang H; Okoro EU; Guo Z. 2014. Up-regulation of cholesterol absorption is a mechanism for cholecystokinin-induced hypercholesterolemia. J Biol Chem 289(19):12989-99. PubMed: 24692543 MGI: J:214128
Zhou Q; Mei Y; Shoji T; Han X; Kaminski K; Oh GT; Ongusaha PP; Zhang K; Schmitt H; Moser M; Bode C; Liao JK. 2012. Rho-associated coiled-coil-containing kinase 2 deficiency in bone marrow-derived cells leads to increased cholesterol efflux and decreased atherosclerosis. Circulation 126(18):2236-47. PubMed: 23011471 MGI: J:210071
Zhou X; He W; Huang Z; Gotto AM Jr; Hajjar DP; Han J. 2008. Genetic deletion of low density lipoprotein receptor impairs sterol-induced mouse macrophage ABCA1 expression. A new SREBP1-dependent mechanism. J Biol Chem 283(4):2129-38. PubMed: 18029360 MGI: J:130725
Zhu L; Stalker TJ; Fong KP; Jiang H; Tran A; Crichton I; Lee EK; Neeves KB; Maloney SF; Kikutani H; Kumanogoh A; Pure E; Diamond SL; Brass LF. 2009. Disruption of SEMA4D ameliorates platelet hypersensitivity in dyslipidemia and confers protection against the development of atherosclerosis. Arterioscler Thromb Vasc Biol 29(7):1039-45. PubMed: 19390055 MGI: J:167817
Zhu SN; Chen M; Jongstra-Bilen J; Cybulsky MI. 2009. GM-CSF regulates intimal cell proliferation in nascent atherosclerotic lesions. J Exp Med 206(10):2141-9. PubMed: 19752185 MGI: J:153507
Zirlik A; Maier C; Gerdes N; MacFarlane L; Soosairajah J; Bavendiek U; Ahrens I; Ernst S; Bassler N; Missiou A; Patko Z; Aikawa M; Schonbeck U; Bode C; Libby P; Peter K. 2007. CD40 ligand mediates inflammation independently of CD40 by interaction with Mac-1. Circulation 115(12):1571-80. PubMed: 17372166 MGI: J:133045
Zotes TM; Arias CF; Fuster JJ; Spada R; Perez-Yague S; Hirsch E; Wymann M; Carrera AC; Andres V; Barber DF. 2013. PI3K p110gamma deletion attenuates murine atherosclerosis by reducing macrophage proliferation but not polarization or apoptosis in lesions. PLoS One 8(8):e72674. PubMed: 23991137 MGI: J:204917
de Claro RA; Zhu X; Tang J; Morgan-Stevenson V; Schwartz BR; Iwata A; Liles WC; Raines EW; Harlan JM. 2011. Hematopoietic Fas Deficiency Does Not Affect Experimental Atherosclerotic Lesion Formation despite Inducing a Proatherogenic State. Am J Pathol 178(6):2931-7. PubMed: 21550016 MGI: J:173162
de Haan W; Out R; Berbee JF; van der Hoogt CC; van Dijk KW; van Berkel TJ; Romijn JA; Jukema JW; Havekes LM; Rensen PC. 2008. Apolipoprotein CI inhibits scavenger receptor BI and increases plasma HDL levels in vivo. Biochem Biophys Res Commun 377(4):1294-8. PubMed: 18992221 MGI: J:143183
de Nooijer R; Bot I; von der Thusen JH; Leeuwenburgh MA; Overkleeft HS; Kraaijeveld AO; Dorland R; van Santbrink PJ; van Heiningen SH; Westra MM; Kovanen PT; Jukema JW; van der Wall EE; van Berkel TJ; Shi GP; Biessen EA. 2009. Leukocyte cathepsin S is a potent regulator of both cell and matrix turnover in advanced atherosclerosis. Arterioscler Thromb Vasc Biol 29(2):188-94. PubMed: 19095996 MGI: J:163799
de Oliveira J; Hort MA; Moreira EL; Glaser V; Ribeiro-do-Valle RM; Prediger RD; Farina M; Latini A; de Bem AF. 2011. Positive correlation between elevated plasma cholesterol levels and cognitive impairments in LDL receptor knockout mice: relevance of cortico-cerebral mitochondrial dysfunction and oxidative stress. Neuroscience 197:99-106. PubMed: 21945034 MGI: J:184047
de Souza JC; de Oliveira CA; Carneiro EM; Boschero AC; de Oliveira HC. 2010. Cholesterol toxicity in pancreatic islets from LDL receptor-deficient mice. Diabetologia 53(11):2461-2; author reply 2463-4. PubMed: 20694455 MGI: J:166652
van Dijk KW; van Vlijmen BJ; de Winther MP; van 't Hof B; van der Zee A; van der Boom H; Havekes LM; Hofker MH. 1999. Hyperlipidemia of ApoE2(Arg(158)-Cys) and ApoE3-Leiden transgenic mice is modulated predominantly by LDL receptor expression. Arterioscler Thromb Vasc Biol 19(12):2945-51. PubMed: 10591674 MGI: J:59826
van Eck M; Bos IS; Kaminski WE; Orso E; Rothe G; Twisk J; Bottcher A; Van Amersfoort ES; Christiansen-Weber TA; Fung-Leung WP; Van Berkel TJ; Schmitz G. 2002. Leukocyte ABCA1 controls susceptibility to atherosclerosis and macrophage recruitment into tissues. Proc Natl Acad Sci U S A 99(9):6298-303. PubMed: 11972062 MGI: J:76337
van Es T; van Puijvelde GH; Ramos OH; Segers FM; Joosten LA; van den Berg WB; Michon IM; de Vos P; van Berkel TJ; Kuiper J. 2009. Attenuated atherosclerosis upon IL-17R signaling disruption in LDLr deficient mice. Biochem Biophys Res Commun 388(2):261-5. PubMed: 19660432 MGI: J:152718
van Gils JM; Derby MC; Fernandes LR; Ramkhelawon B; Ray TD; Rayner KJ; Parathath S; Distel E; Feig JL; Alvarez-Leite JI; Rayner AJ; McDonald TO; O'Brien KD; Stuart LM; Fisher EA; Lacy-Hulbert A; Moore KJ. 2012. The neuroimmune guidance cue netrin-1 promotes atherosclerosis by inhibiting the emigration of macrophages from plaques. Nat Immunol 13(2):136-43. PubMed: 22231519 MGI: J:181210
van Gils JM; Ramkhelawon B; Fernandes L; Stewart MC; Guo L; Seibert T; Menezes GB; Cara DC; Chow C; Kinane TB; Fisher EA; Balcells M; Alvarez-Leite J; Lacy-Hulbert A; Moore KJ. 2013. Endothelial expression of guidance cues in vessel wall homeostasis dysregulation under proatherosclerotic conditions. Arterioscler Thromb Vasc Biol 33(5):911-9. PubMed: 23430612 MGI: J:218812
van Kampen E; Beaslas O; Hildebrand RB; Lammers B; Van Berkel TJ; Olkkonen VM; Van Eck M. 2014. Orp8 deficiency in bone marrow-derived cells reduces atherosclerotic lesion progression in LDL receptor knockout mice. PLoS One 9(10):e109024. PubMed: 25347070 MGI: J:223099
van Kampen E; Jaminon A; van Berkel TJ; Van Eck M. 2014. Diet-induced (epigenetic) changes in bone marrow augment atherosclerosis. J Leukoc Biol 96(5):833-41. PubMed: 25024399 MGI: J:220135
van Leeuwen M; Kemna MJ; de Winther MP; Boon L; Duijvestijn AM; Henatsch D; Bos NA; Gijbels MJ; Tervaert JW. 2013. Passive immunization with hypochlorite-oxLDL specific antibodies reduces plaque volume in LDL receptor-deficient mice. PLoS One 8(7):e68039. PubMed: 23874490 MGI: J:204410
van Puijvelde GH; Hauer AD; de Vos P; van den Heuvel R; van Herwijnen MJ; van der Zee R; van Eden W; van Berkel TJ; Kuiper J. 2006. Induction of oral tolerance to oxidized low-density lipoprotein ameliorates atherosclerosis. Circulation 114(18):1968-76. PubMed: 17060383 MGI: J:127201
van Stijn CM; Kim J; Barish GD; Tietge UJ; Tangirala RK. 2014. Adiponectin expression protects against angiotensin II-mediated inflammation and accelerated atherosclerosis. PLoS One 9(1):e86404. PubMed: 24466075 MGI: J:225166
van Vlijmen BJ; Rohlmann A; Page ST; Bensadoun A; Bos IS; van Berkel TJ; Havekes LM; Herz J. 1999. An extrahepatic receptor-associated protein-sensitive mechanism is involved in the metabolism of triglyceride-rich lipoproteins. J Biol Chem 274(49):35219-26. PubMed: 10575007 MGI: J:58704
van Vlijmen BJ; van Dijk KW; van't Hof HB; van Gorp PJ; van der Zee A; van der Boom H; Breuer ML; Hofker MH; Havekes LM. 1996. In the absence of endogenous mouse apolipoprotein E, apolipoprotein E*2(Arg-158 --> Cys) transgenic mice develop more severe hyperlipoproteinemia than apolipoprotein E*3-Leiden transgenic mice. J Biol Chem 271(48):30595-602. PubMed: 8940032 MGI: J:37473
van der Hoogt CC; Berbee JF; Espirito Santo SM; Gerritsen G; Krom YD; van der Zee A; Havekes LM; van Dijk KW; Rensen PC. 2006. Apolipoprotein CI causes hypertriglyceridemia independent of the very-low-density lipoprotein receptor and apolipoprotein CIII in mice. Biochim Biophys Acta 1761(2):213-20. PubMed: 16478678 MGI: J:110564

Also Known As: Ldlr KO

Donating Investigator

Genetic overview

Research Applications

Base Price

Detailed Description

Development

Control Suggestions

Additional Information

Selected References

Ldlrtm1Her

Allele Symbol: Ldlrtm1Her

Disease Terms

Research Areas By Genotype

This mouse can be used to support research in many areas including:

Genotype: Ldlrtm1Her related

Mammalian Phenotype Terms by Genotype

Genotype: Ldlrtm1Her/Ldlr+B6.129S7-Ldlrtm1Her

homeostasis/metabolism phenotype

Genotype: Ldlrtm1Her/Ldlrtm1HerB6.129S7-Ldlrtm1Her

homeostasis/metabolism phenotype

adipose tissue phenotype

growth/size/body region phenotype

cardiovascular system phenotype

immune system phenotype

liver/biliary system phenotype

behavior/neurological phenotype

nervous system phenotype

hematopoietic system phenotype

Genotype: Ldlrtm1Her/Ldlrtm1HerB6.129S7-Ldlrtm1Her/J

homeostasis/metabolism phenotype

liver/biliary system phenotype

endocrine/exocrine gland phenotype

cardiovascular system phenotype

integument phenotype

Genotype: Ldlrtm1Her/Ldlr+involves: 129S7/SvEvBrd * C57BL/6 * DBA/2

homeostasis/metabolism phenotype

Genotype: Ldlrtm1Her/Ldlrtm1Herinvolves: 129P2/OlaHsd * 129S7/SvEvBrd * C57BL/6 * DBA

homeostasis/metabolism phenotype

Genotype: Ldlrtm1Her/Ldlrtm1Herinvolves: 129S7/SvEvBrd

homeostasis/metabolism phenotype

cardiovascular system phenotype

Genotype: Ldlrtm1Her/Ldlrtm1Herinvolves: 129S6/SvEvTac * 129S7/SvEvBrd * C57BL/6

cardiovascular system phenotype

homeostasis/metabolism phenotype

Genotype: Ldlrtm1Her/Ldlrtm1Herinvolves: 129S7/SvEvBrd * C57BL/6J

cardiovascular system phenotype

homeostasis/metabolism phenotype

Genotype: Ldlrtm1Her/Ldlrtm1Herinvolves: 129S7/SvEvBrd * C57BL/6

growth/size/body region phenotype

pigmentation phenotype

cellular phenotype

liver/biliary system phenotype

homeostasis/metabolism phenotype

nervous system phenotype

cardiovascular system phenotype

behavior/neurological phenotype

vision/eye phenotype

hematopoietic system phenotype

immune system phenotype

Genotype: Ldlrtm1Her/Ldlrtm1Herinvolves: 129S7/SvEvBrd * C57BL/6 * SJL

homeostasis/metabolism phenotype

References

Additional References

Additional - Ldlrtm1Her related

Genotyping Protocols

Dietary Information

Breeding Considerations

Mating System

Appearance

Citation

Animal Health Reports

Live Mouse

Cryorecovery - Pricing

Progeny testing is not required

Payment Terms and Conditions

The Jackson Laboratory's Genotype Promise

Terms of Use

Licensing Information

JAX® Mice, Products & Services Conditions of Use

Ldlr^tm1Her

Allele Symbol: Ldlr^tm1Her

Genotype: Ldlr^tm1Her related

Genotype: Ldlr^tm1Her/Ldlr⁺
B6.129S7-Ldlr^tm1Her

Genotype: Ldlr^tm1Her/Ldlr^tm1Her
B6.129S7-Ldlr^tm1Her

Genotype: Ldlr^tm1Her/Ldlr^tm1Her
B6.129S7-Ldlr^tm1Her/J

Genotype: Ldlr^tm1Her/Ldlr⁺
involves: 129S7/SvEvBrd * C57BL/6 * DBA/2

Genotype: Ldlr^tm1Her/Ldlr^tm1Her
involves: 129P2/OlaHsd * 129S7/SvEvBrd * C57BL/6 * DBA

Genotype: Ldlr^tm1Her/Ldlr^tm1Her
involves: 129S7/SvEvBrd

Genotype: Ldlr^tm1Her/Ldlr^tm1Her
involves: 129S6/SvEvTac * 129S7/SvEvBrd * C57BL/6

Genotype: Ldlr^tm1Her/Ldlr^tm1Her
involves: 129S7/SvEvBrd * C57BL/6J

Genotype: Ldlr^tm1Her/Ldlr^tm1Her
involves: 129S7/SvEvBrd * C57BL/6

Genotype: Ldlr^tm1Her/Ldlr^tm1Her
involves: 129S7/SvEvBrd * C57BL/6 * SJL

Additional - Ldlr^tm1Her related